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Abstract
The project was designed to investigate a new class of unconjugated enediynes under transition
metal-catalysis conditions, as this was expected to provide direct access to aromatic bicyclic
products. Firstly, construction of the stereodefined (Z)-enynols was achieved using a multistep
procedure, starting from commercially available methyl propiolate. As part of this sequence,
(Z)-3-iodoacrylate was synthesized via a hydrohalogenation reaction by treating methyl
propiolate with NaI in acetic acid at 70 °C. This was then converted via a Sonogashira crosscoupling and reduction to a (Z)-enynol. The novel unconjugated enediyne substrates were
synthesized finally prepare from this (Z)-enynol, which upon treatment with NaH and
propargyl bromide successfully furnished the simple unconjugated O-tethered (Z)-enediynes.
Initially, this enediyne was reacted under Au(I)-catalyzed conditions to provide the
cycloaromatized product. Interestingly, at room temperature, this reaction underwent a single
cleavage mechanism providing the 5-membered intermediate. This intermediate undergoes
tandem cyclization via a second Au(I)-catalyst activation under thermal conditions to the
cycloaromatized isobenzofuran product. However, the substituted enediynes failed to undergo
cycloaromatization and the CH3-substituted enediyne provided an unstable 5-membered
intermediate and trace amounts of a 6-membered ring product. These unsuccessful cyclization
reactions of substituted enediynes could be a result of the steric hindrance to formation of the
fused cyclopropane Au-carbene intermediate leading to single cleavage rearrangement.
Therefore, attention was turned to investigate a Rh(I)-catalyzed oxidative cyclization
process. This process proved to be more general than the Au-catalyzed cycloisomerization. A
range of highly functionalized and variously tethered (NTs, O, and C(CO 2Me)2) enediynes
were synthesized and smoothly converted to the corresponding isoindoline, isobenzofuran and
indane products in good to excellent yields. The Rh(I)-catalyzed cycloaromatization reactions
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of unconjugated enediynes occurred at room temperature and this method also effectively
transformed terminal alkynes enediynes to isoindoline products, however, the dual Au(I)catalyzed cyclization reaction failed. Moreover, to understand this facile room temperature
tetradehydro-Diels-Alder (TDDA) reaction further, mechanistic investigations were performed
on the enediynes to provide support for a strained cyclic allene intermediate. This was further
supported by a computational analysis of the reaction mechanism.
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Chapter -1: Chemistry of enediynes and their cycloaromatization
reactions to construct polycyclic aromatic compounds
1. Enediynes:
The construction of aromatic and heteroaromatic molecules plays a key role in many branches
of synthetic chemistry due the broad importance of these structures in materials chemistry and
medicinal chemistry.1-3 However, methodologies to prepare aromatic systems by
cycloaromatization reactions of polyunsaturated molecules have been relatively underexplored
compared to direct functionalization of aromatic rings. Among the existing cycloaromatization
strategies, enediynes, dienynes, and enyne-allenes have been shown to be powerful precursors
for the synthesis of these aromatic molecules.4 Conjugated enediynes are also important parts
of natural products with antitumor and anticancer activity, where they undergo a Bergman
cycloaromatization as a part of their mechanism of action. Many groups have undertaken
substantial research efforts to synthesize these unique enediyne natural products and
understand their powerful antitumor activities, including their anticancer mechanism of action
within the cell.5 Curiously, unconjugated enediynes, while able to undergo intramolecular
cycloaromatization to fused aromatics, have not been explored in the same depth as the
conjugated systems. This introduction will discuss the cycloaromatization reactions of both
conjugated and unconjugated enediyne systems towards biologically important polycyclic
aromatic compounds with a focus on transition metal-catalyzed processes.

1.1 Conjugated-enediynes:

In this thesis, the general 1,5-diyne-3-ene structure 1 will be referred to here as simply a
conjugated enediyne. This skeletal structure contains one double bond at the C3 position and
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triple bonds at the C1 and C5 carbons (Figure 1.1a).6 These conjugated enediyne structures
show highly potent antibacterial and antitumor activities.7 Notably, dynemicin A,
calicheamicin, esperamicin A1, kedarcidin and neocarzinostatin are members of the naturally
occurring enediyne family of anticancer antibiotics.

For example, dynemicin A was first

isolated in Gujarat State, India from a soil sample of Micromonospora chersina [strain No.
M956-1]. This was a new member of the esperaicin/calicheamicin antibiotic family, having a
distinctly functionalized anthraquinone unit and a 1,5-diyne-3-ene moiety. It was found to
exhibit low toxicity and had promising in vivo antibacterial and anti-cancer activities (Figure
1.1 b).8
The mode of action for antitumor activity of dynemicin A is similar to that of the other
classes of calcheamicine/esperamicin and neocarzinostatin antibiotics. This mechanism was
potentially enhanced by the anthraquinone nucleus, which intercalates into DNA and then
undergoes bio-reduction, which leads to epoxide ring-opening (see 3 in Scheme 1.1). The
resulting conformational changes in the molecule makes a strained enediyne system
(intermediate 4 to 5), which undergoes Bergman cyclization to generate a reactive 1,4benzenoid diradical 6. This highly reactive species, abstracts a hydrogen atom from a sugar
molecule, generating the DNA-damaging diradical species, which then reacts with O2,
ultimately leading to double or single-stand DNA cleavage (Intermediate 6 to 7).7, 9 As well as
occurring in biologically active natural products, it should be noted that conjugated enediynes
are also very useful in polymer and material sciences.10 The different modes of
cycloaromatization of these systems as well as synthetic methods are now discussed.
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Figure-1.1: a) Structure of conjugated enediyne 1 and b) enediyne-containing Dynemicin A natural product

Scheme 1.1: Dynemicin A 2 DNA cleavage mechanism.

3

1.2 Cycloaromatization of conjugated enediynes:

In general, the activation of conjugated enediynes to undergo cycloaromatization can occur via
three different methods:
1) Thermal activation;
2) Photochemical activation; and
3) Transition metal-catalyzed activation.

1.2.1 Bergman cyclization (thermal activation):

Robert Bergman first reported the cycloaromatization of a conjugated enediyne in 1972.
In this report, the conjugated (Z)-1,5-diyne-3-ene 1 was treated under thermal conditions,
where the substrate was heated at 200 °C for 30 seconds in the presence hydrocarbon solvents
to successfully yield benzene 9 (X = H) (Scheme 1.2).11 A diradical mechanism was proposed
for this reaction, involving a highly reactive 1,4-benzenoid diradical 8, which abstracts Hatoms from the hydrocarbon solvent to give benzene 9 (X = H). Furthermore, experiments were
also conducted to support the formation of the proposed diradical intermediate, including
reaction in toluene which produced diphenylmethane, and in CCl4 which formed 1,4dichlorobenzene 9 (X = Cl).

Scheme 1.2: The Bergman thermal cycloaromatization of enediyne 1.
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1.2.2 Photochemical activation of enediynes:

The high temperatures required for the thermal activation of enediynes and their structural
importance in biological systems has prompted studies towards activation of enediynes to
cycloisomerization under milder reaction conditions. Towards this goal, several groups
investigated the development of photochemical activation of enediynes to facilitate formation
of the highly reactive biradical intermediate and then the final cycloaromatization products. 4
The first photochemical cyclization of conjugated enediynes was reported by Turro,
Evanzahav, and Nicolaou.12-13 This photochemical activation process was triggered when
enediyne 10 was irradiated with a light source, which produced the same aromatic structure 11
as formed in the thermal Bergman cyclization. The phenyl-substituted enediyne 10 (R = Ph)
was irradiated in a Rayonette photochemical reactor using wavelengths below 313 nm in the
presence of isopropanol as a hydrogen atom donor. This resulted in the formation of the
naphthalene derivative 11 and a mixture of the cis/trans reduction products 12 and 12′ (Scheme
1.3). After developing this enediyne photoactivation process, it became popularly known as
the photo-Bergman cycloaromatization.

Scheme 1.3: First photochemical activation of enediyne 10/photo-Bergman cycloaromatization
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In another study, Raymond and co-workers reported an interesting sunlight-induced photoBergman cyclization process. The strained ortho-dialkylpyrene 13 was synthesized and the
resulting substrate was exposed to sunlight in acetonitrile solution for 3 h, which provided a
quantitative yield of the benzpyrene 14 (Scheme 1.3a). Moreover, the application of this
protocol was further investigated by making the water-soluble ortho-dialkylpyrene 18 to test
its DNA photocleaving nature. Enediyne 15 was modified to dialkylarene 18 in a synthesis
starting by reacting it with the homochiral ditriflate 16 forming 17, which was then converted
to the water soluble enediyne 18. This was treated with supercoiled plasmid pUC19 DNA (38
µM in base pairs) and irradiated in a Pyrex instrument with a Hanova 450 W light. The
dialkylarene 18 resulted in single strand cleavage of the DNA (see Scheme 1.4). Interestingly,
the same substrate did not react in the absence of light.14-15
Despite these advances, the photo-Bergman process often results in low yields of
products, despite the milder conditions than the thermal process. The yields can also depend
on the electronic nature of the attached fused ring and the nature of the terminal alkyne
substitutions.
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1.2.3: Transition metal-catalyzed activation of enediyne cycloaromatization

The characteristic nature of conjugated enediyne 1, with its double bond and electron-rich triple
bonds represent useful coordinating sites for transition metal-catalyzed activation. Given this,
and the limitations of the thermal and photochemical activation of enediynes, several research
groups have exploited transition metal-activation under mild reaction conditions to provide
structurally varied aromatic products. For example, Uemura and co-workers reported the first
Rh(I)-catalyzed activation of the acyclic (Z)-3-dodecene-1,5-diyne 21a. The optimized
reaction conditions utilized RhCl(iPr3P)2 as catalyst in a triethylamine/benzene solvent system,
which provided cycloaromatized 27a in 58% isolated yield (Scheme 1.5).16 The reaction
tolerated a range of alkyne substituents (21a to 21e) and all reactions occurred smoothly to
provide the cycloaromatization products (27a to 27e) in yields up to 68%.

Scheme 1.5: Rh(I)-catalyzed activation of conjugated enediynes 21a-e.
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The proposed reaction mechanism shows an interesting catalytic cycle, where the Rh(I)catalyst coordinates to one of the alkyne terminal carbon to form the vinylidene-rhodium
complex [RCH=C=Rh] 22. This intermediate undergoes cyclization to the 1,4-diradical 23,
which is akin to a Myers reaction;17 then upon an intramolecular 1,5-hydride shift from the
alkyl chain the intermediate 24 is formed. This intermediate undergoes diradical coupling to
deliver rhodacycle 25 and this then undergoes sequential syn β-hydrogen elimination to give
Rh-hydride 26 and reductive elimination to deliver the final aromatic product 27.
Another interesting study was reported by Rai-Shung Liu and co-workers, who
developed the Ru(II)-catalyzed activation of the simple enediyne 28 to synthesise a range of
substituted arenes 33 via addition of external nucleophiles (e.g. water, alcohols, anilines,
dimethyl malonate, acetylacetone and pyrrole). Mechanistic experimental studies revealed
surprisingly that the reaction does not follow the well-known Myer−Saito cyclization4
pathway, or the previously discussed Rh(I)-catalyzed enediyne activation pathway in Scheme
1.5. The active catalyst [(Tp)Ru(CH3CN)2]+ first coordinates to the alkyne of the enediyne 28,
which gives the Ru 𝜋-alkyne complex 29. This complex then undergoes insertion of the NuH
to the coordinated alkyne to form 31 via pathway a; or ligand exchange of nucleophile with
CH3CN via path b − both pathways ultimately provide vinyl-Ru intermediate 31. Intermediate
31 then undergoes a 6-endo-dig cyclization to 32 and finally, this intermediate provides the
substituted aromatic products 33 in good yields up to 84% (Scheme 1.6).18
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Scheme 1.6: Ru-catalyzed activation of enediyne 28 to produce substituted arenes 33.

A year later, the same group reported the PtCl2-catalyzed cycloaromatization of
halogenated enediynes 34 (X = halogen). It was found that 5 mol% of the PtCl2 catalyst was
effective for cycloaromatization of enediynes 34, a process which involved a key C−H bond
insertion step. In contrast to the previously described methods, this catalytic system was
effective for both terminal and internal alkynes (Scheme 1.7).19 This novel mechanism for
enediyne activation involves enediyne 34 coordinating to the catalyst to form the di-𝜋-alkyne
complex 35, which gives the 1,5-biradical intermediate 36 − a resonance form of carbenoid
intermediate 37. The next step is a formal C‒H insertion of this carbenoid 38 onto the pendant
alkyl chain, which finally provides the desired aromatic indane 39. This outcome should be
compared to Uemura’s reaction (Scheme 1.4), which did not undergo C‒H insertion, instead it
formed a branched alkene product via vinylidene-metal complex 22, which might have less
carbenoid character. The 1,4-diradical 23 underwent a 1,5-hydrogen shift and then eventually
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β-hydride elimination led to the branched alkene product 27a, whereas in this method, the C−H
bond insertion occurred more favorably due to the carbenoid nature of the platinum-stabilized
benzene intermediate 37.

Scheme 1.7: Synthesis of indanes 39 via PtCl2 catalyzed activation of conjugated enediyne 34

Pd–catalyzed enediyne cycloaromatizations have also been developed, with Ma et al.
describing the Pd(II)-catalyzed conversion of enediynes 40 bearing a pendant sulfonamide
chain into naphthalene derivatives 48. This reaction proceeds via a Pd(II)-catalyzed
dimerization and subsequent oxidative annulation to provide highly substituted naphthalenes
48 (Scheme 1.7).20 In the first step of this reaction, the palladium(II)-catalyst selectively
activates the alkyne of 41a towards a 5-endo-dig anti-aminopalladation to form the
vinylpalladium intermediate 42. This then reacts with another molecule of enediyne 40a via
two-fold carbopalladium process to give the alkyne-intermediate 43, which undergoes a 5endo-dig aminopalladation to form 44. Reductive elimination then releases the Pd(0)-catalyst
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and polyene 45. The delocalized Kekulé-type radical 46 reacts with O2 in the presence of NaI
to give the final naphthalene product 48a. The Pd(0)-catalyst in the presence of HX and
molecular oxygen regenerates the active Pd(II)-species, allowing it to re-enter the catalytic
cycle.
The reaction mechanism was examined by an 18O2 isotopic labelling study, which resulted in
the incorporation of 18O into the two hydroxy groups of 48a. The same reaction was repeated
using TEMPO as the oxidizing reagent which afforded 48a as a mixture of 18O2 48a: 18O1 48a:
48a (1:2.5: 1.75) in 71% yield. The addition of TEMPO to polyene intermediate 45 results in
free radical intermediate 47, which is further captured with TEMPO or O2. These experimental
results are consistent with a mechanism involving formation of the diradical intermediate 46
(Scheme 1.8).
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Scheme 1.8: Pd-catalyzed intermolecular annulation reaction of enediyne 40a and proposed mechanistic
pathway for synthesis of naphthalene derivatives 48a.

.

Gold is another versatile transition metal-catalyst that has the ability to selectively coordinate
to the unsaturated double and triple bonds of enediynes ‒ initiating cyclization to form a wide
variety of skeletally diverse structures. Of relevance here, the Zhang group investigated the
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Au-catalyzed activation of enediynes and, in another study, Hashmi reported DFT studies on
the reaction mechanism.21-22
In Zhang’s work, the enediyne 49 was reacted under Au-catalysis conditions using
Mor-DalPhosAuNTf2, 2,6-dibromopyridine N-oxide 50 in DCE solvent, providing three
different products: the indane 60 as well as trace amount of its isomer 61 and the phenol 62
(Scheme 1.9).22 To support the proposed enediyne C‒H insertion mechanism DFT calculations
were conducted using +AuPH3 as a model for the Au catalyst, which also supported by the
previously reported work of Ohno and Hashmi.23-24
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Scheme 1.9: Dual Au-catalyzed intramolecular cyclization of conjugated enediyne 49 to cycloaromatized
indane 60.

Initially, the cationic Au-catalyst coordinated to the terminal alkyne, then with help of 2,6dibromopyridine N-oxide acting as a mild base, formed the alkynyl Au-species 51.
Coordination of a second molecule of the cationic Au-catalyst to the disubstituted alkyne
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moiety gives the dual-Au activated intermediate 52, which can undergo divergent reactions via
5-exo-dig or 6-endo-dig cyclization pathways to give intermediates 53 and 55 intermediates,
respectively. The 𝛼-auronaphthyl intermediate 55 rearranges to Au-coordinated benzyne 56,
followed by a lower-energy-barrier migration to 57. This intermediate has significant carbene
character, which leads to C(sp3)-H insertion, eventually providing indane 60. On the other
hand, the mechanistic rationale also explains formation of 62 from 57 via addition of a H2O
molecule. Formation of 61 is also rationalized using the previously reported PtCl2 enediyne
activation mechanism by Liu and co-workers (see Scheme 1.7).
1.3 Cycloaromatization and cycloisomerization of unconjugated-enediynes – the
tetradehydro-Diels-Alder (TDDA) cycloaddition.

As discussed in the previous sections, cycloaromatization reactions of conjugated enediynes
allows for the construction of a wide range of biologically important polycyclic aromatic
molecules. Researchers have also found the related, but distinct, unconjugated enediyne
systems to be useful, but a less explored platform for cycloaromatizations. These systems are
particularly interesting as they can lead to valuable fused aromatics, are generally easier to
prepare than the fully conjugated enediynes described above and are more stable.
The general reactivity of unconjugated enediynes is classified into Type I or Type II
cycloadditions. When tethered to an alkyne, 1-en-3-ynes undergo Type I cycloadditions,
whereas Type II cycloadditions involve 3-ene-1-ynes linked to an alkyne. Both structurally
distinct substrates can undergo thermal intramolecular [4+2] cycloaromatization reactions,
which are classified as Tetradehydro-Diels-Alder (TDDA) cycloadditions (Scheme 1.10).25-27
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Scheme 1.10: Type-I and II thermal intramolecular TDDA (or) [4+2]-cycloaromatizations of unconjugated
enediynes 64 and 66.

Danheiser and Echavarren have reported alternative Bergman-type cyclizations of
unconjugated enediynes. Firstly, Danheiser reported a Type I cycloaddition where the 1-en-3yne-alkyne substrate 64 was cyclized under thermal conditions by heating at 180 °C (Scheme
1.10). Similarly, Echavarren developed a Type II cycloaddition, using the 1-yne-3-en-alkyne
substrate 66 by heating at 150 °C. Interestingly, both reactions were proposed to proceed via
an intramolecular TDDA [4+2]-cyclization via similar, highly strained, 6-membered allene
intermediates 64-a and 66-a, respectively, to provide the corresponding cycloaromatization
products 65 and 67 (Scheme 1.10).
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These alternative unconjugated enediyne systems have become attractive to many researchers
as a variety of different tethers between the enyne and alkyne can be incorporated. In contrast,
the conjugated enediyne systems only allows for a limited substrate scope to make substituted
aromatic products due to the limited arrangement of the unsaturated groups. To fill this gap in
enediyne cycloaromatization, the alternative unconjugated enediyne system represents a
tremendous opportunity to introduce different functionality on the enediyne skeletal system,
which upon cycloaromatization would provide a range of highly complex bicyclic-aromatic
products. Some of the current work involving synthesis of aromatic systems with unconjugated
enediynes is now discussed.

1.3.1 Type-I [4+2]-cycloaromatization reactions of unconjugated enediynes

Danheiser and co-workers reported a particularly interesting [4+2] cycloaromatization
method of the benzyne linked precursor 70 formed from 69. The benzyne intermediate 70 was
generated in situ by treating the ortho-(trimethylsilyl)aryl triflate tether with TBAT and BHT
in THF solvent. The mechanism of this reaction involves formation of

the benzyne

intermediate 70, which undergoes a Type I TDDA reaction, first forming the strained 6membered allene intermediate 71, which then possibly undergoes rearrangement or radicalmediated hydrogen atom transfer to give the highly condensed naphthalene products 72
(Scheme 1.11).28
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Scheme 1.11: Type I cycloaromatization of unconjugated enediyne 58 to synthesis highly condensed
naphthalene products 61

In another example, Hashmi et al. disclosed a novel Au(I)-catalyzed cascade reaction, which
is related to a formal Type I enediyne [4+2] cycloaddition, to yield functionally important
meta-substituted phenol derivatives. However, this mechanism is quite distinct from the
traditional enediyne Diels-Alder reaction. This reaction was conducted with IPrAuCl/AgSbF6
in DCE at room temperature resulting in phenol derivatives 82, which were isolated in yields
of up to 99% (Scheme 12).29 The mechanism of this reaction suggests that the enediyne-alcohol
73 undergoes a domino reaction via the furan intermediate 74. Based on their previously
proposed reaction mechanism, intermediate 77 was formed by a 5-endo-dig cyclization of the
pendant alcohol onto the alkyne of the enyne 73 and in the second part of the cascade reaction
via intermediates 75 and 76, which leads to the arene oxide intermediate 77.30 Furthermore, the
key transformation steps is dependent upon the nature of the R group. The monosubstituted
derivative 77 undergoes ring opening, which selectively forms the meta-substituted phenol 82
via intermediate 81. On the other hand, the disubstituted intermediate undergoes possible
epoxide ring-opening and a 1,2-alkyl shift to produce the by-products 84, 85 and 80. While this
is an excellent example of a formal cycloaromatization reaction of an enediyne, the reaction
relies on the presence of the pendant alcohol, meaning it is a rather specialized case.
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Scheme 1.12: Au(I)-catalyzed domino reaction of unconjugated enediyne 73 to synthesize substituted phenols
82.

Min Shi and co-workers illustrated an interesting construction of an eight-membered ring
containing indolizine structure via a Au(I)-catalyzed cycloisomerisation (Scheme 1.13). This
system is quite distinct from the simple enediynes in that the unconjugated ene portion is the
double bond of an indole. This serves to highlight the limited number of simple enediynes
explored in transition metal-catalysis – with aromatic ring formation being incidental to the
reaction, rather than a technical cycloaromatization.31 To investigate optimization of the
reaction conditions, 86 was synthesized as a model substrate and was treated with the
20

JohnPhosAuCl/AgSbF6 catalytic system, however, only a low yield of the desired product 91
was obtained. When they switched to the pre-synthesized sterically bulky and electron-rich
ligand, PAd3, this provided the hydroarylated indolizine products in excellent yields (Scheme
1.12). Using this optimized reaction condition, a range of 8-membered ring containing
indolizine products were synthesized in excellent yields up to 94%.

Scheme 1.13: Construction of an eight-membered ring products 91 containing an indolizine moiety via Aucatalyst promoted Type II cycloaromatization of indole linked unconjugated enediynes 86.
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Initially, through Au-activation of the aryl-attached triple bond of 87, C2 nucleophilic attack
of the indole in a 6-endo-dig fashion occurs to give 88. Another activation of the remaining
alkyne by the Au(I)-catalyst initiates a second cyclisation, this time via nucleophilic attack of
the remaining unsubstituted C3 position of the indole 89. The resulting 8-membered ring
intermediate 90 then undergoes protodemetallation to afford the observed organic product 91.

1.3.2 Type-II [4+2]-cycloaromatization reactions of enediynes

Very few studies have been reported on the non-thermal Type II cycloadditions of
unconjugated enediynes where the alkyne of the enyne unit is in a terminal position (Scheme
1.9). In this area, Yamamoto and co-workers disclosed an interesting Pd-catalyzed [4+2]cycloaromatization of unconjugated enediynes 92. This enediyne skeleton was treated with
tetrakis(triphenylphosphine)palladium(0) (Pd(PPh3)4), 1,1’-Bis(diphenylphosphino)ferrocene
DPPF and the resulting reaction was heated at reflux in toluene to provide mixtures of phthalide
99 and 𝛾-lactone 100 products in moderate to good yields (Scheme 1.14).32 The catalytic
system begins which the Pd(0)-catalyst coordinating to both alkyne functional groups to give
93, which leads to formation of the palladacycle intermediate 94. Intermediate 94 then cyclizes
to the cyclic allene 95, which further releases the Pd(0)-catalyst to give the final
isobenzofuranone product 99. During the reaction optimization, they also noticed trace
amounts of 100, which would be formed via an alternative pathway, where the propargylic-Pd
intermediate 97 rearranges to the allenyl-Pd intermediate 98 that upon reductive elimination
leads to the side product 100. In this reaction mechanism, the additional double bond of
substrate facilitates the formal [4+2] TDDA reaction to occur, which leads to formation of the
key Pd-allyl complex 94 (Scheme 1.14). Again, it should be highlighted that while 92 contains
an enediyne skeleton, the reactivity is dependent upon the additional double bond, which
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allows for formation of the Pd-allyl complex in 94. However, it does proceed via a cyclic allene
95, similar to that in the thermal type-II cycloaromatization reactions.

Scheme 1.14: Pd(0)-catalyzed [4+2]-cyclaromatization of type II unconjugated enediyne 92 to synthesis
phthalides 99.

Most recently, Van der Eycken et al. reported an interesting methodology in which the
unconjugated enediyne was tethered to a free N−H group as in the N-alkynic-2-ynamides 101.
These were reacted under mild reaction conditions using a JohnPhosAuCl/AgNTf2 Au(I)catalyst with the N-H initiating the reaction via nucleophilic attack on the Au-activated enyne
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moiety. Specifically, under these conditions 101, rather than undergoing a [4+2]cycloaromatization, underwent sequential nucleophilic attack, enyne cycloisomerization and
finally 1,2-migration of R1 to provide the indolizidine scaffolds 105 in good yields of up to
91% (Scheme 1.15).33 The unique reactivity of the key unconjugated N-H tethered enediyne
allowed for the synthesis of the biologically important natural product decumbenine B 106,
which is used as a treatment for hypertension, hemiplegia, rheumatoid arthritis and sciatic
neuralgia.34
The mechanistic pathway of this reaction was proposed based on various mechanistic
investigation reactions and also a previously reported method.35 The catalytic cycle begins with
the Au(I)+-catalyst selectively coordinating to the triple bond of the enyne moiety of 101 to
give the 102, which then undergoes 6-endo-dig cyclization via attack of the free N−H to form
vinyl gold intermediate 103. This cyclic intermediate then undergoes enyne cycloisomerization
to provide the Au-carbenoid intermediate 104. Finally, 1,2-alkyl or aryl group migration
provides the pyrrolo[1,2-b]isoquinolines 105 and releases the Au(I)-catalyst.
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Scheme 1.15: The Au(I)-catalyzed Type II-cycloisomerization of N-alkynic 2-ynamides 86 to indolizines 90.

As described in the above section, various unconjugated enediynes have been studied under
transition metal-catalyzed conditions providing a diverse set of cyclic molecules – often via
mechanisms not clearly related to the thermal cycloaromatization processes. Simple enediyne
systems, such as 110, proceeding via mechanisms thermal aromatization reactions have not yet
been investigated under transition metal-catalysis. It is also important to note that the thermal
TDDA reaction (Scheme 1.9) provided poor yields and limited substrate scope. The exception
here is the Danheiser TDDA that proceeds via formation of an in-situ generated benzyne,
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however this requires the synthesis of a specialized substrate and is less atom-efficient than a
standard cycloaromatization.
One reason that it is attractive to investigate the catalytic cycloisomerization reactions of
simple enediynes 110, is that they can be easily made from propargylating enynols 108, which
themselves can be prepared by a range of simple synthetic routes. Development of a transition
metal-catalyzed TDDA reaction of these simple enediynes 110 would allow construction of
bicyclic

aromatic

products

111,

including

isoindolines

(X

=

NR)

and

1,3-

dihydroisobenzofurans (X = O), both of which are heterocycles found in an array of bioactive
compounds (Scheme 1.16).

Y
109

TM catalyzed [4+2]
TDDA reaction

R

R

1) SN2 alkylation

X
X

2) coupling
OH

108
enynol

Y = Br, Cl, NHTs

110

R
111

enediyne

Scheme 1.16: Hypothesis for the transition metal-catalyzed TDDA reaction of enediyne 110

1.4 Synthesis of stereodefined (Z/E)-enyn-ols

If enediynes are to be exploited in developing new reactivity, then there needs to be
efficient methods available for their preparation. Fortunately, they should be easy to prepare
from enynols 108 and corresponding nitrogen and oxygen tethered enediynes derivatives 110
can be easily prepared via propargylation or coupling reaction (Scheme 1.16). In the literature,
several methods have been reported to prepare highly substituted stereodefined enynols. The
most facile approaches are: a) a multistep transformation with the key step involving a
Sonogashira coupling of vinyl halides and terminal alkynes; b) transition metal-catalysed
coupling reactions, c) one pot cross-coupling reactions, and; d) transmetalation of Z-
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telluroenynes. A selection of important and efficient methods under these categories will be
discussed in the following section to highlight the ready availability of enynols en-route to enediynes.

1.4.1 Transition metal-catalysed synthesis of stereodefined enynols

In 1968 Wilkinson and Singer demonstrated a Rh(I)-catalyzed selective dimerization
of the homopropargylic alcohol 112, which was heated in benzene for 6 h to produce (E)enynol 117 in 78% yield (Scheme 1.17).36 The proposed reaction mechanism explains the headto-head dimerization of 2-methylbut-3-yn-2-ol 112, which co-ordinates to the metal center
trans to the chloride, forming 113 - the cis addition of a second propargyl alcohol then forms
114. In the next step the acetylide is transferred from the metal to the carbon atom of
coordinated propargyl alcohol via transition state 115. Finally, hydride transfer from 116
selectively gives the trans enynol product 117.

Scheme 1.17: Homocoupling reaction of terminal alkyne 112 under Rh(I)-catalysis
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Recently, Shaughnessy et al. developed a selective cross dimerization of arylacetylenes with
propargyl alcohols and amides using a Pd-trialkylphosphine catalyst to synthesize the linear
(E)-enynols 120 in good yield (R = aryl, 44-88%) (Scheme 1.18a).37 Based on the observation
that catalyst 121a – prepared from catalyst 120 by reacting with phenylacetylene – could also
catalyse the reaction, the mechanism shown in Scheme 1.18b was put forward. This catalytic
cycle begins with formation of palladacyclic monomer 122, which is in equilibrium with the
catalyst dimer 121. Phenylacetylene reacts with the acetate monomer in a C−H activation
process giving acetic acid and the Pd(II)-intermediate 123 that is also in equilibrium with the
off-cycle catalyst 121a. The Pd-acetylide intermediate 123 then coordinates with the propargyl
alcohol to give the less sterically hindered cis palladacycle intermediate 124. It was assumed
that the cis position of the acetylide relative to the phosphorus intermediate is more favorable
for the incoming propargyl alcohol due to the less sterically demanding carbon of the
palladacycle 124. This allows migratory insertion to form intermediate 125 and this insertion
step promotes the regioselectivity of the reaction. Finally, the initially formed acetic acid assists
proteolysis to form the final enynol product 120.
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Scheme 1.18: (a) Pd-catalyzed synthesis of enynols 120, (b) Proposed reaction mechanism

Venkataraman and co-workers synthesized ethyl (E)-pent-2-en-4-ynoates 127 using a Cu(I)catalysed cross coupling protocol of vinyl-iodo ester 126 and terminal alkynes 118 (Scheme
1.19).38 During optimization, they found that the combination of [Cu(bipy)PPh3Br] and K2CO3
as base allowed a wide variety of electron-withdrawing and donating alkyne partners to couple
to vinyl-iodides 126 with excellent yields (up to 99%) and with complete retention of the
stereochemistry of the starting vinyl-iodide 127. The synthesized esters 127 could be easily
transformed to their corresponding enynols by DIBAL-H reduction. The stereodefined (Z)-3iodoacrylate 126 was readily synthesised via a hydrohalogenation reaction by treating methyl
propiolate 242 with NaI in acetic acid at 70 °C.
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Scheme 1.19: Cu(I) catalyzed cross coupling synthesis of ethyl (E)-pent-2-en-4-ynoate 127 form alkyne 118 and
vinyl-iodoester 126.

In 2004 Stefani and co-workers reported a novel Suzuki-type coupling method to synthesize
the enynol 131 from the potassium alkynyltrifluoroborate salt 130 and vinylic telluride 129.
The vinylic tellurides have become useful intermediates and are widely used in total synthesis.
In general, vinyl tellurides are non-toxic, are relatively cheap and these are easy to prepare
form the hydrotelluration of alkynes.39 In this study, after careful screening of several
optimization reaction conditions, using a Pd(acac)2 catalyst (15 mol%) and Et3N (3 eq) in
MeOH as the solvent provided a good yield of enynol 131 (77%) (Scheme 1.20).40 This method
was also highly stereoselective, with complete retention of the corresponding vinylic telluride
double bond geometry in 129.

Scheme 1.20: Suzuki-type cross-coupling reaction of potassium alkynyltrifluoroborate 130 and vinyl tellurides
129

`1.4.2 Transition metal-catalyzed cross-coupling reactions with alkynes and aldehydes
Liu and co-workers developed a Zr-mediated cross coupling reaction involving three different
components to synthesize the Z-selective enynols 136 (Scheme 1.21).41 This one pot method

30

allowed cross-coupling between alkynes 132, ketones 133 and alkynyl bromides 135, forming
stereodefined (Z)-enynols 136 in good-high yields (57−92%) (Scheme 1.21). The proposed
reaction mechanism involved an intramolecular coupling reaction leading to the formation of
oxazirconacyclopentene 134, which further reacts with the alkynyl bromide under Cucatalyzed conditions. Specifically, intermediate 134 undergoes transmetallation of the Zr-C
bond to form a Cu-C bond, followed by alkynylation with 135 to form (Z)-enynols 136. It was
found that the addition of CuCl was essential as 134 did not react with the alkynyl bromide 135
without this salt present. These reactions also occurred more efficiently when LiCl was added,
which was thought to accelerate the transmetallation step and stabilize the resulting Cu-C bond
in solution.

Scheme 1.21: Zr-mediated alkyne-aldehyde coupling reaction to (Z)-selective enynols 136

Similar to the Zr-mediated coupling reaction (Scheme 1.22), Liu and co-workers
reported the synthesis of (E)-enynols 141 from in situ generated Ti(II)-butadiyne complexes
by reacting Ti(OiPr)4 complex and 1,3-butadiyne 137 (Scheme 1.22).42 Firstly, compound 139
reacts with Ti(OiPr)4 to give the titanacyclopropene intermediate 138. Addition of aldehyde
139 (1.0 equiv) afforded the key oxatitanacyclopentene intermediate 140, which upon
quenching with H2O and NaHCO3 forms a mixture of stereodefined (E)-enynols 141 in good
yields (52-85%). A small amount of the allenyl carbinol 142 was also formed, presumably by
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the hydrolysis of oxatitanacyclopentene intermediate 140, however, the reaction was generally
highly selective for the enynol.

Scheme 1.22: Selective synthesis of (E)-enynols 141 via dialkyltitanium promoted coupling reaction of 1,3butadiynes 137 with aldehydes 139.

In another study, the Zeni group demonstrated a stereoselective synthesis of (Z)-enynols
146 from the (Z)-vinylic tellurides 143 (Scheme 2.23).43 The vinylic tellurides were prepared
according to previously reported methods for the hydrotelluration of alkynes.44

Pre-

synthesized vinyltellurides 143 were converted to a (Z)-vinyllithium intermediates by treating
with n-BuLi (1.1 equiv to tellurides 0.5 mmol) in dry THF at −78 °C. The resulting vinyllithium
intermediates were treated with a range of substituted aldehydes and ketones 144, providing a
wide range of (Z)-enynols 146 in excellent yields (up to 95%).
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Scheme 1.23: Stereoselective synthesis of (Z)-enynols 146 from (Z)-vinyl tellurides 143.

Yong-Qiang and co-workers developed a straightforward route to synthesise 1,3-enynols, via
a KOtBu promoted three-component coupling reaction of two alkynes and an aldehyde,
producing stereodefined (E)-1-en-4-yn-3-ols 156 or (Z)-2-en-4-yn-ols 157 (Scheme 1.24).45
This one pot reaction is a very convenient route for making highly substituted enynols.
The reaction mechanism involves a sequential addition/isomerization/addition
pathway, which gives two types of products depending on the workup procedure. A workup
procedure involving H2O under neutral conditions gives 156, however, using aqueous acid
(10% H2SO4 at 0 °C) causes a rearrangement giving the conjugated and more
thermodynamically stable enynol 157. On the other hand, as 156 could be converted to 157,
this suggests 156 is formed first then isomerizes under the acidic workup conditions. The
proposed mechanism of this reaction starts with the addition of the aldehyde to alkynyl
potassium, forming intermediate propargyl alkoxide 150, which involves a proton exchange
process to give intermediate 151. The allene intermediate 153 forms via a 1,3-hydride shift
process, then allenol-enone tautomerization leads to the trans-configured enone intermediate
154. In the next step, this enone intermediate undergoes nucleophilic attack from in situ formed
alkynylpotassium 151. Finally, 156 or 157 are formed depending on the workup procedure
used in the reaction.
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Scheme 1.24: KOtBu-promoted one pot coupling reaction of alkynes and aldehydes to (Z)-enynols 156 and
proposed reaction mechanism.

1.5 Aims of the project:

The activation of enediynes by transition metal-catalysts allows for their cycloaromatization
reactions via different mechanistic pathways providing aromatic polycyclic scaffolds.
However, many of these are specialized substrates with additional unsaturation or nucleophilic
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groups – also the double bond moiety is often embedded in an aromatic ring. In many cases
the reactions do not represent a true cycloaromatization. Overall, the potential of the simple
enediyne system, readily synthesized from enynols as demonstrated above, to prepare complex
heterocycle-fused aromatic systems in a catalytic fashion has not been fully harnessed.46-47
Synthesizing highly substituted hetero- and carbocyclic-fused aromatic systems is an important
goal as these structures are often found in medicinally important molecules. The primary aim
of this thesis was therefore the development of an unconjugated enediyne system 110 for Type
II cycloaromatization reactions with transition metal-catalysts, primarily Au(I) and Rh(I)
(Scheme 1.25).
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b) Project 1: Au(I)-catalyzed [4+2]-cycloaromatization of enediyne 110
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c) Project 2: Rh(I)-catalyzed oxidative [4+2]-cycloaromatization of enediyne 110
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Scheme 1.25: a) Proposed hypothesis of new unconjugated 3-en-18-diyne 110 and its [4+2]-cycloaromatization
under transition metal-catalysis to highly functionalized bicyclic aromatic compounds 111. b) Project-1 Au(I)catalyzed cycloaromatization and c) Project-2 Rh(I)-catalyzed [4+2]-cycloaromatization

Paramount to this proposed methodology is the position of the alkene and alkyne functional
groups in a 3-en-1,8-diyne, which should allow for the synthesis of a highly substituted
aromatic system fused to a 5-membered heterocycle or carbocycle, depending upon the nature
of the tether. Specifically, isoindoles (X = NR), dihydrobenzofurans (X = O) and indanes (X =
CR2) could all be prepared and feature in numerous biologically important molecules. Usually,
direct synthetic access to highly functionalized aromatic compounds of this kind has been
problematic via traditional methods or required long multi-step sequences.48-49 However, polysubstituted 110 is easily synthesized from accessible enyols 108 and could undergo a transition
metal-catalyzed formal [4+2]-cycloaromatization leading rapidly to more functionalized
isoindoles, dihydrobenzofurans and indanes 111.
In order to achieve this goal, the project aimed to study reactions catalyzed by gold
(Au) and rhodium (Rh) by drawing upon inspiration of the cyclosiomerisation of simple 1,6-
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enynes in the presence of these catalysts.50-52 The proposed enediyne system 110 also contains
a 1,6-enyne in its structure, which could possibly react in a similarly manner to simple isolated
1,6-enynes, undergoing cascade reaction pathways involving the additional triple bond, leading
directly to cycloaromatized products 111 (Scheme 1.25). Advantage of this proposed method
is the potential to synthesize chiral enantioenriched (ee) products by using various chiral
ligands in the catalytic system or stereodefined starting materials. For example, escitalopram
161 is a well-known antidepressant drug which contains an isobenzofuran and has one chiral
center on the 5-membered ring (Figure 1.2). The industrial method for making this compound
involves a multistep synthetic process to achieve the final drug molecule. In comparison to the
proposed method could potentially make the related enantioenriched scaffold in a single step.
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O
HO (CH2)5CH3

F
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Escitalopram
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HO
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Corollosporine

OH
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Caraphenol B

Figure 1.2: Examples of aromatic bicyclic natural products and drug molecules

In Chapter 2 an introduction to Au-catalyzed cycloisomerization reactions is provided
and the Au(I)-catalyzed reactions of the model substrates 110 are investigated. This system
could undergo a 1,6-enyne-type single cleavage cycloisomerization to (Z)- dienyne
intermediate 158, which is predisposed to undergo a second Au(I)-activation to bring about
aromatization to 111 (Scheme 1.25b).
In Chapter 3, the enediyne 110 is investigated under oxidative cyclization conditions
using Rh(I)-catalysis. This reaction proceeds via a different mechanism, forming Rh(I)-
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cyclopentene intermediates 159, followed by insertion of the alkyne to the metal-catalyst to
form cycloaromatized product 160 (Scheme 1.25c).
Finally, in Chapter 4 future work and initial experiments towards the preparation of
heteroaromatics, enediynes with longer tethers and asymmetric variants of the reaction will be
discussed.
As discussed above, the development of new methods for the synthesis of polycyclic
aromatic and heteroaromatic compounds is an important area in modern organic chemistry.
Polycyclic heteroaromatics are valuable synthetic precursors to biologically active natural
products, electroactive material molecular devices and pharmaceutical drug molecules. 53-54 In
the last decade, there have been several classical approaches developed for making
heteroaromatic molecules. One of these approaches employs substitution strategies,55-56 which
often

generates

large

amounts

of

by-products.

In

contrast,

cycloaddition

and

cycloisomerization reactions are powerful techniques and represent a more environmentally
friendly and greener approach, as they provide 100% atom economy and highly complex ring
systems from pre-synthesized starting materials.57-60 Moreover, complexity of the final
products can be increased by careful placement of functional group substituents, and
unsaturation bonds on the starting materials.61-63 There have been extensive methodologies
developed, for example, transition metal-catalysed [4+2]-cycloaddition reactions of dienynes
and enediynes have become significant pathways for making complex polycyclic carbocycles
and dihydroaromatic heterocycles.4,

26, 46, 64-67

These scaffolds are found in many natural

products which show a wide range of biological activities.68 For example, escitalopram 161 is
a well-known antidepressant drug which is a selective serotonin reuptake inhibitor (Figure
1.2).69 Corollosprine 162, isolated from Staphylococcus aureus, has antibacterial acitivity.69
The indane natural product carapenol B 163, isolated form the dried roots of the plant Carana
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sinica, is used to treat hypertension.70 In this thesis conceptually new routes to these classes
of fused-aromatics are uncovered.
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Chapter
2.
Gold(I)-Catalysed
Intramolecular
[4+2]Cycloaromatization Reactions of O-tethered (Z)-Enediynes
2.1 Introduction

At the start of this project, our group reported a dual Au-catalyzed cycloaromatization of novel
unconjugated enantiomerically enriched (E)-enediynes 165, which provided enantiomerically
enriched isoindolinone products 168 in high yields up to 85% (Scheme 2.1).71 In the presence
of the basic [(Ph3PAu)3O]BF4 catalyst (2.5 mol%) in toluene under reflux conditions, the
substrate 165 underwent cycloisomerization via a novel dual Au(I)-activation process.
Selective deprotonation at the terminal propiolic proton generated a Au-acetylide 166 with a
second Au-species undergoing 𝜋-activation to generate the intermediate 167. This intermediate
has Au-vinylidene and Au-allenyl moieties that react together to provide the isoindolinones
168 after ring-expansion 167a to 167b intermediates formation. While this process had a novel
mechanism and good substrate scope, relatively high temperatures were required in order to
form the gold acetylide, which was confirmed by computational studies as an energetically
uphill sequence. Furthermore, the carbonyl group was required both for product stability and
was intrinsically important to the mechanism for the formation of the dual-gold activated
intermediate. Due to the requirement for a gold acetylide to be formed the substrate scope was
limited to terminal acetylides as well as the need for high temperatures for the dual-gold
cyclization to occur.
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Scheme 2.1: Dual Au-catalyzed cycloaromatization of unconjugated (E)-enediyne 165 to enantioenriched
isoindolinones 168

Using the advantage of dual Au(I)-catalysis, work on ene-ynamides was also reported
separately by Zi and Gazosz.72-73 In Zi’s work, the model substrate was reacted with IPrAuNTf2
catalyst in the presence of DIPEA in DCE with heating at 80 °C to provide a range of indolines
173 in good yields up to 99% (Scheme 2.2). Based on a deuterium labelling study, a catalytic
cycle was proposed, in which the substrate 169 underwent deprotonation at the terminal alkyne
carbon to form Au-acetylide intermediate 170, and a second cationic Au ion coordinated to the
alkyne to produces the ,𝜋-digold complex 171. A 5-exo-dig cyclization then forms the key
vinylidene intermediate 172, which upon the 6-𝜋 electrocyclization and then a 1,2-H shift
releases the catalyst provides the final product 173.
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Scheme 2.2: Dual Au-catalyzed formal cycloaromatization of ene-ynamide 169 to the carbazole derivatives
173.

In order to provide a complimentary method to the dual-gold catalyzed
cycloaromatization of enediynes that proceeds under milder conditions and can accommodate
substituents on the propargyl tether, it was proposed to harness a cycloisomerization of the 1,6enyne moiety embedded in the enediyne material to produce an ene-diyne in-situ that could
then undergo aromatization (Scheme 2.3a). While there have been previous reports of transition
metal-catalysed [4+2] cycloaddition reactions of unconjugated dienynes 174 (Scheme 2.3b),74
an analogous process to give fully aromatic rings are limited to those discussed above and
require relatively high temperatures. A detailed mechanistic discussion of the goldcatalyzed reactions of the related simple 1,6-enynes and analogues with added unsaturated
groups is now provided to contextualize to this goal.
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Scheme 2.3: a) Proposed scheme for Au-catalyzed novel [4+2] cycloaromatizations of unconjugated enediynes
110 b) Previously reported transition metal-catalysed [4+2]-cycloaddition reactions of dieneynes 174

2.2 Chemistry of 1,6-enynes and their Au(I)-catalyzed cycloisomerization reactions

1,6-Enynes are interesting reactive starting materials having unsaturated groups on the alkyne
and alkene at the C-1 or C-6 positions. They are easy to make from commercially available
starting materials using two types of mild reactions conditions: a) the coupling of propargyl
alcohols with allyl bromide in the presence base and b) amide/alcohol or acid/alcohol coupling
reactions in one step. In general, transition metal-catalyzed cycloisomerization of 1,6-enynes
has become an attractive carbon-carbon bond forming reaction, which allows the synthesis of
a range of complex cyclic organic compounds. For example, the total synthesis of complex
natural product (+)-schisanwilsonene A having antiviral activity, was successfully achieved
under Au(I)-cyclization of 1,6-enyne 176 via formation of the key cyclopropyl Au-carbene
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intermediate 178, which then undergoes 1,5-acetoxy migration and reaction with 177 to form
the cyclopentene 179. This was then converted to the important bioactive natural product 180
in 13 steps (ca 4% overall yield) (Scheme 2.4).75

Scheme 2.4: Au(I)-catalyzed cyclization of 1,6-enyne 176 to give the natural product 180

2.2.1 Transition metal-catalyzed activation of 1,6-enyne

The activation of 1,n-enynes to cyclization reactions under transition metal-catalysis is well
studied using different metal-catalysts including, Pd, Rh, Co, Ti, Ru, Pt and Au (Scheme 2.5).76
Generally, substituted 1,6-enynes in the presence of various oxidative metal-catalysts undergo
reactions via three different types of cycloisomerization pathways leading to key electrophilic
intermediates 182 to 184. These predominantly undergo reductive elimination and form two
types of diene products 186 and 187. However, the study of 1,6-enyne electrophilic activation
was first reported by the Trost group. In this cycloaddition reaction the Pd(II)-catalyst
underwent simultaneous coordination to the alkyne and the alkene which leads to an Alder-ene
type cyclization forming a 1,3 or 1,4 diene product (pathway ii),.77 Similarly, Ru(II)-activation
was reported by the Murai and Chatani groups.78 In contrast to these metal-catalyzed oxidative
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cyclizations, Au(I)-catalysts cannot generally undergo oxidative activation to form a Au(III)metallacycle intermediate. Instead, Au(I) selectively activates the alkyne triple bond to form a
highly reactive (η2-alkyne) Au-complex 185 which undergoes skeletal rearrangement to give
the 1,3-diene product 188.

Scheme 2.5: The transition metal-catalyzed oxidative cyclization of 1,6-enynes 181 to 5-membered diene
products 186, 187 and 188

Considering the advantage of a highly reactive Au 𝜋-metal complex intermediate 185,
the 1,6-enyne Au-activation studies have become a more fascinating cyclisation method in
organic synthesis and similar reactivity is also found with Pt(II) catalysts. 52, 79 Recent studies
discovered that, cationic Au(I)-catalysts are often more effective for the activation of alkynes
and alkenes overshadowing Pt(II)-activated cyclisation.52
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2.2.2 1,6-Enynes Au(I)- skeletal rearrangement reactions

When a 1,6-enyne is treated with an in situ generated, highly active, cationic Au(I)-catalyst,74,
80

selective coordination to the alkyne triple bond forms a highly reactive (η2-alkyne) species

189 (similar to intermediate 185, Scheme 2.5), which undergoes intramolecular double bond
attack. This leads to two or more types of favourable cyclisation pathways, which are the anti
5-exo-dig and the 6-endo-dig cyclisation pathways to form bicyclic Au-carbenoid-like
intermediates 190 and 197, respectively (Scheme 2.6).81 Intermediate 190 can undergo two
different type of reactions: 1) Intra or intermolecular nucleophilic attack82 and 2) in the absence
of a nucleophile undergoes a skeletal rearrangement to form a wide range of cycloisomerized
diene products 194. A deeper understanding of the skeletal rearrangements has been assisted
with the help of DFT studies,81, 83 which suggest that the 5-membered bicyclic Au(I)-carbenoid
intermediate 190 reacts via a single cleavage rearrangement mechanism, producing the (Z)configured 5-membered diene product 194.
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Scheme 2.6: General skeletal rearrangement mechanism of Au(I)-cycloisomerizations of 1,6-enynes

The single-cleavage rearrangement of intermediate 190 leads to the 6-membered diene product
196 via intermediate 195. The second pathway involves a 6-endo-dig cyclisation of 189,
resulting in intermediate 197, which further undergoes 𝛼-proton elimination to form the 6membered bicyclo[4.1.0]hept-2-ene type derivatives 198. Furthermore, intermediate 197 also
leads to the (η2-cyclobutene)-Au(I) complex 199, which then isomerizes to cyclobutene 200 -
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on the other hand, it also undergoes ring opening to Au(I)-diene complex 201, then
protodeauration provides diene 194 (Scheme 2.6).51, 79, 82, 84-85
Mechanistic investigations and experimental reports suggesting that the activation of
1,6-enynes by Au(I) leads to various intermediates (intermediate 190 and 197), giving a wide
variety of rearranged cyclic products.85 This is in contrast to other metal-catalyzed reactions,
which involve non-rearrangement mechanisms to give a limited scope of diene products. 81
Compared to other metal activation pathways the Au(I)-catalyzed activation pathway is
dependent on the substitution of the alkyne and alkene moieties of the 1,6-enyne. For example,
in one study, the 1,6-enyne (E)-202 having a methyl substituted alkene underwent Au(I)cycloisomerization to selectively give the single cleavage rearranged (E)-5-membered ring
diene product (E)-203 in 96% yield and (Z)-1,6-enyne 202’ also selectively provided (Z)-diene
product 230’. Interestingly, the simple 1,6-enyne 204 leads to two types of single cleavage
products: one 5-membered ring product 205 and one 6-membered ring product 206 in a 10:1
ratio respectively, giving a combined yield of 51%. The 1,6-enyne 207 having a more electron
donating cyclopropyl group at the alkene gave single cleavage rearrangements product 208
(90% yield, Z/E = 17:1) (Scheme 2.7a).86 On the other hand, the double cleavage rearrangement
occured in the methyl substituted alkyne 209 substrate selectively gave the double cleavage
rearrangement product (E)-210 (95% yield) (Scheme 2.7b).81, 87 In general reactions of 1,6enynes under electrophilic metal-catalysis process are stereoselective with respect to the alkene
geometry, however, when the 1,6-enyne alkene double bonds bears an electron-donating group
(R1), the reaction is non-stereospecific and proceeds through an open carbocation intermediate
211’ (Scheme 2.7b).87
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Scheme 2.7: Reaction products from substituted 1,6-enynes under Au(I)-catalysis.

The Echavarren group uncovered interesting non-stereospecific behavior of 1,6-enynes under
Au(I)-catalysis.88 When R1 is an electron-donating substituent both (E)-1,6-enynes 212 and (Z)1,6-enyne 213 undergoes non-stereospecific cyclization to both give the (Z)-diene as the
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product 216 (Scheme 2.8).87 This convergence towards the (Z)-diene is consistent with a
mechanism that proceeds via open carbocations that undergo facile bond rotation prior to the
rearrangement. Indeed, computational results suggested that this is because the intermediate
214 undergoes faster bond rotation prior to formation of cyclopropane 215, which is a result of
the ability of the electron donating group (R1) to stabilize the positive charge.

Scheme 2.8: Substituted (E/Z)-1,6-enynes having R1 = an electron-donating group under single cleavage
rearrangement to give (Z)-selective diene product 216.

Au(I)-catalyzed asymmetric cyclizations of tethered 1,6-enynes have also been
developed to make enantioenriched heterocycles.82, 89-90 Many of the catalytic asymmetric
reactions of 1,6-enynes under Au(I)-catalysis were developed by the Echavarren group. In one
of their studies, they reported the synthesis of highly enantioenriched pycnanthuquinones A-B
220 using a chiral phosphine Au(I)-catalysts 221. Under optimized reaction conditions they
achieved 217a in a high yield of 99%. With the methoxy analogue 217b the yield was lower
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(44%) but the reaction produced an equally impressive enantiomeric excess (ee) of 92%
(Scheme 2.9).91 In a mechanistic proposal, the substrate 217 undergoes 5-exo-dig cyclization
to form the cyclopropyl Au(I) carbene intermediate 218, followed by a Nazarov-type
cyclization to produce the intermediate 219 via cyclopropane ring opening by the electron-rich
aromatic ring giving eventually a highly enantiomerically enriched product 220.

OCH3
t-Bu

t-Bu
tBu
P
AuCl

H3CO

OCH3
t-Bu
t-Bu

AuCl
P

H3CO

OCH3
t-Bu

t-Bu

t-Bu
OCH3

221

[(R)-DTBM-MeOBIPHEP](AuCl)2

Scheme 2.9: Enantioselective synthesis of pycnanthuquinone scaffolds 217 under 1,6-enyne Au(I)cycloisomerisation
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2.2.3 1,6-Enynes having an additional unsaturated group on the alkene double bond
under Au(I)-cycloisomerization.

In contrast to the simple 1,6-enynes introduced above, 1,6-enynes having additional
unsaturated substituents, including dienynes, enediynes and dienediynes are only emerging
building blocks in transition metal-catalyzed organic synthesis to form complex organic
products. Recently, several methods have been developed in Au(I)-cyclization of higher
enynes, which have pre-designed and appropriately placed unsaturated groups. In the presence
of a suitable Au(I)-catalyst these systems form highly substituted polycyclic products, and the
mechanisms are often interesting, due to the presence of added reactive unsaturated groups.9293

In one of these reports, Yu and co-workers reported unprecedented reactivity when
linear dienediynes 222 reacted under Au(I)-catalyzed reaction conditions to afford the fused 7membered ring containing tricyclic products 225 (Scheme 2.10).94 The mechanism of this
reaction begins with a 6-endo-dig type cyclisation of the 1,6-enyne to give the bicyclic fused
cyclopropane metal carbene intermediate 223 (similar intermediate to 197 in Scheme 2.6). This
intermediate then undergoes a Cope rearrangement, forming the strained 7-membered cyclic
intermediate 224. This undergoes sequential C-H activation and [1,2]-hydride or [1,2]-acetoxymigration, leading to the fused 5,7,6-tricyclic scaffolds 225, which have a similar skeleton
structure to that of the daphnane and tigliane diterpene natural products.
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Scheme 2.10: Synthesis of diterpene skeletal structures 225 from linear dienediyne 222 under Au(I)-catalysis

In another exciting study, the Iwasawa group, synthesized the medicinally important
bicyclo-[4.3.0]nonane scaffold 230a from (E/Z)-3-siloxy-1,3-dien-8-ynes 226a,b via a Au(I)catalyzed, formal [4+2] cycloaddition, providing the products as single diastereomers in high
yields (75-92%) (Scheme 2.11).95 This tandem cyclization reaction starts with a 5-exo-dig
cyclization, initiated by a silyl enol ether directed nucleophilic attack to form the Au-activated
𝜋-alkyne zwitterionic intermediate 227. This zwitterionic intermediate then undergoes
intramolecular cyclisation to the fused bicyclic Au-carbene intermediate 228. This intermediate
finally undergoes a [1,2]-alkyl migration of the benzylic carbon which preferentially migrates
over the adjacent unsubstituted carbon due to its higher electron-density. The resulting ringexpanded product 229 then undergoes protodeauration to form 230a and regenerates the
catalyst.
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Scheme 2.11: Tandem [4+2] cyclisation reaction of (E/Z)3-siloxy-1,3-dien-8-ynes 226a to bicyclo[4.3.0]nonane 230a

Another interesting finding was reported by Chan and co-workers who developed an
efficient [4+2] Au(I)-catalyzed route to synthesize cis-cyclohepta-4,8-diene-fused pyrrolidines
235 from pre-synthesised 1,6,8-dienyne esters 231 (Scheme 2.12).96 The reaction of ester 231
proceeded using a Au(I)–phosphine catalyst (2 mol%) in toluene at 80 °C, affording the
pyrrolidine product 235 in 91% yield. To understand the reaction mechanism, they performed
control reactions by treating the starting material under the optimised reaction conditions at
room temperature (rather than reflux) and isolated intermediate 234 in 88% yield. The Au(I)catalyst first activated the alkyne triple bond to form complex 232, which undergoes 1,2migration to form the carbenoid adduct 233, which then leads to intermediate 234 and
regenerates the Au(I)-catalyst. The isolated intermediate 234 was further heated at reflux in
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toluene which initiated a thermal Cope rearrangement reaction to give the final fused
pyrrolidine product 235, thus showing it is a likely intermediate in the catalytic cycle.

Scheme 2.12: Au-catalyzed reactivities of ester and carbonate substituted dienynes 231.

The Young group reported the synthesis of 2-tosyl-2,3,3a,6-tetrahydro-1H-isoindole
237 from the unactivated dienyne 236 via an intramolecular [4+2] Au(I)-cycloaddition reaction
(Scheme 2.13).74 In initial optimization studies they tested [Au(PPh3)Cl] and in situ generated
cationic Au(I)-catalyst [AuPPh3Cl/AgSbF6]. Both catalysts supplied poor yields and a mixture
of the single cleavage rearrangement products 238 and 239 and the [4+2] cycloaddition product
237. Other counter ions, like BF4−, NTf2−, PF6− gave similar results. Surprisingly, a highly
reactive and stable Au(PPh3)OPOF2 catalyst was prepared from Au(PPh3)Cl/AgPF6 in DCM.
This stable catalyst was used for the first time in an intramolecular [4+2] Au(I)-cycloaddition
of an enediyne. Enediyne 236 with the alkyne terminal carbon having H or TMS group
substituents, in the presence of Au(PPh3)OPOF2 (5 mol%) in dry THF solvent selectively
provided the [4+2] cycloaddition product 237 in excellent yield (99%). Under these conditions
the TMS substituted dienyne 236 undergoes slowly desilylation process provided [4+2]
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bicyclic product 237 via intermediate c, which then undergoes a 5-exo-dig cyclization to
intermediate d which upon skeletal rearrangement produces the products (237 and 239). When
R is a methyl substituent, 236 undergoes a 6-endo-dig cyclization to intermediates a and b,
which proceed to form the cyclopropanated product 238.

Scheme 2.13: Au(PPh3)OPOF2-catalysed intramolecular [4+2] cycloadditon to synthesize isoindole 237 form
unconjugated dienyne 236.
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2.3 Proposed scheme for the Au(I)-catalyzed cycloaromatization of simple tethered
enediynes

Based on the above earlier literature it is clear that direct access to aromatic bicyclic products
from higher 1,6-enynes undergoing Au(I)-catalyzed [4+2] reactions has not been reported
(Scheme 2.14).79,

93, 97-98

Therefore, this chapter aims to achieve this through Au(I)-

cycloaromatization of various tethered unconjugated enediyne systems. By referring to the
general reactivity of 1,6-enynes in the presence of gold catalysts (Scheme 2.6), the enediyne
110a is proposed to a initially undergo a single cleavage mechanism to provide the (Z)-dienyne
158a. This geometry was expected based on the prior work of Echavarren (Scheme 2.8), which
showed an electron-donating group attached to the alkene portion led to (Z)-diene products. It
was anticipated that the alkyne might be able to stabilize an open propargylic carbocation 110aint similar to 214 (Scheme 2.8), thus leading to the desired (Z)-dienyne 158a.

This

intermediate is then setup to undergo a second Au(I)-cycloaromatization leading to the
isobenzofuran product 111a (Scheme 2.14).99 In order to achieve this exciting project goal, an
initial aim of this project was to synthesize highly substituted enediyne substrates and
cycloaromatize them to bicyclic isobenzofuran products 111.

Scheme 2.14: Au(I)-catalyzed cycloaromatization of O-tethered enediyne 110a
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2.4 Results and discussion:

2.4.1 Synthesis of O-tethered (Z)-enediynes

Scheme 2.15: General synthetic approach for the synthesis of stereodefined unconjugated enediynes 110 from
methyl propiolate 240

In order to explore the potential cycloaromatization reactions, the unconjugated O-tethered (Z)enediynes 110 were first targeted – these were initially chosen over the N-tethered systems as
they required fewer steps to prepare (Scheme 2.15). Firstly, construction of the stereodefined
(Z)-enynols 108 was achieved using a multistep procedure, which allows the preparation of
highly substituted stereodefined enynols, starting from commercially available methyl
propiolate 240 (Scheme 2.16).100 The (Z)-3-iodoacrylate 242 was synthesized via a
hydrohalogenation reaction by treating methyl propiolate 240 with NaI in acetic acid at 70 °C.
This gave exclusively the (Z)-isomer in good yields (50−70%) at ambient temperature.101

Scheme 2.16: Hydrohalogenation mechanism of methyl propiolate 240
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The nucleophilic attack of iodide ion to terminal carbon of the propynoate produces
intermediate 241’ the repulsion of carbanion and halogen electron pair 241’’ being responsible
for the observed (Z)-stereoselectivity in 242 (Scheme 2.16).

Scheme 2.17: Multi step synthesis of substituted 1,3-enynols 108

The (Z)-3-iodoacrylate 242 was then converted to methyl (Z)-5-phenylpent-2-en-4-ynoate 243
under standard Sonogashira coupling conditions (Scheme 2.17). The ester was then reduced to
(Z)-5-phenylpent-2-en-4-yn-1-ol 108 using DIBAL-H at −78 °C, which is the key scaffold for
making enediyne 110. In order to make more highly substituted starting materials, the (Z)-5phenylpent-2-en-4-yn-1-ol 108 was then transformed to (Z)-5-phenylpent-2-en-4-ynal 244 by
treating with the mild oxidizing reagent MnO2. This aldehyde was treated with alkyl and aryl
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Grignard reagents to produce the secondary alcohols 108a-c, ready for propargylation to the
required enediynes.
The structure of the key (Z)-stereoisomeric alcohol 108a (R1 = Ph) was confirmed form
NMR spectroscopy by comparison of its 1H NMR data with those reported in the literature.102
The 1H NMR spectrum showed key resonances for (Z)-coupled alkene protons at δ 6.14 (d, J
= 10.9 Hz, 1H, =CH), and 5.81 (d, J = 10.9 Hz, 1H, =CH) protons with a resonance at δ 1.84
(bs, 1H, OH) for the hydroxy group (Figure 2.1).

Figure 2.1: 1H NMR (CDCl3, 500 MHZ) of synthesized key 1,3-enyneol scaffold 108a
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2.4.2 Synthesis of O-tethered (Z)-enediynes 110 and optimization of novel Au(I)catalyzed cycloaromatization

Scheme 2.18: Synthesis of stereodefined O-tethered (Z)-enediyne 110a from enynols 108a-d

Having synthesized the stereodefined 1,3-enynol 108a it was treated with NaH in THF and
then with propargyl bromide at room temperature to give the desired enediyne 110a in good
yield (79%) (Scheme 2.18). This compound is previously unknown in the literature and the
structure of this product was confirmed by 1H and

13C

NMR spectroscopic analysis which

showed characteristic resonances for the terminal alkyne proton at δ 2.44 (t, J = 2.4 Hz, 1H)
and the two CH2 groups at δ 4.43 (dd, J = 6.5, 1.4 Hz, 2H) and δ 4.19 (d, J = 2.4 Hz, 2H). The
(Z)-double bond protons resonated at δ 6.08 (dt, J = 10.9, 6.5 Hz, 1H, =CH), and 5.88 (dt, J =
10.9, 1.5 Hz, 1H, =CH) (Figure 2.2). The product was also analyzed by HRMS (ESI-OTF) m/z
calcd for C14H12ONa [M + Na]+ 219.0786, found 219.0793.
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1

H NMR spectrum (500 MHz, CDCl3) of 1,3-enynol 110a

13

C NMR spectrum (125 MHz, CDCl3) of 1,3-enynol 110a

Figure 2.2: 1H and 13C NMR (CDCl3, 500 MHZ) spectra of tethered enediyne 110a
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With the model starting material 110a in hand, its reactivity under Au(I)-cycloaromatization
reaction conditions was probed (Scheme 2.19). The first catalyst was a cationic Au/Ag system,
which was a proven efficient catalyst for the previously studied 1,6-enyne cycloisomerization
chemistry in Scheme 2.7a.51

2.4.3 Optimization of the Au(I)-cycloaroamtization reaction of the unconjugated Otethered enediyne 110a

b)
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Scheme 2.19: a) Au(I)-catalyzed activation at room temperature b) formation of 245a via single cleavage
rearrangement mechanism

As shown Scheme 2.19, enediyne 110a was treated with the in situ generated cationic
Au(I)-catalysts, formed by mixing an equimolar amount of (5 mol %) AuPPh3Cl and AgBF4
in dry DCM at room temperature with stirring for 2 h. TLC analysis of the reaction mixture
showed 100% conversion of the starting material. Therefore, the reaction was stopped and
filtered through a small silica pad and the solvent was evaporated and the resulting crude
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reaction mixture was analyzed by 1H NMR spectroscopy. This confirmed complete conversion
of the starting material and showed new characteristic resonances for the 5-exo-dig cyclisation
product 158a, likely formed via single cleavage rearrangement, as well as the 6-membered
product 245a (158a and 245a = 8.8:1) (intermediate 190 leads to 196 via single cleavage
rearrangement 195 shown in Scheme 2.19b) in 49% yield (based on NMR analysis using
difluorobenzaldehyde as an internal standard) (Table 2.1 entry 1). The IPrAuCl catalyst system
provided good results and resulting crude reaction products were purified by flash column

chromatography over silica gel giving 158a as a pure product in 67% yield (158a and 245a =
4.4:1, 91% yield) (Table 2.1 entry 2), however 245a was highly unstable and it decomposed
upon purification.
The resulting pure dieneyne 158a was characterized by 1H NMR spectroscopic analysis
showing characteristic resonances for a Z-alkene at δ 6.47 (d, J = 11.4 Hz, 1H), and 5.71 (d, J
= 11.4 Hz, 1H) and the other alkene proton resonance as a singlet at δ 6.07 ppm. HSQC analysis
also identified the two methylene groups having 13C NMR resonances at δ 74.7 and 75.0 ppm
correlating to (in blue colour) CHa2 and CHb2, respectively, adjacent to the oxygen (Figure
2.3b). The pure compound was also analyzed by mass spectrometry showing a HRMS (ESI)
ion peak [M + Na]+ at m/z 219.0793 which is consistent with the molecular formula calculated
for C14H13ONa 219.0786 of 158a.
The 6-membered ring product 245a was unstable upon purification by column
chromatography over silica gel. A similar result occurred when neutral alumina used in place
of silica gel. However, for the confirmation of this mechanistic evidence 245b (R2 = Me) was
able to be isolated in 87% yield after rapid column chromatography and was characterized by
1H

NMR spectroscopy (see spectra in experimental section for compound number 245b –

unfortunately, the compound was too unstable to obtain a

13C

NMR). The NMR spectral

analysis data confirmed the formation of products 158a and 245a, which was clear evidence
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for the proposed cycloaromatization mechanism (1,6-enyne single cleavage products, Scheme
2.3), where the enediyne 110a undergoes anti 5-exo-dig cyclisation to give a similar
intermediate to 190 which further leads to two possible single cleavage rearrangement
pathways forming 158a and 245a (see mechanism Scheme 2.6). Additionally, an intermediate
trapping reaction was also attempted by using MeOH as a nucleophile, however, the reaction
was unsuccessful, and the 5-memebered dieneyne 158 was the only observed product (Scheme
2.20).87

a) 1H NMR (CDCl3, 500 MHZ)

b) HSQC spectrum for the dienyne intermediate 158a
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Figure 2.3: a) 1H NMR (CDCl3, 500 MHZ) and b) HSQC spectrum for the dienyne intermediate 158a

It was very pleasing that the tethered enediyne 110a successfully underwent Au(I)-catalyzed
activation leading to the single cleavage rearrangement products 158a and 245a. However, the
second part of the proposed mechanism for cycloaromatization of dienyne 158a to 111a
reaction did not proceed at room temperature.
Based on the confirmed preliminary results, further reaction conditions were optimized
to find an effective catalyst system and conditions for the cycloaromatization step to form the
isobenzofuran product 111a (Table 2.1). Surprisingly, switching the phosphine ligand of the
Au(I)-catalyst [AuPPh3Cl] to an NHC ligand in the catalyst (IPrAuCl/AgSbF6) resulted in the
starting material being completely consumed within 10 min. The isolated yield of 158a was
again good (61%), however 245a was again too unstable for column purification to be isolated,
the resonances in the 1H NMR spectrum were similar to those for 245b (Table 2.1, entry 2).
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Another interesting result was that the highest yields were observed at room temperature, as
obtained in the 1,6-enyne cycloaddition reaction (Scheme 2.7a). However, at room temperature
the expected cycloaromatization reaction did not progress further even after stirring for 24 h.
In order to form a cycloaroamatized product, the reaction was heated at reflux for 4 h (Table
2.1, entry 3). TLC analysis of this reaction showed 158a being slowly converted to a new
product, which proved to be the cycloaromatization product 111a. In contrast, compound 245a
slowly disappeared by TLC analysis which again showed the instability of the single-cleavage
6-membered ring product.103 Work-up and purification provided the 5-membered ring product
158a and the cycloaromatized bicyclic product 111a, in yields of 22% and 32%, respectively
(Table 2.1, entry 3).

Scheme 2.20: Intermediate trapping reaction with MeOH nucleophile.

The structure of the 4-phenyl-1,3-dihydroisobenzofuran 111a was confirmed by 1H and
13C

NMR spectroscopic analysis showing characteristic signals at 𝛿 7.45 -7.25 (m, 8H, ArCH)

and at 5.17 (s, 2H, OCH2) and 5.20 (s, 2H, OCH2) ppm for the two pairs of CH2O protons. The
13

C NMR resonances at 𝛿 73.5 and 73.7 corresponded to the two methylene carbons. The

product 111a is a known compound and its NMR data matched with those reported.104
Given the incomplete conversion to the cycloaromatization product, this result
suggested the need to heat the reaction at reflux temperature for a longer time or higher
temperature. When the reaction was repeated at reflux temperature for 12 h the starting material
110a was fully converted to the aromatized product 111a, which was isolated in a moderate
yield of 50% (Table 2.1, entry 4). Increasing the catalyst loading to 10 mol% IPrAuCl/AgSbF6
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had essentially no effect on the yield, but the amount of aromatized product 111a was
dramatically increased (158a:245a of 1:20) (Table 2.1, entry 5). The reaction was also tested
in two different aprotic solvents, DCE and toluene, however, they provided poor combined
yields of 42% and 33%, respectively (Table 2.1, entries 6 and 7). Changing to acetonitrile as
the solvent provided only 10% yield of 158a and 245a in a 2.9:1 ratio, and curiously the
formation of 111a was not observed (Table 2.1, entry 8).
When the isolated pure diene 158a was subjected to Au-catalysis by heating at reflux
temperature overnight, the substrate underwent 100% conversion to give the isobenzofuran
111a as the sole product in a good yield of 70% (Table 2.1, entry 9). Further the role of the
additives, AgBF4 and AgOTf were examined. The one pot yield of 111a increased slightly to
55% with AgBF4, while AgOTf provided a lower yield of 33% (Table 2,1, entry 10 and 11).
As explained in the introduction, Pt(II) is an effective catalyst and it activates 1,6-enynes to
give 5-membered ring products.52 When the substrate 110a was treated with PtCl2 at room
temperature a mixture of cis and trans isomers of 158a and 245a, as well as 111a were obtained
(Table 2.1, entry 13). A control reaction was also performed in the absence of Au(I)-catalyst
(Table 2.1, entry 14). In this experiment the addition of Ag(I)-salt alone in dichloromethane at
room temperature showed no reaction, indicating that the cationic Au(I)-catalyst is key for the
electrophilic activation of the alkyne via a 𝜋-alkynyl Au-complex (Table 2.1, entry 14). A
thermal tetradehydro Diels-Alder [4+2]-cycloaromatization reaction was also attempted by
refluxing 110a in DCE, however, the substrate remained unreacted and could be recovered
(Table 2.1, entry 15). Finally, the isolated 158a also tested under thermal TDDA reaction
condition, however, the starting material remain unchanged (Table 2.1, entry 16).
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Table-2.1: Optimization of the reaction conditions for the cycloaromatization of 110a

Entry

Au-cat
(mol%)

Additive
(mol%)

Solvent

Temp

%Con

Time/h

Ratio and
Yieldsa,b
(158a:245a:111a)
49a
(8.8:1:0)
91a
(4.4(61)b:1:0)

1

AuPPh3Cl (5)

AgBF4 (5)

DCM

rt

100

2

2

IPrAuCl (5)

AgBF4 (5)

DCM

rt

100

0.10

3

IPrAuCl (5)

AgSbF6 (5)

DCM

reflux

100

4

(22)b:(0)b:(32)b

4

IPrAuCl (5)

AgSbF6 (5)

DCM

reflux

100

12

50b
(0:1:4.5)a

5

IPrAuCl (10)

AgSbF6
(10)

DCM

reflux

100

12

51b
(0:1:20)a

6

IPrAuCl (10)

AgSbF6
(10)

toluene

reflux

100

24

42a
(1:1.6:1.7)

7

IPrAuCl (10)

AgSbF6
(10)

DCE

reflux

100

24

33b
(0:0:1)

8

IPrAuCl (10)

AgSbF6
(10)

ACN

reflux

58

24

10a
(2.9:1:0)

9c

IPrAuCl (10)

AgSbF6
(10)

DCM

reflux

100

12

70b
(only 111a)

10

IPrAuCl (10)

AgBF4 (10)

DCM

reflux

100

12

55b
(0:1:20)a

12

IPrAuCl (10)

AgOTf (10)

DCM

reflux

100

24

38a
(2.7:1.4:0)

13

PtCl2 (5)

-

DCM

rt

100

24

14

-

AgSbF6
(10)

DCM

rt

NR

24

34a
(1.3:(245a:245a’)d:1)
0

69

15

-

-

DCE

reflux

NR

12

0

16c

-

-

DCE

reflux

NR

12

0

a) Yields and ratio based on 1H NMR analysis using 3,5-difluorobenzaldehyde as an internal standard b) isolated yield c) 158a
was used as the starting material d) 245a:245a’ cis:trans = 4.9:4.8 e) NR = no reaction

During these optimization reactions often, low yields were obtained. When increasing the
catalyst loading form 5 mol% to 10 mol% the isolated yields increased by only 1% (Table 2.1,
entry 4 and 5). In contrast to this result, when the pure isolated compound 158a was subjected
to the optimized conditions the dihydroisobenzofuran 111a was formed as the sole product in
a good yield of 70% (Table 2.1, entry 8).105 Indeed, this significant result occurred due to two
potential factors: 1) the starting material 245a will not undergo conversion to 111a and 2) given
the air and light sensitive nature of the product 111a, it is well known that isobenzofuran 246
when exposed to atmospheric air and in presence of light reacts with molecular oxygen then
spontaneously forms the peroxide 247 (Scheme 2.21).106 Therefore, this potential problem was
solved by wrapping the reaction flask with aluminum foil and also avoiding atmospheric
exposure.

Scheme 2.21: Isobenzofuran 246 spontaneous formation of peroxide 247

With this preliminary optimization results in hand, the next objective was to analyze
the substrate scope for the cycloaromatization reaction using substituted O-tethered (Z)enediynes. These substrates were prepared using MnO2 oxidation of alcohol 108 to aldehydes
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244 and Grignard reaction provides substituted enynols 108 (Scheme 2.17), which upon
propargylation (Scheme 1.8) gave the required enediynes. It was anticipated that compounds
110 can cycloaromatize to more stable products 111 as shown in Table 2.2.

2.4.4:

Optimization

of

substituted

O-tethered

enediynes

110

under

Au(I)-

cycloisomerization

With the best optimized reaction condition of IPrAuCl/SbF6 (Table 2.1, entry 9) in
hand, further investigations of substituted O-tethered enediynes 110 under the Au(I)cycloaromatization reaction conditions were undertaken. The required enediynes were
synthesized with varying substitutions at the R2 and R4 position on 110 (Scheme 2.18).
Previously unknown O-enediynes 110b, b’, c, c’, d and e were synthesized using the multistep
synthesis procedure (shown in Scheme 2.23 and 2.24). To obtain them, the corresponding
alcohols 108 from the Grignard addition reaction were reacted with propargyl bromide in the
presence of NaH to provide the enediyne substrates 110 in excellent yields.
Having these substituted starting materials in hand, the substrate having a methyl group
at the R2 position 110b was reacted with IPrAuCl/SbF6 catalyst system in DCE solvent, which
are the optimum Au(I)-cycloaromatized condition to form 111a from 110a in Table 2.1, entry
5 and same catalytic system also provided 70% isolated yield of 111a from 158a in Table 2.1,
entry 9 (Table 2.2, entry 1). TLC analysis of the reaction showed the disappearance of starting
material and no evidence of corresponding product spots. Also, 1H NMR analysis of the crude
reaction material was performed which clearly indicated the disappearance of characteristic
signals of 110b resulting from decomposition. However, this time the reaction was repeated
under the same reaction condition but at room temperature. Surprisingly, after only 10 min at
room temperature, the starting material 110b completely converted to the corresponding
mixture of the 5-membered ring dienyne intermediate 158b along with the trace amount of the
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6-membered ring product 245b (Table 2.2, entry 1). Like 245a, compound 245b was also
unstable upon column chromatography purification with only 2 mg of pure material was
isolated following chromatography, 8b isolated in 7% yield.

Table 2.2: Reactions of substituted enediynes under Au(I)-catalysis ((10 mol%)
IPrAuCl/AgSbF6) in DCE solvent:

S.no

Enediyne

Time

Conversion

%Yields of
(158:245:111) a,b

1

87a:10a:0

10 min

100%b

5 min

Decomposedc

-

Complex

-

2

(reflux)
3

15 min

mixture

e
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4

30 min

Decomposedb

5 min

Decomposedb

-

5

-

a) Isolated yields b) Reaction performed at room temperature c) Reaction performed under reflux condition d)
Catalyst used [(PPh3Au)3O]BF4 (2.5 mol%) in toluene at reflux e) Reaction performed at -10°C

The isolated pure dienyne 158b was re-subjected to the cycloaromatization reaction conditions
to see if aromatization could be induced at higher temperatures, however, the dienyne 158b did
not undergo cycloaromatization as previously occurred with 158a to 111a in Table 2.1, entry
9. Instead, the compound decomposed after 5 min of stirring at reflux temperature and a
complex mixture was formed when reaction performed at -10 °C (Table 2.2, entries 2 and 3).
With these disappointing results, further investigations continued on the substrate 110c, where
the CH3 substituent was placed at the R3 position instead to see if the corresponding products
would be formed more efficiently. However, when 110c was subjected to the Au(I)-catalyzed
cycloaromatization conditions none of the desired products were obtained (Table 2.2, entry 4)
and starting material had decomposed. As discussed in the introduction of 1,6-enynes, it is
evident that Au(I)-catalyzed 1,6-enynes rearrangement is highly dependent on the substitution
on the 1,6-enyne (Scheme 2.13). The failure of substrate 110c (R3 = CH3) to undergo
cycloaromatization, might be due to reaction occuring via a double cleavage rearrangement
pathway (Scheme 2.6, intermediate 189 to 192) leading to intermediate 248, which might then
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decompose under the reaction conditions as it does not have the correct connectivity for
aromatization to occur (Scheme 2.22a).83

Scheme 2.22: a) Favorable rearrangement pathway for the Au(I)-cycloaromatization reaction of
enediyne 110 b) Steric hindrance effect of R2 substitution towards 6-endo-dig cyclization

The phenyl-substituted derivative 110d was also prepared and subjected to the
optimized cycloaromatized conditions. A black precipitate immediately formed, and TLC
analysis showed complete decomposition of the starting material (Table 2.2, entry 5). Perhaps,
this might also be the result of steric hindrance between the Ph group in 110d and the terminal
Ph of the enyne (see 158-int) preventing the 6-endo-dig cyclization pathway (Scheme 2.22b).
This also appeared to be the case for the CH3 analogue, 110b, however in this case the single-
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cleavage cycloisomerisation product could be isolated- it is not clear why this could not be
isolated for 110d, but presumably the phenyl substituent rendered it unstable.
To find if the double bond geometry of the enediyne had any impact on the Au(I)cycloaromatization, the E-isomers of 110b’ and 110c’ were synthesized (Scheme 2.23a). The
(E)-vinyl iodo-ester 242’ was synthesized via a previously described method (Scheme 2.17),
in which 242 was treated with HI in acetic acid solvent.100 Both the O-tethered (E)-enediynes
110b’

and

110c’

completely

decomposed

under

the

optimized

Au-catalyzed

cycloisomerization reaction conditions and only in case of 110b’ a 5-membered ring dienyne
product 158b’ was isolated but in very low yield (Scheme 2.23b).

Scheme 2.23:a) Synthesis of (E)-eneidyne from (Z)-vinyl iodoester 242 using HI reaction conditions. b) Au(I)catalyzed cycloaromatization of (E)-enediynes 110b’ and 110c’
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In order to probe the effects of a different tether in the enediyne, propiolic acid and the enynol
108a were reacted under coupling reaction conditions using DCC with catalytic DMAP in THF
to give ester linked enediyne product 110e in 86% yield (Scheme 2.24). However, the resulting
enediyne was also tested under the Au(I)-catalyzed conditions, which resulted in
decomposition at room temperature (Scheme 2.25a).

Scheme 2.24: Synthesis of ester linked enediyne 110e via acid alcohol coupling reaction.

As the failure of 110e to react is potentially due to the electron-deficient nature of the
propiolic ester, disfavouring coordination of the π-philic gold catalyst, the substrate was next
treated with the Lewis-basic [(Ph3PAu)3O]BF4 catalyst. This would potentially enable a dual
Au(I)-catalysed cyclization via formation of a gold-acetylide. Such a species might be favoured
by the increased acidity of the propiolic ester vs. a propargyl ether. This catalyst system was
effective for our groups study of propiolic amide enediynes (see Scheme 2.1) and effectively
cycloaromatized them to the corresponding isoindolinone products via a gold-acetylide.
Surprisingly, the starting material remained intact and unreacted 110e was recovered after
stirring for 12 h at reflux temperature (Scheme 2.25b). The failure of this substrate to react
maybe due to a different conformation of the starting material in comparison to the amidelinked systems in Scheme 2.1 - or the fact that these propiolic amides had a (Z)-enyne
geometry. For this reason, the ester-linked substrate 110e failed to react under the optimized
condition, it might be instructive to investigate amide-based systems, especially since other
reports have found success with these in gold-catalysed reactions.
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Scheme 2.25: Attempted dual Au(I)-catalysed cycloaromatization of O-tethered enediyne 110e

For example, a literature report by Shin and co-workers explained the propionamide
1,6-enyne activation (Scheme 2.26a).107 In this report the propiolamide-derived 249 reacted
under Ag(I) or Ag(I)-activation via a 5-exo-dig cyclization to intermediate 250 in contrast to
the single cleavage skeletal rearrangement. It then underwent an Alder-ene type cyclization via
transition state intermediate 251. This unexpected reactivity occurred by polarized triple bond
co-ordination with the Lewis acidic metal-catalyst and the synergistic interaction of the
carbonyl oxygen to the metal-catalyst (intermediates 250 and 251) leading to formation of the
1,4-diene 252. Furthermore, Shin and co-workers reported that when X = NPh the 1,6-enyne
253 gave a cyclopropyl Au(I)-carbenoid intermediate which was trapped with Ph2SO as an
oxidant to form 254. They also found trace amounts of the corresponding single cleavage
rearranged diene product 255 (Scheme 2.26b).108 In future work, such an approach might be
explored with amide-linked enediynes.

77

a) Shi and co-workers
[M]
O

O

5-exo-dig
M = Ag and Au

X

O
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×
rearrangment

X

X

X

RT

[M]
O

Alder-ene type
cycloisomerization √

H

X = NPh
250

249

252
1,4 diene

251

b) Shin and co-workers
O
PhN

[(SPhos)AuNTf2) (5 mol%)
CH3

Ph2SO
DCM, 60 °C, 24-94%

253

10 examples

O

O

O
+

PhN

PhN

CH3

CH3
254, (56%)

255, ( 7%)

Scheme 2.26: a) Au(I)-catalyzed 5-exo-dig Alder-ene type cyclization of 1,6-enyne to 1,4-diene 252 b)
Intramolecular trapping reaction of an Au(I)-cyclopropyl carbene intermediate 254

2.5: Conclusion

In summary, the above investigation of substituted O-tethered enediynes under Au(I)-catalyzed
cycloaromatization conditions for 110b, b’, c, c’, d, e and did not provided the corresponding
aromatized products 111 for a broad range of substrates (Table 2.2). Overall, these results
indicating that substituted enediynes are not efficient for Au(I)-catalyzed cycloaromatizations
and show only a limited tolerance to the steric demand of the substituents.
While a broad scope was not realised, novel conjugated enediyne substrates 110 were
synthesized via a multistep synthesis procedure via stereodefined (Z)-enyne-ols 108 (Scheme
2.18 and 19). Furthermore, compound 110 was reacted under optimized Au(I)-catalyzed
conditions to provide the cycloaromatized product 111a in good yield providing proof of
principle for the concept. Interestingly, at room temperature, this reaction underwent a
traditional single cleavage mechanism providing the 5-membered intermediate 158a. This
intermediate undergoes tandem cyclization via a second Au(I)-catalyst activation under
thermal conditions to the cycloaromatized isobenzofuran product 111a (Scheme 2.23). The
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proposed mechanism for the Au(I)-catalyzed cycloaromatization was supported by
characterization of the isolated single cleavage intermediates 158a and 245a. Compound 158a
was transformed to the isobenzofuran 111a via a second, separate, Au(I)-catalyzed activation
reaction.105 Curiously, other substituted enediynes failed to undergo cycloaromatization and
the CH3-substituted 110b provided an unstable 5-membered intermediate 158b-int and trace
amounts of a 6-membered ring product 245b (Table 2.2). These unsuccessful cyclization
reactions of substituted enediynes could be a result of the steric hindrance to formation of the
fused cyclopropane Au-carbene intermediate 110a-int, leading to single cleavage
rearrangement (see an overview Scheme 2.27). In future work, a computational analysis of the
reaction mechanism should be carried out in order to understand the exact reasons for the
failure of substituted systems to react.

Scheme 2.27: An overview Scheme for the Au(I)-catalyzed enediyne 110 cycloaromatization
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In this chapter, the Au(I)-cycloaromatization method was not effective for the substituted
enediynes 110 which failed to provide the products 111. Therefore, to overcome this problem
it was decided to change the catalyst system and mechanistic approach, which is demonstrated
in the following Chapter 3.
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Chapter

3:

Rhodium-Catalyzed

Tetradehydro

Diels–Alder

Reactions of Enediynes via a Rhodium-Stabilized Cyclic Allene

3.1 Introduction
The initial investigation of the cycloaromatization reactions of enediynes 110a under Au(I)catalysis suffered from limited substrate scope (Table 2.2), which was hypothesized to be due
to a number of factors, including competing double-cleavage rearrangement, steric hindrance
during the cycloaromatization process and synergistic interactions of the carbonyl oxygen to
the metal-catalyst. Attention was then shifted to transition metal-catalyzed oxidative
cyclization processes, as seen in the general 1,6-enyne oxidative cyclization mechanism shown
in Scheme 2.5. The reason for pursuing the Au-catalyzed cycloaromatization formal TDDA
reaction was to provide complementary substrate scope to the dual-Au-catalyzed
cycloaromatization of (E)-N-benzyl-N-(pent-2-en-4-yn-1-yl)propiolamides 165 (Scheme
3.1).71

Scheme 3.1: Dual-Au catalyzed cycloaromatization of (E)-enediyne 165

While this gold-catalysed method was mechanistically novel and had a good substrate
scope, it did require moderately high temperatures and required a terminal alkyne, in order
form the Au-acetylide to form catalytically. Unfortunately, while the concept of utilizing a
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traditional 5-exo-dig/single cleavage pathway, followed by aromatization was demonstrated
for a couple of substrates in chapter 2, the scope was limited. In particular, systems with a
substituent on the alkyne did not work, which had been a primary goal for this approach in
order to provide complementarity to the dual-Au-cycloaromatization previously developed in
our group (Scheme 3.2).

Chapter-2: Au(I)-cycloaromatization of unconjugated enediyne 110

no group here

R3
O

single cleavage
rearrangment
(AuL)
5-exo-dig

R2

[4+2]
cycloaromatization

O
H

AuL+
R2

O
R2

R1

R1
R1

110

(O)-tethered eneidyne

158-int
(Z)-dieyne

111
one successful product

Scheme 3.2: Limited scope of Au(I)-catalyzed [4+2]-cycloaromatization of enediynes 110

Therefore, an alternative catalytic approach to develop a reaction that could
accommodate these substrates and run at lower temperatures was investigated. In this context,
attention was shifted to the possibility of forming of a cyclic allene intermediate 260 similar to
that proposed in the thermal cycloaromatization pathway 66-a (Scheme 1.10), but under a
lower energy catalytic pathway. In this chapter, the harnessing of a Rh-catalyzed oxidative
cyclization process for a formal TDDA reaction via a Rh-stabilized allene 259 is presented
(Scheme 3.3). Before these results are discussed a brief background to known Rh(I)-catalyzed
cyclizations of 1,6-enynes and dieneynes is presented.109-114 A short background on Rhcatalysed cycloisomerisation reactions is now presented as background to this work.
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Scheme 3.3: Possible intermediates to cycloaromatize the enediyne 110 via a cyclic allenylrhodium species.

3.2 Rh-Catalyzed 1,6-enyne cycloisomerization

Trost developed the first intramolecular Alder-ene oxidative cyclization of enynes using both
a Pd-and a Ru-catalyst.115-116 However, Rh(I)-catalyzed activation of 1,6-enynes 260 was first
reported by Zhang and co-workers using [Rh(dppb)Cl]2/AgSbF6 to catalyze the
cycloisomerization of enynes 260 to form the 1,4-diene products 264 (Scheme 3.4).110 The
catalytic cycle begins with the active catalyst first selectively undergoing coordination to the
alkene and alkyne to give 261, followed by oxidative cyclization leading to the
rhodacyclopentene intermediate 262. This fused bicyclic intermediate undergoes β-hydride
elimination to give vinyl-Rh(III) intermediate 263. Finally, reductive elimination forms the
organic 1,4-diene product 264 and regenerates the active Rh(I)-catalyst (Scheme 3.4). In this
study, the optimized catalytic system successfully enabled different tethered (Z)-enynes to
provide 5-membered ring diene products. However, this process was not amenable to (E)enynes, as no diene product was formed.
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Scheme 3.4: First Rh(I)-catalyzed Alder-ene cycloisomerizations of 1,6-enynes 260.

In a related study, Zhang et al. developed the first asymmetric Rh(I)-catalyzed cyclization of
1,6-enynes. In contrast to their previous study (Scheme 3.4), the (E)-enynes 265 were smoothly
converted to diene products 266 in high enantiomeric excess (99% ee) and excellent yields
using RhL(COD)BF4 (L = Tangphos) (Scheme 3.5a).117 Moreover, these exceptionally high
yields and superior enantioselectivities were achieved by preparing in situ an active catalyst
from [Rh(COD)Cl]2 (5 mol%), AgSbF6 (20 mol%) and the chiral phosphine ligands 267 and
268. Additionally, DFT calculations were performed to understand the role of the chiral ligands
for the 1,6-enyne cyclization. Finally, further experimental observations suggested that the
cationic Rh(I)-BINAP catalytic system was effective for (Z)-1,6-enynes, but not effective for
(E)-1,6-enynes. Whereas the Rh(I)-TangPhos catalytic system was an exceptionally effective
catalyst for both (Z) and (E)-1,6-enynes. The computational studies explained the different
reactivities of the Rh(I)-catalyst with BINAP and TangPhos ligands, in the Rh(III)metallacyclopentene intermediates the distortion angle (olefin methyl group and the substituent
on phosphine ligand) of intermediate B is less than that of the intermediate A, so that the
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BINAP ligand is more sensitive to steric effects. On the other hand, the planar transition state
intermediates C and D were not located due to severe steric repulsion between the Me of the
1,6-enyne and the Ph and tBu substituents groups of the ligands (Scheme 3.5b).
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H H
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Scheme 3.5: Enantioselective Rh(I)-catalyzed cyclization of (E/Z)-1,6-enyne 265to give the enantiomerically
pure diene products 266 b) Rh(III)-tetracordinated transitional state intermediates A,B and C,D

3.3 The Rh(I)-catalyzed [4+2]-cycloisomerizations of unactivated dienynes

Various groups have studied the dehydro-Diels–Alder reactions of unactivated trienes and
dieneynes under bisphosphine Rh(I)-catalyzed [4+2] reaction conditions.118-123 However,
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Hayashi and co-workers demonstrated a catalytic Rh(I)-diene complex which is more reactive
and highly enantioselective for intramolecular [4+2]-cycloaddition reactions compared to its
Rh(I)-bisphosphine counterparts (Scheme 3.6). The kinetic analysis data revealed that, when
the un-activated dieneyne 269 was treated with Rh-COD complex (2 mol%) in DCM solvent,
the reaction occurred rapidly with 97% conversion within 10 min. Whereas, Rh-bisphosphine
catalyzed (e.g. Rh-dppe or Rh-dppb) reactions proceeded sluggishly only undergoing 3−4%
conversion in 10 min (Figure 3.1).

Figure 3.1: A diagram of conversation versus time for the [4+2]-cyclization of 269 in DCM (3.0 mL) Rh (2
mol%) and AgSbF6 (3.9 mol%) at 25 °C. (Original picture was regenerated from Hayashi’s published work).124

Based on the experimental and kinetic results, this study concluded that the diene ligand
274 is desirable for the Rh(I)-catalyzed intramolecular [4+2]-cyclization of 269. Furthermore,
an asymmetric catalytic cycle was also proposed, where the dieneyne 269 coordinated to the
Rh-diene catalyst to give 270 which led to oxidative cyclization forming the rhodacyclopentene
intermediate 271. This then gives the rhodacycloheptadiene 272 via a suprafacial 1,3-allylic
migration of rhodium. This is an important step as it demonstrates the ability for these
rhodocyclopentene intermediates with pendant unsaturation to undergo ring-expansion
processes when there is no available -hydride present. Eventually, reductive elimination of
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the metal-catalyst produces enantiomerically pure product in 96% yield (>99% ee) and
regenerates the Rh(I)-diene complex (Scheme 3.6).124 Overall, the formation of the
rhodacyclopentene 271 is the stereo-determining step in this asymmetric process.
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Ph

MeO2C
MeO2C

Ph
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Scheme 3.6: Rh(I)-diene complex catalyzed asymmetric [4+2]-cyclization of dieneyne 269 synthesis of highly
enantiomeric excess bicyclic product 273.

In 2017 Dudley et al. reported an related reaction discovery using neopentylenetethered dieneyne 275, now bearing an electron-withdrawing ester on the diene fragment.

46

This material was subjected to oxidative cyclization condition using Wilkinson’s catalyst
[RhCl(PPh3)3] in toluene in a sealed vial at 130 °C (Scheme 3.7), however, these conditions
provided an inseparable mixture of dihydro-indane 278 and the aromatic indane 279. The
dihydro-indane was later exposed to air which completely converted it to the oxidized indane
279. They later found that instead of the air oxidation process, the resulting reaction mixture
could be treated with DDQ to provide indane 279 in yields up to 95%. Surprisingly, the Rh(I)catalyst and ligand screening for this reaction also revealed that diene complexes are more
effective than phosphine ligand complexes. In contrast to the Wilkinson’s catalyst, the
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combination of [RhCl(nbd)]2 and AgSbF6 in DCM (in situ generated Rh-cationic catalyst, 2
mol%) provided exceptional reactivity, allowing the reaction to proceed at room temperature instead of 130 °C - and with a reaction time of 30 min vs 3 h. The proposed reaction mechanism
involves the neopentylene tether dieneyne undergoing initial Rh-catalyst coordination to the
diene and alkyne of 275 to form complex 276, which was not seen in the previously reported
malonate-, ether- and sulfonamide tethered dieneynes (Scheme 3.6). This complex undergoes
oxidative cyclization to vinyl(𝜋-allyl)Rh(III)-intermediate 277, which finally upon reductive
elimination regenerates the catalyst and forms dihydro-indane 278. The first step of the Rh(I)coordination to the double bond attached to the electron-withdrawing group (ester) is taking
place simultaneously and undergoes Diels-Alder type cyclization to dihydro-indane 278. It can
also explain how weakly bonded norbornadiene ligand Rh(I)-catalyst systems are more
effective than the Wilkinson’s catalyst. This work represents a good way to prepare fused
aromatics, such as indanes, however the need for a separate oxidation step reduces the
efficiency of the procedure.

Scheme 3.7: Rh(I)-catalyzed [4+2]-cycloisomerization of neopentylene 275 and DDQ-oxidation to indane
product 279
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3.4 Proposed Rh(I)-cycloaromatizations of unconjugated enediynes.

Based on the capability of cationic Rh(I)-catalysts to trigger oxidative cyclisation of 1,6-enynes
to give rhodacyclopentenes and the ability for these intermediates to undergo ring-expansion
when exocyclic unsaturation is present (e.g. Scheme 3.6), a new conceptual Rh-catalysed
cycloaromatization of enediynes was proposed (Scheme 3.8).

Scheme 3.8: Hypothesized Rh(I)-catalyzed tetradehydro-Diels–Alder reaction (TDDA) of unconjugatedenediyne 110 to cycloaromatized bicyclic product 160

As shown in the proposed reaction in Scheme 3.8, the Rh(I)-catalyst should only
coordinate to the alkyne and the double bond portion of the enyne to give complex 280.
Coordination to the triple bond of the enyne is unlikely due to geometric constraints imposed
by the Z-configuration of the enyne. Oxidative cyclization of 280 should form the 5-membered
rhodacyclic intermediate 281. The resulting intermediate is well known in the 1,6-enyne Alderene reactions as describe above and usually contains a Me-group on the alkene terminal double
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bond (see Scheme 3.4, intermediate 262), allowing β-hydride elimination to give 1,4-diene
products (e.g., 264). In contrast a similar intermediate with the Me group replaced by an alkene
instead (Scheme 3.6, intermediate 271) allowed for a 1,3-allylic-migration/ring-expansion to
occur. Related substrates with an alkyne in place of the Me or the alkene group have not been
reported but given this precedent for 1,3-migration it is anticipated that the proposed
intermediate 281 could undergo a 1,3-propargyl-migration, which leads to the formation of a
7-membered rhodacyclic allenyl intermediate 259. In comparison to the cyclic allene formed
in the thermal TDDA reaction (Scheme 1.10), this cyclic allene is anticipated to be lower in
energy, due to the larger ring size and longer Rh-C bond lengths. Several pathways towards
the organic, aromatized product could be envisaged, including a Rh-assisted hydride
migration125-127 to give rhodacycloheptatrienyl intermediate 282, which would afford the
aromatized organic product following reductive elimination. Alternatively, the allenylrhodium intermediate 259 could directly undergo reductive elimination to give the highly
strained allene intermediate 260. Finally, a 1,5-hydride shift could provide the aromatic
bicyclic product 160.

Overall, this process would represent a formal Rh(I)-catalyzed

tetradehydro-Diels–Alder reaction of an unconjugated enediyne and should be compatible with
substrates having a range of substituents.
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3.5. Results and discussion
3.5.1 Synthesis of NTs-tethered unconjugated (Z)-enediyne 91f
The NTs-tethered enediyne 160f was synthesized and was chosen as a model substrate
to investigate the proposed intramolecular tetradehydro Diels–Alder reactions (TDDA) of
unconjugated enediynes (Scheme 3.9). The stereodefined (Z)-enyneol 108b was successfully
synthesized via a multistep synthesis procedure shown in the Chapter 2 (Scheme 2.19). The
(Z)-enyne-ol 108b was reacted with 4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide 109b
under Mitsunobu reaction conditions using PPh3 and DIAD in THF solvent at room
temperature to provide the NTs-tethered enediyne 110f in moderate yield 53%. The synthesized
stereodefined (Z)-enediyne 110f was purified by flash column chromatography and the
resulting product was confirmed by 1H NMR analysis. Firstly, the characteristic resonance peak
at 𝛿 2.18 ppm (t, J = 2.5 Hz, 1H, CH-alkyne) indicated the presence of the terminal propargyl
alkyne protons. The Ts-CH3 group was clearly present from the singlet resonance at 𝛿 2.36 (s,
3H, CH3(Ts)) and the two dd resonances at 𝛿 4.26 (dd, J = 18.5, 2.5 Hz, 1H, CHA(N)), and 4.11
(dd, J = 18.5, 2.5 Hz, 1H, CHB(N)) confirmed the presence of the 4-methyl-N-(prop-2-yn-1yl)benzenesulfonamide moiety. Secondly, the enyne part of the molecule was confirmed by the
presence of two distinctive alkene proton resonances at 𝛿 6.09 (dd, J = 10.8, 9.0 Hz, 1H, =CH),
and 5.66 (dd, J = 10.8, 0.9 Hz, 1H, =CH), which also indicated that the cis-configuration of
(Z)-enynol 108b was retained in the final structure of enediyne 110f (Figure 3.2). The

13C

NMR spectrum showed the correct number and types of carbon resonances. HRMS (ESI-OTF)
m/z calcd for C22H21NO2SNa [M + Na] + 386.1191, found 386.1183 also confirmed the correct
structure of 110f.

91

Scheme 3.9: Synthesis of the NTs-tethered (Z)-enediyne 110f from the stereodefined 1,3-enyneol 108b.

Figure 3.2: 1H NMR spectrum of NTs-enediyne 110f (500 MHz, CDCl3)

With the model unconjugated enediyne 110f in hand, the tetradehydro Diels–Alder
reaction of 110f under Rh(I)-catalyzed cycloaromatization reaction conditions was investigated
(Scheme 3.10). The substrate was treated with [RhCl(COD)]2/AgSbF6 and (rac)-BINAP at
room temperature in DCE solvent which was previously shown to be a powerful catalytic
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system for 1,6-enyne oxidative cycloaddition reactions providing 5-membered ring diene
products. 50

Scheme 3.10: Investigation of tetradehydro Diels–Alder reaction of unconjugated enediyne 110f under Rh(I)cycloaromatization

Gratifyingly, under these conditions the enediyne 110f was completely consumed and
a new clean spot was observed on the TLC plate after 12 h. The spot turned to burgundy colour
upon anisaldehyde staining. The crude product was directly analysed by 1H NMR spectroscopy
which showed clean conversion to the isoindoline product 160f without any by-product
formation. Interestingly, the synthesised product was not known in the literature; it was further
purified by flash column chromatography, eluting as a white crystalline product in 79% yield
(Table 3.1, entry 1). The structure of the novel isoindoline 160f was analysed by 1H NMR
spectroscopy, clearly showing no presence of an enediyne alkyne terminal proton which
appears at 𝛿 2.18 ppm in 110f. The alkene proton resonances at 𝛿 6.09, 5.66 ppm (Figure 3.3)
had also disappeared. On the other hand, the chemical shifts for the corresponding -CH3 and
Ts-CH3 groups were now shifted downfield compared to those in the starting material 110f and
the new chemical shifts for these groups appeared at 𝛿 1.70 ppm and at 𝛿 2.37 ppm, respectively
(Figure 3.3a).

93

Figure 3.3: a) 1H NMR (500 MHz, CDCl3) spectrum of 160f b) 13C NMR (126 MHz, CDCl3) spectrum of 160f.
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Furthermore, the chemical shifts of the methine and the diastereotopic methylene proton
resonances at 𝛿 4.94 (dt, J = 8.7, 4.3 Hz, 1H, CH(CH3)), and 𝛿 4.79 (dd, J = 13.7, 2.6 Hz, 1H,
CHA(N)) and 4.60 (d, J = 13.7 Hz, 1H, CHB(N)), respectively were different to those of the
enediyne 110f. Importantly, the number of aromatic proton resonances had increased from
9×ArCH in the enediyne 110f to 12×ArCH in the product. Also, the number of aromatic carbon
resonances (14) matched with the expected isoindoline structure 160f (Figure 3.3b). The
crystalline product was also analyzed by HRMS (ESI-OTF)−m/z calcd for C22H21NO2NaS [M
+ H] + 364.1371, found 364.1365. Finally, the structure of the novel isoindoline 160f was
determined unambiguously by X-ray crystallography carried out by Dr. Christopher
Richardson from the University of Wollongong (Figure 3.4).

Figure 3.4: X-ray crystal structure of isoindoline 160f (CCDC 1999577, performed by Dr.Christopher
Richardson)
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With the initial reaction results in hand, further optimization reactions for this
cycloaromatization reaction were conducted. We first tested the role of the ligand in the
cycloaromatization reaction, the enediyne 160f was reacted with the catalyst system without
an additional ligand using in situ generated cationic [Rh(COD)Cl]2/AgSbF6 catalyst in DCE
solvent. In this case, no desired cycloaromatized product was obtained even after stirring for
24 h at room temperature (Table 3.1, entry 2). This result concludes that the ligand is essential
for the Rh(I)-catalyzed [4+2]-cycloaromatization to occur. Our attention was then shifted to
replacing the BINAP ligand with dppb as an alternative bidentate phosphine ligand, however,
it exhibited a deleterious effect on the yield 49% (Table 3.1, entry 3). When the catalyst loading
for the TDDA reaction was lowered to 2.5 mol%, the resulting reaction only proceeded to 75%
conversion and the product 160f was obtained in 44% yield after 24 h (Table 3.1, entry 4).

Table 3.1: Optimization of Rh(I)-catalyzed tetradehydro Diels–Alder reactions of
unconjugated enediynes 110f and 110g

Entry

R

Catalyst

%Conv

Temp
/°C

% of
yieldc

1

CH3

[RhCl(COD)]2, (5 mol%)/ (rac)BINAP (12 mol%)/ AgSbF6 (20
mol%)

100

rt

79

2a

CH3

[RhCl(COD)]2, (5 mol%,), AgSbF6 (20
mol% ),

0

rt

0

3

CH3

[RhCl(COD)]2, (5 mol%)/ dppb (12
mol%)/ AgSbF6 (20 mol%)

100

rt

49

4

CH3

[RhCl(COD)]2, (2.5 mol%)/ (rac)BINAP (6 mol%)/ AgSbF6 (10 mol )

75

rt

44

5

CH3

[RhCl(COD)]2, (5 mol%)/ (rac)BINAP (12 mol%)/AgBF4 (20 mol%)

80

rt

60

96

6b

CH3

[RhCl(COD)]2, (5 mol%)/ (rac)BINAP (12 mol%)/ AgSbF6 (20
mol%) in DCM

100

rt

62

7

CH3

AgSbF6 (20 mol%))

0

rt

0

8

CH3

refluxed in DCE

0

80

0

a) reaction time was 24 h b) DCM as solvent c) isolated yields.

The in situ generated catalyst system prepared using AgBF4 instead of AgSbF6 also proved
detrimental resulting in only 80% conversion and providing only a 60% yield of the isoindoline
160f (Table 3.1, entry 5). When the solvent system was changed to dichloromethane (DCM),
the starting material was smoothly converted to the isoindoline product, however, the yield was
reduced to 62% (Table 3.1, entry 6). No reaction occurred when the substrate was reacted with
only AgSbF6 (Table 3.1, entry 7). The thermal TDDA reaction of the unconjugated enediyne
110f was also attempted. Interestingly, when 110f was heated at 80 °C for over 12 h the starting
material remained intact (Table 3.1, entry 8). This result clearly indicated that the highly
reactive nature of the cationic Rh(I)-catalyst is promoting oxidative cyclization under mild
reaction conditions without any background thermal reaction occuring. Therefore, the (5
mol%) Rh(COD)Cl]2, (12 mol%) (rac)-BINAP, and 20 mol % of AgSbF6 system was chosen
as an effective catalytic system to further study the enediyne TDDA cycloaromatization
reactions of related substrates (Table 3.1, entry 1).

3.5.2 Synthesis of densely functionalized isoindoline and isobezofurans

With an effective Rh(I)-catalyst system in hand, the substrate scope was established with a
range of NTs- and O-tethered enediynes 110a-t from stereodefined enyne-ols 108a-k (Scheme
3.9). The functionalized enediynes 110a-t were synthesized using three general methods (A, B
and C) as shown in Scheme 3.11. As discussed earlier in Chapter 2, standard Sonogashira
coupling with PdCl2(PPh3) and CuI followed by reaction with Grignard reagents (RMgX)
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allowed the synthesis of highly functionalized enynols 108a-k (Scheme 2.18). Later, the
synthesized substituted eneynols 108 were coupled to the NTs-propargyl amides 109b using
Mitsunobu coupling reaction conditions, via method A (DIAD/DEAD and PPh 3) or method B
coupling of TsNHBoc amide, following deprotection of Boc group and finally alkylation
reaction ((DIAD/DEAD and PPh3, TFA and alkylation), provided the NTs-tethered substrates
110f-l, v and w. Finally, using method C, the alcohols 108 under propargylation reaction
conditions using NaH, THF solvent provided O-tethered enediynes 110a-d and n-t (Scheme
3.11).
R3

109b
R2

R4

NHSO2R

NSO2R

DIAD, PPh3
THF, 0 °C−rt

R1

Method-A
110f-l,v and w

R2

R5

TsNHBOC

R3
R4
OH
R1
108

283
DEAD, PPh3

R4
TsBocN

Method-B

R4

DCM, rt

R3
R4

NaH
THF, 0 °C−rt

TsHN

R4

R4
TsN

MeCN, rt

R1
5
110m R

R1 = Ph, 4-F-(C6H5), 4-(C6H5)OMe, n- pentane,TMS

R2

109a/d X

R4

R2

K2CO3

285

284

R5
Method-C

R3

R3 TFA

THF, rt

109a

R2

R2

R3
Br

110a-u =

O

R2 = H, CH3
R3 = H, CH3, D
R4 = H, CH3, i-Pr, Ph, n-propyl

R1

109a X= Br
109d X= Cl

R5 = H, Et, Ph

R5
110a-d and n-t

108a = R1 = Ph, R4 = H

108g = R1 = TMS, R4 = Me

108b = R1 = Ph, R4 = Me

108h = R1 = Ph, R4 = n-propyl

108c = R1 = Ph, R4 = Ph

108i = R1 = Ph, R4 = iso-Pr

108d = R1 = 4-F-Ph, R4 = Me

108j = R1 = Ph, R2 = Me, R4 = Me

108e = R1 = 4-OMe-Ph, R4 = Me

108k = R3 = CH3

108 = R1 = n-heptyl, R4 = Me

Scheme 3.11: General scheme for the synthesis of highly substituted tethered enediyne (110a-u). Yields and
characterization are in the experimental section.

98

Table 3.2: Synthesis of the enediyne substrates 110a,b

a

Method A and B: DIAD/DEAD (1.3 equiv.), PPh3 (1.3 equiv), sulfonamide (1.15 equiv.), THF, rt, 3h. Method C: NaH (1.2

equiv.), propargyl bromide/chloride (2 equiv.), THF, 0 °C to rt, 3-4h. bIsolated yields.
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As shown in Scheme 3.11, various densely functionalized tethered enediynes 110a-u were
synthesized. The Sonogashira coupling method allowed the R1 group to comprise phenyl or
aromatic rings containing electron-withdrawing or electron-donating groups (Table 3.2, 110fi). R1 could also be n-heptyl (110j and 110p) or TMS (110k). Furthermore, R2 and R3 could be
methyl group (110s), R4 could be H, alkyl or phenyl and R5 ethyl (110m) or phenyl (110t). The
Ns-protected enediyne (110l)) was also synthesized (Table 3.2). Additionally, a carbontethered enediyne 110u was synthesized according to a previously reported method using
commercially available dimethyl malonate 286, which was reacted with enyne 287 to give 288
then propargylation provided the enediyne 110u in 72% yield (Scheme 3.12).

Br

CO2Me
MeO2C

286

+

CO2Me

NaH, TBAI
MeO2C
Cl

THF, 0 °C−rt
overnight
Ph
287

109a

MeO2C

NaH

MeO2C

THF, 0 °C−rt
4h
Ph
288, 82%

Ph
110u, 72%

Scheme 3.12: Synthesis of C-tethered enediyne 110u from dimethyl malonate 286 and enyne 287

The synthesized enediynes 110a-u were subjected to the optimised TDDA Rh(I)catalyzed cycloaromatization reaction conditions (Table 3.3). When the NTs- and O-tethered
R1 = aryl substituted enediynes 110f-i and 110a-o were reacted with the Rh(I)-catalyst at room
temperature, they smoothly underwent cycloaromatization to provide the corresponding
isoindoline products 160f-i and 160a-o in good yields of up to 83% (Table 3.3). The substrates
160j-k and 160p were R1 = n-heptyl and TMS were also well tolerated (Table 3.3,). The Nsprotected enediyne 110l reacted under TDDA conditions and formed the isoindoline product
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160l in a very good yield of 81%. Other N-protecting groups like benzyl were not investigated
due to the established instability of the corresponding isondolines; isoindolines are stable only
when the N-group is protected by electron-withdrawing groups, including -Ts, -Ns, Msprotecting groups.71, 128-130 Substrates 110m and 110t, in which the R5 substituent was Et and
Ph, respectively provided the highly densely functionalized isoindolines 160m and 160t in
excellent yields of 82% and 81%, respectively (Table 3.3). However, when the R 4 CH3
substituent was replaced by a n-propyl 110q, isopropyl 110r and phenyl substituent 110d, only
110q underwent cyclcoaromatization giving the isobenzofuran 160q. The enediyne substrates
110r (R4 = iPr) and 110d (R4 = Ph) were not tolerated, as evidenced by TLC analysis of crude
reaction mixture. 1H NMR analysis indicated decomposition of the starting material,
presumably due to steric hindrance imposed by branched or aromatic substituents, which
inhibited the cycloaromatization process. The dimethyl substituted substrate 110s reacted
under TDDA reaction conditions leading to the tri-substituted isobenzofuran 160s in a good
yield of 77%. Finally, the carbon-tethered enediyne 110u when subjected to the standard
TDDA conditions provided the substituted indane 160u in 77% yield.

Table 3.3: Synthesis of substituted isoindolines 160 under Rh(I)-catalyzed
cycloaromatization conditionsa,b,c
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a yields

are isolated yields, breactions conducted under a N2 atmosphere, c reactions occurred over different times (1 to 12

h, see Table for specific details), dstarting material decomposed
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3.6 Mechanistic investigation of the mechanism of the Rh(I)-catalyzed tetradehydro
Diels–Alder reaction of unconjugated enediyne 110f-D.

The successful substrate scope of the Rh(I)-catalyzed [4+2]-cycloaromatization reaction was
investigated with a new class of tethered unconjugated enediynes 110 and provided good yields
of bicyclic products 160 (Tables 3.2 and 3.3). Our attention was then shifted to investigate the
proposed reaction mechanism illustrated for the deuterated substrate 110f-D in Scheme 3.13.
A deuterated version of 110f was prepared along with collaborative computational studies to
provide evidence for the involvement of a hydride shift in the strained allene intermediate
shown in Scheme 3.13.

Scheme 3.13: Initial proposed TDDA reaction of unconjugated enediyne 110f-D under Rh(I)-cycloaromatization
conditions
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3.6.1: Deuterium isotopic labelling study

The deuterium labelling studies were performed on the substrate 110f-D which was prepared
as shown in Scheme 3.14 using similar chemistry to that described in Scheme 2.17, except that
the 𝛼-deuterated, β-iodo acrylate 242-D was used as the starting material. As shown in the
Scheme 2.14 the acetic acid-D (99% D) selectively incorporated the deuterium at the adjacent
carbon to the ester group of 242-D.
The deuterated ester 110f-D was successfully prepared with 87% deuterium
incorporation at the C3-position of enediyne 110f-D which was determined by 1H NMR
spectroscopic analysis (Figure 3.5). The deuterated substrate 110f-D was reacted under the
standard Rh(I)-TDDA conditions (Scheme 3.12). This reaction proceeded smoothly to the
isoindoline product 160f-D, which showed 72% deuterium incorporation at C-6 of the
isoindoline benzenoid ring, with partial loss (ca 15%) of deuterium from 1H NMR analysis
(Figure 3.6). The stacked 1H NMR spectra clearly show the reduced intensity of the H-6
resonances at δ 7.43 (d, J = 8 HZ, 0.30 H, ArCD/H). The neighbouring proton H-7 at δ 7.16
also appears as a singlet as expected if deuterium incorporation had taken place at C-6 (Figure
3.6). In comparison the non-deuterated isoindoline 160f the resonance for H-6 and H-7 appear
at δ 7.46 (d, J = 9.5 Hz, 1H, 1ArCH), and (7.16 (d, J = 8.0 Hz, 1H, ArCH) which helped
establish the position of the deuterium incorporation in 160f-D (Figure 3.6, bottom spectrum).
Gratifying, this result supports the potential involvement of a hydride (deuteride) shift in the
reaction (Scheme 3.15).
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Scheme 3.14: Synthesis of deuterated enediyne 110f-D from methyl (Z)-3-iodoacrylate-2-d 242-D

Scheme 3.15: Deuterium labelling study of enediyne-d 110f-D under cycloaromatization conditions

105

Figure 3.5: Stacked 1H NMR spectra of non-deuterated (top) 110f and deuterated (bottom) enediyne 110f-D.

Figure 3.6: Stacked 1H NMR spectra of non-deuterated 160f (top) and deuterated (bottom) 160f-D isoindolines.
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3.6.2: 1,3- or 1,5-Methyl group migration study and stereochemical competition of
TDDA.

To provide more mechanistic insights, the C-3 deuterium was replaced by a C-3 methyl group
in the enediyne 110v. This was synthesised using vinyl-iodoalcohol 289 in a Sonogashira
coupling reaction with phenyl acetylene, which provided the Me substituted enynol 108l in
87% yield. Then a Mitsunobu coupling reaction with amide 109b provided 110v in 64% yield
(Scheme 3.16). This substrate was then tested under the cycloaromatization conditions.
However, the starting material remained unchanged even after the reaction was allowed to
proceed for 24 h at room temperature. This result suggested the important role of this position
in the reaction.

Scheme 3.16: Potential methyl group migration study using enediyne 110v

The sensitivity of double geometry in the cycloaromatization reaction was also
investigated by synthesizing the O-tethered (E)-enediyne 110b’ (Scheme 2.17), which also
provided the corresponding isobenzofuran 160b’ in a comparable yield to that from the (Z)-

107

enediyne 110b. In contrast to the previously developed Rh(I)-catalytic systems for 1,6-enyne
cycloaddition reactions, the Rh(I)-catalyzed TDDA process ([Rh(COD)Cl]2, (rac)-BINAP and
AgSbF6) developed here has proven as powerful catalytic system for both (E) and (Z)enediynes, smoothly converting them to the corresponding bicyclic aromatic products (Scheme
3.17).110

Scheme 3.17: Tolerance of double bond geometry in TDDA reactions

3.6.3: Computational investigation of proposed Rh(I)-catalyzed tetradehydro Diels–
Alder reaction of unconjugated enediyne 110f

To gain more insights into the proposed mechanism, DFT calculations were carried out
via discussions of plausible reaction mechanism with our collaborators Dr. Alireza Ariafard
and Dr. Kaveh Farshadfar (University of Tasmania). Based on the deuterium labelling studies
in the prior section, the DFT calculations mainly considered our proposed cyclic allenyl-Rh
intermediate 300 (Scheme 3.19) which was derived from the model substrate (Z)-enediyne 110f
in the presence of [Rh(COD)Cl]2, AgSbF6. Instead of (rac)-BINAP ligand, the dppb phosphine
ligand was used to simplify the DFT calculations, as it also effectively catalyses the TDDA
reaction in combination with the Rh(I)-catalytic system (Table 3.1, entry 3).
Compare to simple 1,6-enynes Rh(I)-catalyzed oxidative cyclization reactions, the
computational studies suggested that the initial Rh-catalyzed oxidative cyclization process
occurs via coordination to the enyne double bond and the triple bond of the propargyl
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sulfonamide 290. Another possibility is the metal also selectively coordinates to two triple
bonds of the enediyne 291 (Scheme 3.19). DFT calculations further showed that initially, while
oxidative cyclization via 291 starting from 0.00 kcal/mol would directly offer the proposed
allenyl-Rh(III) intermediate 296, the barrier for this process was considerably higher (24.8
kcal/mol) when compared to the oxidative cyclization process via the 290 pathway (via
intermediate 292 11.4 kcal/mol) to afford the Rh(III)-metallacyclopentene 294. Following this
exergonic process, the resulting 294 undergoes an endergonic ring-expansion transformation
with an energy barrier of −0.7 kcal/mol to provide the key Rh(III) intermediate 296.
Intermediate 296 can be represented by two resonance contributors: an allenyl-Rh(III) 296' and
Rh(I)-stabilized cyclic allene 296'', these intermediates are represented by the calculated
hybrid structure (Figure 3.7), which is a bent allenyl rhodium species.
The resulting allenyl-Rh intermediate could potentially further undergo two different
reaction processes involving: (a) β-hydride elimination via transition structure 297 affording
298 which required a higher energy of 11.8 kcal/mol and (b) this process involved in C–C
reductive elimination via transition structure 299 with an energy barrier of −3.5 kcal/mol
leading to form strained Rh(I)-stabilised cyclic allene intermediate 300. For example, when
1,6-enyne 260 having Me-substitution on the alkene terminal carbon readily undergoes βhydride elimination via intermediate 262, however, enediyne 110 under Rh(I)-cyclization
condition leads to similar oxidative cyclization and resulting intermediate 281 cannot undergo
β-hydride elimination due to the abscence of β-hydrogen atom (Scheme 3.18).

109

Scheme 3.18: Competing reaction between β-hydride elimination and allenyl Rh formation

Surprisingly, the C–C reductive elimination process is computed to be significantly more
favourable (-3.5 kcal/mol energy) than the β-hydride elimination (11.8 kcal/mol). This process
occurred due to the fact that allenyl Rh resonance contributor 296' makes a significant
contribution to the overall structure 296 which indicates that there is significant s-bond
character between the Rh and C1, thus encouraging reductive elimination. The C–C reductive
elimination resulted intermediate 300 can be considered as a stabilized version of the cyclic
allene, which was a key cyclic allene intermediate in the thermal TDDA reactions of enediynes.
The Rh(I)-stablized version of cyclic allene is playing a key role in Rh catalyzed TDDA
reaction to occur at room temperature (Chapter 1, Scheme 1.10).
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Scheme 3.19: Free energy profile for Rh(I)-catalysed TDDA reaction of unconjugated (Z)-enediyne. Free
energies (potential energies) are given in kcal mol_1.

296′

296′′

Figure 3.7: Calculated hybrid structures of cyclic allenyl-Rh intermediate 296' (left) and Rh(I)stabilized cyclic allene 296'' (right)

Next, the allenyl bound Rh(I) intermediate 300 is computed to undergo oxidative addition of
the C–H bond to form the Rh(III)-hydride species 302. In this form of the structure rhodium is
attached to one face of the aromatic ring, and there is also a formal anion at C6 position.
Interestingly, this oxidative addition process clearly explains the experimental result of 110v
having a Me group under the optimized reaction conditions and which failed to undergo
cycloaromatization. This is a result of lowered ability of a C–C bond to undergo oxidative
addition to the Rh catalyst as compared to the C–H bond.
Following reaction process is an important mechanistic point which differe to the
previously known thermal TDDA reaction (Scheme 1.10), wherein the cyclic allene
intermediate 66-a undergoes 1,3- or 1,5-hydride shift which eventually leads to
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cycloaromatized product. However, in this catalytic mechanism, coordination of Rh to the 𝜋system of intermediate 300 avoids such a hydride migration and favours the C–H oxidative
insertion process. Next, the hydride inserted complex 302 undergoes rearrangement to form
303, which is primed for a highly favourable H–C6 reductive elimination. Finally, the reductive
elimination step generates the organic product 160f and the Rh(I)-catalyst re-enters the
catalytic cycle. The deuterium experimental results are consistent with computational results
and the proposed Rh-TDDA reaction mechanism supporting the incorporation of deuterium at
C6, the loss of deuterium potentially occurring between rhodium hydrides 300/302 and
solvent/adventitious water.

Scheme 3.20: Allene trapping experimental reactions with furan under Diels–Alder reaction condition
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Additionally, several experimental reactions were also attempted to trap the cyclic allene
intermediate 300 (derived from ene-diyne 110f and 110v) via Diels–Alder reactions with furan
(Scheme 3.20).131 However, these reactions were not successful, with the reaction of 110f
providing only isoindoline product (Scheme 3.20a) and with 110v the reaction did not form the
expected product and only starting material was recovered (Scheme 3.20b). The reasons for
this unsuccessful reaction are, firstly, due to the favourable oxidative addition process towards
intermediate 302 (-27.4 kcal/mol energy) – this step is a fast-intramolecular process that
outcompetes cycloaddition with furan. Secondly, oxidative addition of the methyl group to the
Rh catalyst (Scheme 3.20b) in intermediate 308 is not favourable to form the product 309 due
to the stronger C-C bond compared to the C-H bond.132

3.6.4: Proposed Rh(I)-catalyzed TDDA reaction mechanism of unconjugated enediyne
110f

Based on the DFT calculations and the mechanistic experimental studies, the catalytic cycle
was proposed as a Rh(I)-catalyzed intramolecular tetradehydro Diels−Alder (TDDA) reaction
of unconjugated enediyne 110f (Scheme 3.21). This Rh(I)-TDDA mechanism begins with
coordination of Rh(I)-catalyst to the enediyne 290, which undergoes oxidative cyclization to
form the Rh(III)-metallacyclopentene 294. This intermediate undergoes ring expansion to give
296, which upon C-C reductive elimination forms a Rh-stabilized cyclic allene intermediate
300. Next, a C-H insertion process take place wherein, the hydrogen atom oxidatively added
to the Rh species 302, intermediate 302 involves metal-catalyst rearrangement to give 303.
Finally, C-H reductive elimination of intermediate 303 via incorporating a hydrogen atom at
the C6 position provides the final isoindoline product 160f. In contrast to the thermal TDDA
cycloaromatization, the Rh(I)-catalyzed TDDA reaction occurs at room temperature via
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formation of novel intermediates 7-membered rhodacyclic-allene intermediate and the Rh(I)stabilized version of cyclic allene makes the reaction plausible this type of reaction is not
known in the literature.

Scheme 3.21: Proposed Rh(I)-catalyzed intramolecular TDDA mechanism for the unconjugated enediyne 110f
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3.7: Synthetic transformations of substituted isoindoline and isobenzofuran:

The initial goal of this project was to develop a powerful catalytic system for the
cycloaromatization of unconjugated enediynes via a formal TDDA reaction under mild
reaction conditions to provide functionalized bicyclic aromatic products in high yields, which
are important biologically relevant molecules.69 Some of the bicyclic molecules (Table 3.3)
were therefore subjected to synthetic transformations to give isoindoline and isobenzofuran
products. Gratifyingly, the isoindoline 160f was successfully transformed to the corresponding
isoindolinone in good yield using the mild and green oxidizing agent sodium chlorite (NaClO 2)
(Scheme 3.22a).133 Isoindolinones are present many natural products and are useful scaffolds
for making bioactive molecules, for example, Pazinaclone is a sedative and an anxiolytic drug
which contains an isoindolinone scaffold in its structure.134
Isobenzofuran 160a was also successfully oxidized under the same conditions to the
corresponding isobenzofuranone as a mixture of regioisomers, which was expected, given the
lack of steric differentiation of the two methylene positions afforded by the remote phenylsubstituent (Scheme 3.22b).
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Scheme 3.22: a) Synthesis of isoindolinone 310 from isondoline 160f, b) Synthesis of isobenzofuranone 311 and
311’ from isobenzofuran 160a using sodium chlorite as the oxidizing reagent.

The structure of oxidized product isoindolinone 310 was confirmed from

1H

NMR

spectroscopic analysis. The characteristic resonances for the isoindoline 160f for the
diastereotopic CH2 protons at 𝛿 4.79 ppm (dd, J = 13.7, 2.6 Hz, 1H, CHA(N)), 4.60 (d, J = 13.7
Hz, 1H, CHB(N)) had disappeared (Figure 3.8a) and the 13C NMR spectrum showing a carbonyl
carbon resonance at δ 166.3 ppm which further confirmed the structure of the isondolinone 310
(Figure 3.8b). On the other hand, the structures of the isobenzofuranones 311 and 311' were
confirmed by comparisons made with previously reported spectroscopic data.135

a)
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b)

Figure 3.8: Stacked 1H NMR spectra of isoindoline 160f and isoindolinone 310 b) 13C NMR spectrum of 310
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Next, the N-Ts group of isoindoline 160f was successfully deprotected by treatment with
Mg/MeOH over 40 min under ultrasonication conditions. This reaction involves a single
electron transfer mechanism, whereas the methanol provides hydrogen atom to the Nitrogen.
This reaction gave the desired product 312 in an excellent yield of 91% (Scheme 3.23).134 136
However, it should be mentioned that, this product was not purified by flash column
chromatography due to the instability of the isoindole without having an electron-withdrawing
protecting group on the N, which underwent rapid autooxidation in the presence of air.129 This
is still an important result, as sulfonamides are often challenging to remove137-138 and the free
N-H can be functionalized following deprotection to other potentially more stable structures.

Scheme 3.23: Deprotection of isoindoline product 160f using Mg/MeOH reagent under sonication condition.
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Chapter-4.: Conclusions, Future Directions and Summary

4.1. Future directions and preliminary results towards these.
4.1.2 Kinetic resolution of enediynes
As discussed in Chapter 1, one of initial aims of this project was also to prepare
enantiomerically enriched aromatization products (Chapter 1, Scheme 1.16) using kinetic
resolution.139-140 It is always challenging to synthesize enantiomerically pure compounds from
a racemic starting material and there are continued efforts to develop such a technique due to
the importance of chirality in medicinal compounds. The advantage of this process is when the
racemic starting material is reacted with a catalyst system that incorporates an enantiomerically
pure ligand, one of the enantiomers of the starting material selectively reacts at a faster rate
than the other one, providing an enantiomeric enriched product and unreacted and
enantioenriched starting material. For example, Zhang and co-workers developed a highly
selective kinetic resolution process for a Rh(I)-catalyzed intramolecular 1,6-enyne
cycloisomerization reaction (Scheme 4.1).141 In this methodology, the racemic 1,6-enyne 313
reacted with a Rh(I)-catalyst and racemic BINAP ligand to provide an excellent yield (97%)
of the cycloisomerized tetrahydrofuran product (Scheme 3.19a). Secondly, the highly
enantioselective formation of the tetrahydrofuran 314 was achieved via a kinetic resolution
process (Scheme 4.1b). This process was developed by treating both the anti- and syn-mixture
of 1,6-enyne 313 with enantiomerically pure BINAP ligand, AgSbF6 and [Rh(COD)Cl]2 at 15
°C for just 2 min resulting in 50% conversion and 314 in 47-49% yields. The syn-1,6-enyne
313 using (S)-BINAP gave the corresponding enantiomerically pure (2R, 3S)-product 314 in
49% yield and (R)-BINAP provided the (2S, 3R)-product 314 (>99% ee) in 47% yield, along
with unreacted 313 (2R, 5S) and (2S, 5R), respectively – (>99% ee). Next, the anti-1,6-enyne
also displayed excellent selectivity towards kinetic resolution using (S)-BINAP and gave the
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(2R, 3S) product in 48% yield, while (R)-BINAP generated (2S, 3R)- 314 in 49% yield (>99%
ee) with the corresponding unreacted starting materials also obtained in 49% yield (>99% ee)
(Scheme 4.1b).

Scheme 4.1: a) Rh-catalyzed 1,6-enyne 313 cycloaddition to synthesis racemic tetrahydrofuran 314 b) Rhcatalyzed kinetic resolution of 1,6-enyne 313 to enantiomeric pure tetradehydrofuran 314

This type of kinetic resolution process might be applicable to the unconjugated
enediyne 110f, leading to the enantiomerically enriched bicyclic aromatic product 160f and
starting material (Scheme 4.2). This process could be an especially useful method for making
enantiomerically pure isobenzofurans and isoindolines, which are found in many important

121

natural products as well as in pharmaceuticals.54 For example, citalopram is an antidepressant
drug which is a racemic mixture of the (R)-(−)-enantiomer and (S)-(+)-enantiomers, however,
only (S)-citalopram exhibits the desired antidepressant activity. The development of a kinetic
resolution version of the Rh(I)-cycloaromative formal TDDA reaction of the unconjugated
enediynes 110 could provide a pathway to various highly substituted enantiomeric pure
analogues.

Scheme 4.2: Proposed catalytic system to develop kinetic resolution of Rh(I)-catalyzed cycloaromatization of
unconjugated enediyne 110f

To develop the cycloaromatization as a kinetic resolution process, a preliminary
investigation was performed on racemic starting material 110f and isoindoline 160f using a
chiral HPLC method (Phenomenex Lux Cellulose-3- column) to resolve both the starting
material and the product (Figure 4.1). Given the successful kinetic resolution developed by
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Zhang and co-workers using BINAP, it was anticipated that a similar process might work for
enediynes 110f and this will be developed in future work.
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Figure 4.1: Chiral HPLC analysis of the racemic enediyne 110f and isoindoline 160f, both the substrate and
product were performed using (Phenomenex Lux Cellulose-3- column; solvents: n-hexane/isopropyl alcohol
(90:10); flow rate = 0.5 mL/min; two peaks, t = 29.38, 32.48 and 32.88, 35.96 min. peak area ratio = 50:50 and
50:50).

The first trial reaction was performed using (S)-BINAP as a chiral ligand and the
reaction was stopped at 6 h (original time for this reaction is 12 h), surprisingly, starting
material underwent 100% conversion and no starting material was left in the crude reaction
mixture and the isolated yield of pure isoindoline was low 35% (Scheme 4.3).
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40
min

Scheme 4.3: Synthesis of (S)-isoindoline 160f via Rh(I)-TDDA condition using (S)-BINPA.

This indicating one of the enantiomers of enediyne might be reacting faster and the other one
could be decomposing. However, the resulting isoindoline product 160f had a 12% ee by chiral
HPLC analysis (Figure 4.2). Furthermore, this methodology needs extensive ligand screening
and a careful optimization of the reaction conditions, which could offer a kinetic resolution of
enediyne 110 which may provide groundbreaking development for future organic synthesis
methodologies to synthesize enantiomeric pure bicyclic scaffolds.
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Figure 4.2: Chiral HPLC analysis of the racemic enediyne 110f and isoindoline 160f, both the substrate and
product were performed using (Phenomenex Lux Cellulose-3- column; solvents: n-hexane/isopropyl alcohol
(90:10); flow rate = 0.5 mL/min; two peaks, t = 28.69 and 31.7,1min. peak area ratio = 55.73:44.26).
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4.1.3 Cycloaromative formal TDDA reaction towards tetrahydroisoquinolines.

Another potential application of the new enediyne cycloaromative TDDA reaction is that
homologous 6-membered ring, tetrahydroisoquinolines moieties can potentially be synthesized
from the modified enediyne skeleton, with the addition of an extra carbon to the alkyne tether.
To explore this possibility, enediyne 316 was synthesized via a Mitsunobu reaction (Scheme
4.4). This substrate was reacted under the optimized Rh(I)-TDDA cycloaromatization
conditions, surprisingly no reaction took place and the starting material had decomposed (entry
1). The combination of Wilkinson’s catalyst (RhPPh3)3Cl and AgSbF6 (an effective catalyst for
1,6-enyne cycloisomerization) was also not effective for the cyclization of enediyne 316 (Table
4.1, entry 3).114 On the hand, enediyne 316 also examined under Au(I)-cycloaromatization
conditions with cationic Au(I)-catalyst (AuPPh3Cl/AgSbF6) in DCE solvent, however this
resulted decomposition of starting material (Table 4.1, entry 4). In the next attempt, the
substrate was reacted under dual Au(I)-cyclization condition (Au(PPh3)OPOF2) which was a
powerful Lewis basic catalyst system for (E)-enediynes (Scheme 2.4). Using the same reaction
conditions at room temperature the substrate underwent hydration of the alkyne and upon
reflux in DCM and toluene solvents decomposed (Table 4.1, entries 5 to 8). This reaction needs
further investigations to be conducted including changing the reaction conditions or by using
other transition metal-catalysts (Table 4.1). Taking these results into account, future
optimization reactions should be focused on the activation of 1,7-enyne oxidative cyclization
with various metal-catalyst system and also this process should be investigated
computationally.142-144
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Scheme 4.4: Proposed reaction for synthesis of tetrahydroisoquinoline 317.

Table 4.1: Optimization reaction to synthesize tetrahydroisoquinoline

Entry

Catalyst

1

a[Rh(COD)Cl]

a

Additive

Solvent

Temp

Time/h

%conv.

Result

DCE

rt to reflux

24

0

0

(10 mol%)

AgSbF6
(20 mol%)

2

[Rh(COD)Cl]2
(10 mol%)

AgSbF6
(20 mol%)

DCE

rt

24

0

0

3

Rh(PPh3)3Cl
(5 mol%)

AgSbF6
(13 mol%)

DCM

reflux

12

no

SM
recovered

4

AuPPh3Cl
(5 mol%)

AgSbF6
(5 mol%)

DCE

rt

24

Decomp.

0

5

Au(PPh3)OPOF2
(5 mol%)

DCE

rt

72

100

hydration
product

6

Au(PPh3)OPOF2
(5 mol%)

DCE

reflux

12

100

hydration
product

7

Au(PPh3)OPOF2
(5 mol%)

DCM

reflux

12

Decomp.

0

8

[(AuPPh3)3O]BF4
(5 mol%)

toluene

reflux

12

no

SM
recovered

2

-

12 mol% of (rac)-BINAP used
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Another future direction to expand the scope of the Rh-catalyzed dearomative TDDA reaction
involves making an enyne with a nitrile tether via replacement of the propargyl alkyne moiety
as seen in compounds 320 and 328 (Scheme 4.5a and b). Synthesis of this new system 320 was
successful via alkylation using bromoacetonitrile and enynol 108a in the presence of NaH
(61% yield) (Scheme 4.5b). The substrate was reacted under Au(I) and Rh(I)-TDDA reaction
conditions, however, none of these catalyst systems provided the desired product via the
proposed intermediate (321).
In the second method, utilizing a Pd-catalyzed cyanation reaction between vinyl-iodide
325, followed by a propargylation reaction provided the nitrile eneyne 328 (Scheme 4.5b). The
hypothesis was that under the Rh(I)-TDDA conditions the substrate 328 could undergo
oxidative cyclization to form fused 5-membered ring intermediate 329 which then leads to
rhodacyclic ketenimine intermediate 330, which is rare in the literature and this could deliver
pyrrolo-pyridine type derivatives 331.145 These scaffolds are found in many natural products.
For example, camptothecin (CPT) 332 is a natural product which exhibits anticancer activity
having a key pyrrolo-pyridine base structure.146 Towards this goal, we have synthesized key
intermediate (Z)-4-hydroxybut-2-enenitrile 327 but, due to the time constraints this could not
be continued. Further, propargylation of 327 need to be performed to give nitrile enediyne 328,
which then test under the Rh(I)-TDDA reaction condition.
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a) Proposed synthetic route to construct pyrrolo pyridines 322

[RhCl(COD)]2 (5 mol%)
Ph

AgSbF6 (20 mol%)

Ph
HO

108a

NaH

+

X

THF, rt

DCE, rt, 1-12 h

N

N
319

(rac)-BINAP (12 mol%)

Br

X
N
322

320

X = NTs, O

X
Rh N
321
proposed imine
intermediate

b) Proposed route to synthesis nitrile-enediyne 328 and its cycloaromatization

I

DIBAL-H
I
H3CO

O

HO
325

THF, −78 °C
3h

+
HO CN

242

Pd2(dba)3, DPPP
Na2CO3
Ether:DMA

Br
N

NC

X

HO
328

327

326
[RhCl(COD)]2 (5 mol%)
AgSbF6 (20 mol%)
(rac)-BINAP (12 mol%)
H

331

N
Rh

X = O, NTs

RL

X

X

N

N

X
329

330
Rh-cyclic ketenimine

O
N
N
O

332

O

Camptothecin (CPT)
anticancer tratment

Scheme 4.5: Proposed synthetic route to prepare nitrile enediyne starting materials (320 and 328) and their
Rh(I)-cycloaromatization
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4.2. Conclusion

In Chapter 3, the enediyne 110 was investigated under Rh(I)-catalyzed oxidative cyclization
process. This process proved to be more general than the Au-catalyzed cycloisomerization in
Chapter 2. A range of highly functionalized and variously tethered (NTs, O, and C(CO 2Me)2)
enediynes were synthesized and smoothly converted to the corresponding isoindoline 160f,
isobenzofuran 160a and indane 160u products in good to excellent yields. the Au(I)cycloaromatization method was not effective for the substituted enediynes 110 which was
failed to provide the products 111, however, in this chapter we successfully solved this problem
by careful optimization of Rh(I)-TDDA cycloaromatization condition.

Scheme 4.6: An overview scheme for the Rh(I)-catalyzed TDDA reaction

In contrast to the thermal TDDA reactions of enediynes 66, the Rh(I)-catalyzed
cycloaromatization reactions of unconjugated enediynes 110 occurred at room temperature and
this method also effectively transformed terminal alkynes enediynes to isoindoline products.
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Moreover, to understand this facile room temperature Rh(I)-TDDA reaction further,
experimental and computational investigations were performed on the enediynes to provide
support for a strained cyclic allene intermediate 300 and C-H oxidative intermediate 302 which
are unusual intermediates in enediyne TDDA reaction. To investigate this process, deuterated
enediynes were synthesized and provided the corresponding isoindoline showing deuterium
incorporation on the aromatic ring C6-carbon. This result in combination with the DFT
calculations strongly supported the reaction pathway proceeding through the formation of a
strained 7-membered cyclic allene intermediate 296 leading to the 6-membered ring allene
intermediate 300, which was stabilized by the Rh(I)-catalyst. In contrast to the traditional 1,3or 1,5-hydride shift process, intermediate 300 undergoes oxidative addition of the allene-bound
Rh(I) to the adjacent C-H bond towards the final aromatic organic product – these intermediates
were previously not known and finding this result is paramount of our investigation.
Furthermore, product modification reactions were performed, where the synthesized
bicyclic heterocycles were converted to the more complex isoindolinones 310 and
isobenzofuranones 311 and 311', which are important medicinally relevant molecules. On the
other hand, facile N-detosylation of the isoindolines was also performed with using Mg/MeOH
conditions, which selectively removed the Ts group form isoindoline product 160f. In
medicinal chemistry, this reaction is most important which provides free N−H on the relevant
compound and that allows for future derivatization of the free N−H group.
Overall, the project was designed to investigate an underexplored class of unconjugated
enediynes 110 under transition metal-catalysis conditions, as this was expected to provide
direct access to aromatic bicyclic products 111. Therefore, in this thesis, the overreaching aim
was developed the enediyne cycloaromatization reactions under potential Au and Rh transition
metal-catalysis by harnessing mechanistic understanding of how these metals activate 1,6enynes and to transpose this to the more conjugated enediyne substrates. Firstly, simple
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enediyne 110 was reacted under Au(I)-catalyzed conditions to provide the cycloaromatized
product 111a in good yield via a single-cleavage process, however, the Au(I)cycloaromatization method was not effective for other substituted enediynes 110. It was
thought that this was due to competing cycloisomerization pathways towards unstable sixmembered heterocycles, however, the mechanism of these processes needs to be investigated
in detail, ideally with computational chemistry. Fortunately, an alternative strategy using a
Rh(I)-catalyzed oxidative cyclization of ene-diynes proved much more general. Here, the
experimental and computational investigations revealed the formation of novel 7-membered
cyclic allene intermediate 296 leading to the Rh(I)-stabilized 6-membered ring allene
intermediate 300 – such a process was not known in the literature and it is most important
process in the novel Rh(I)-TDDA reaction which could potentially applied in future synthetic
methodology development. Future efforts should focus on looking at other substrate classes,
intermolecular variants and also ways to trap the intriguing cyclic allene intermediates.
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Chapter 5: Experimental Section

General characterization methods

The following general procedures were used for the synthesis of substrates unless otherwise
noted. All reagents and solvents were commercially available. Anhydrous solvents were
purchased (DCE, DCM, THF, MeCN, acetone) and stored under nitrogen over 4Å molecular
sieves. All reactions were conducted under an inert atmosphere of nitrogen in oven dried
glassware. Reactions were monitored by thin layer chromatography (TLC). TLC analysis was
performed on aluminum on aluminum-backed silica gel sheets (F254 nm), TLC plates were
visualized using solution of (KMnO4 or phosphomolybdic acid in ethanol). Synthesized
substrates were purified by flash column chromatography using Silica Gel (40-75 nm) as a
stationary phase. 1H NMR spectra were recorded at 400 MHz or 500 MHz in CDCl3 and
chemical shifts are reported to relative to tetramethylsilane TMS (𝛿 = 0.00). 13C NMR (proton
decoupled) spectra were measured in CDCl3 and chemical shifts are reported relative to the
solvent resonance (𝛿 = 77.16). 1H NMR data are listed as chemical shift, multiplicity (m),
coupling constant (Hz) and integration. The abbreviations used for multiplicity are: singlet (s),
doublet (d), triplet (t), triplet of triplets (tt) quartet (q), doublet of doublet (dd), doublet of
doublet of doublets (ddd), broad doublet (db), doublet of triplets (dt), doublet of doublets of
triplets (ddt) broad (br), Melting points were measured using a Buchi Melting Point M-560
apparatus. Infrared spectra (IR) recorded on a Bruker Vertex 70 FTIR Spectrometer as neat
samples. High-resolution mass spectra (HRMS) were generated on a Waters Xevo G1 QTOF
mass spectrometer with electrospray ionization. Cambridge Crystallographic Data Centre
(CCDC) deposition number for compound 160f was 1999577.
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General synthesis of 1,3-(Z)-enyn-ols-(108)

The substituted stereodefined 1,3-(E-Z)-enyn-ol starting materials (108a-c) were prepared
according to the scheme below, following literature methods.100-101, 147

Synthesis of methyl (Z)-3-Iodoacrylate (242)

To a stirred solution of sodium iodide (1.33 g, 0.008 mmol, 1.5 equiv) in acetic acid (15 mL)
at room temperature was added methyl propiolate 240 (0.52 mL, 0.005 mmol). The reaction
mixture was heated at reflux for 16 h. The solution was cooled to room temperature and diluted
with water. The mixture was extracted with ethyl acetate (3×10 mL) and the combined extracts
were washed with 3 M KOH and brine then dried over Na2SO4, filtered and concentrated in
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vacuo to yield the vinyl iodide as a yellow oil (0.402 g, 67%). 1H NMR (500 MHz, CDCl3) 𝛿
7.47 (d, J = 10.0, 1H), 6.92 (d, J = 10.0, 1H), 3.79 (s, 3H, OCH3). 13C NMR (101 MHz, CDCl3)
δ 164.9, 164.9, 129.5, 95.2, 51.7. NMR data matches the literature values.100

Methyl (E)-3-iodoacrylate (242′)

The title compound was synthesized according to previously synthesised method. 100 (Z)-3iodoacrylic acid methyl ester 242 (1.0 g, 0.47 moles, 1 equiv) was dissolved in benzene (5 mL)
at room temperature then 57% (v/v) (9 mL, 0.070 moles, 15 mol%,) of HI was added. The
resulting mixture was heated at reflux for 4 h. The solution was cooled to room temperature,
the mixture was diluted with ether (5 mL) and the solution was washed with saturated Na 2S2O3,
then brine, dried over Na2SO4, filtered and concentrated in vacuo to yield the trans product
(0.600 g, 60 % yield) as a pale-yellow liquid.
1H

NMR (500 MHz, CDCl3) δ 7.90 (d, J = 14.9 Hz, 1H), 6.89 (d, J = 14.9 Hz, 1H), 3.75 (d, J

= 0.8 Hz, 5H). NMR data matches the literature values.100-101

Methyl (Z)-5-phenylpent-2-en-4-ynoate (243a)

A solution of (Z)-vinyl iodide 242 (163 mg, 0.7 mmol, 1 equiv) in THF (5 mL, 0.15 M), was
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sparged over 30 min with nitrogen at 0 °C, sequentially PdCl2(PPh3)2 (5 mg, 0.007 mmol, 1
mol%), CuI (1.5 mg, 0.007 mmol, 1 mol%), and trimethylamine (0.2 ml,2 equiv), were added
followed by the addition of phenylacetylene (0.08 mL, 0.7 mmol, 1.0 equiv.). The reaction was
stirred at room temperature for 16 h. The crude reaction mixture was filter through a bed of
silica gel using ethyl acetate. The final residue was purified by flash column chromatography
on silica using ethyl acetate/n-hexane (0.5:9.5) as eluent to give the (Z)-enyne ester (132 mg,
93%) as a yellow oil; Rf (ethyl acetate/n-hexane 2:8) = 0.78. 1H NMR (500 MHz, CDCl3) 𝛿
7.54 (m, 2H), 7.35 (m, 3H), 6.37 (d, J =11.4 Hz, 1H), 6.15 (d, J = 11.4 Hz, 1H), 3.81(s, 3H).13C
NMR (101 MHz, CDCl3) δ 165.2, 132.1, 129.3, 128.40, 127.8, 123.2, 122.6,101.4, 86.3, 51.5.
NMR data matches the literature values.148

Methyl (E)-5-phenylpent-2-en-4-ynoate (243a′)

The title compound was synthesised according to the synthesis of 243a, using methyl (E)-3iodoacrylate 242a′ (600 mg, 2.83 mmol, 1 equiv) dry THF (6 mL), PdCl2(PPh3)2 (5 mg, 0.007
mmol, 1 mol%), CuI (1.5 mg, 0.007 mmol, 1 mol%), trimethylamine (0.2 ml,2 equiv), and
phenylacetylene (288 mg, 2.83 mmol, 1 equiv). The product 243a′ was isolated by flash
column chromatography on silica using ethyl acetate/n-hexane (0.5:9.5) to give the title
compound as a yellow solid (132 mg, 93%); Rf (ethyl acetate/n-hexane 2:8) = 0.76. 1H NMR
(400 MHz, CDCl3) δ 7.50 – 7.45 (m, 1H), 7.41 – 7.33 (m, 3H), 6.99 (d, J = 15.8 Hz, 1H), 6.31
(d, J = 15.8 Hz, 1H), 3.79 (s, 3H). 1H NMR data matches the literature values.149

(Z)-5-Phenylpent-2-en-4-yn-1-ol (108a)
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To a solution of methyl (Z)-5-phenylpent-2-en-4-ynoate 243a (100 mg, 0.54 mmol, 1.0 equiv)
in dichloromethane (2.73 mL, 0.2 M) at −78 °C was added dropwise a solution of
diisobutylaluminium hydride (1.0.M) in hexane (1.09 mL, 2 equiv). The reaction mixture was
stirred at the same temperature for 4 h. The crude reaction was quenched with 1 M aqueous
hydrochloric acid, then allowed to warm to room temperature. The organic layer was extracted
with dichloromethane (2×3 mL) and the combined extracts dried over Na2SO4, filtered and
concentrated under vacuo. The resulting crude mixture was purified by flash column
chromatography over silica gel using ethyl acetate/n-hexane (2:8) to give the pure enynol (85.5
mg, 98%) as a pale-yellow oil; Rf (ethyl acetate/n-hexane 2:8) = 0.34. 1H NMR (500 MHz,
CDCl3) 𝛿 7.49-7.40 (m, 2H), 7.32 (m, 3H), 6.14 (dt, J = 10.9, 6.4 Hz, 1H), 5.81 (dd, J = 10.8
Hz, 1H), 4.50 (dd, J = 6.4, 1.4 Hz, 2H), 2.30 (brs, 1H). 13C NMR (126 MHz, CDCl3) δ 141.2,
131.4, 128.4, 128.3, 122.9, 110.6, 95.2, 84.9, 61.1. NMR data matches the literature values. 102

(E)-5-Phenylpent-2-en-4-yn-1-ol (108a′)

This compound was prepared as described for the synthesis of 243a synthesis from methyl (E)5-phenylpent-2-en-4-ynoate 243a′ (376 mg, 2.05 mmol, 1equiv), diisobutylaluminium hydride
(1.0.M) in hexane (4.1 mL, 2 equiv). The resulting crude mixture was purified by flash column
chromatography over silica gel using ethyl acetate/n-hexane (2:8) to give the pure enynol 108a′
(302 mg, 92%) as a pale-yellow oil; Rf (ethyl acetate/n-hexane 2:8) = 0.34.1H NMR (CDCl3,
500 MHz): 7.43-7.41 (m, 2H), 7.30-7.27 (m, 3H), 6.36 (dt, J = 15.9, 5.2 Hz, 1H), 5.99 (dt, J =
15.9, 1.8 Hz, 1H), 4.26 (d, J = 4.3 Hz, 2 H), 1.91 (br s, 1H); 13C NMR (CDCl3, 125 MHz):
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141.9, 131.7, 128.5, 128.2, 123.3, 110.5, 90.3, 87.4, 63.2 1H NMR matches the literature
values.37

(Z)-5-Phenylpent-2-en-4-ynal (244a)

To a stirred solution of the alcohol 108a (0.80 g, 5.0 mmol) in dry DCM (5 mL), at room
temperature was slowly added MnO2 (6.5 g, 15 equiv, 75 mmol) and stirring was allowed
reaction to continue until consumption of starting the material. The resulting mixture was
filtered through a bed of celite and purified by flash column chromatography over silica gel
using ethyl acetate/n-hexane (2:8) to give the pure aldehyde product 244a (700 mg, 88%) as a
pale-yellow oil; Rf (ethyl acetate/n-hexane 2:8) = 0.8

1H

NMR (500 MHz, CDCl3) δ 10.28

(d, J = 8.2 Hz, 1H), 7.56 – 7.43 (m, 2H), 7.41 – 7.25 (m, 3H), 6.87 (dd, J = 10.8, 1.2 Hz, 1H),
6.33 (ddt, J = 10.8, 8.2, 0.6 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 193.0, 139.1, 137.3, 132.5,
132.0, 129.8, 128.6, 121.8, 104.2, 86.0. NMR data matches the literature values.148

(E)-5-Phenylpent-2-en-4-ynal (244a′)

This compound was prepared as described for the synthesis of 244a synthesis from alcohol
108a′ (200 mg, 1.25 mmol, 1equiv), MnO2 (1.63 g, 18.75 mmol, 15 equiv) in dry DCM (15
mL). The crude product mixture was purified by flash column chromatography over silica gel
using ethyl acetate/n-hexane (2:8) to give the pure alcohol 244a′ (140 mg, 71%) as a paleyellow oil; Rf (ethyl acetate/n-hexane 2:8) = 0.8. 1H NMR (500 MHz, CDCl3) δ 9.61 (d, J =
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7.8 Hz, 1H, CHO), 7.54 – 7.47 (m, 2H), 7.42 – 7.35 (m, 3H), 6.82 (d, J = 15.9 Hz, 1H), 6.54
(dd, J = 15.8, 7.8 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 193.1, 139.2, 132.5, 132.0, 129.8,
128.6, 121.8, 104.2, 86.0. NMR data matches the literature values.150

(Z)-6-Phenylhex-3-en-5-yn-2-ol (108b)

HO

CH3

A solution of (Z)-5-phenylpent-2-en-4-ynal 244a (180 mg, 0.97 mmol) in dry THF (2 mL) at
−5 °C was added dropwise a solution of CH3MgCl (3.0 M) in THF (0.97 mL, 2.93 mmol) and
the reaction was completed in 5 min by TLC analysis. The reaction was quenched with 1N HCl
(0.5 mL) and extracted into EtOAc. The combined organic layer was washed with brine and
dried over Na2SO4. The product was obtained after flash column chromatography as a paleyellow liquid (143 mg, 85%) .1H NMR (500 MHz, CDCl3) δ 7.48 – 7.39 (m, 2H), 7.36 – 7.30
(m, 3H), 5.99 (dd, J = 10.9, 8.1 Hz, 1H), 5.73 (dd, J = 10.9, 1.1 Hz, 1H), 4.98 – 4.92 (m, 1H),
1.87 (s, 1H), 1.36 (d, J = 6.4 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 146.2, 131.4, 128.4,
128.3, 123.0, 109.2, 95.0, 84.9, 66.4, 22.5. NMR data matches the literature values.151

(E)-6-Phenylhex-3-en-5-yn-2-ol (108b′)

The title compound was prepared using the synthesis procedure of 108b from (E)-5phenylpent-2-en-4-ynal 244a′ (140 mg, 0.76 mmol, 1 equiv) and CH3MgCl (3.0 M) in THF
(0.76 mL, 3 equiv). 1H NMR (500 MHz, CDCl3) δ 7.49 – 7.40 (m, 2H), 7.32 – 7.29 (m, 3H),
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6.27 (dd, J = 15.9, 6.0 Hz, 1H), 5.93 (dd, J = 15.9, 1.5 Hz, 1H), 4.42 (td, J = 6.0, 1.5 Hz, 1H),
1.63 (d, J = 11.6 Hz, 1H), 1.33 (d, J = 6.5 Hz, 3H). NMR data matches the literature values.151

(Z)-1,5-Diphenylpent-2-en-4-yn-1-ol (108c)

HO

Ph

This title compound was prepared using the synthesis procedure of 108b from (Z)-5phenylpent-2-en-4-ynal 244a (150 mg, 0.96 mmol) and PhMgBr 1.0 M in THF (2.8 mL, 2.88
mmol). The product 108c was obtained after flash column chromatography as a pale-yellow
oil (380 mg, 85%). 1H NMR (500 MHz, CDCl3) δ 7.51 – 7.43 (m, 4H), 7.38 – 7.31 (m, 5H),
6.14 (dd, J = 10.7, 8.6 Hz, 1H), 5.92 (d, J = 8.6 Hz, 1H), 5.83 (dd, J = 10.7, 0.9 Hz, 1H), 1.63
(s, 1H).13C NMR (126 MHz, CDCl3) δ 144.0, 142.3, 131.5, 128.6, 128.5, 128.4, 128.2, 127.7,
125.8, 122.9, 110.0, 9.12, 85.2, 72.1. NMR data matches the literature values.152

Synthesis of unconjugated Enediynes (110a-e)
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(Z)-(5-(Prop-2-yn-1-yloxy) pent-3-en-1-yl)benzene (110a)

To a slurry of NaH (180 mg, 7.5 mmol, 1.2 equiv) in THF (2 mL) cooled to 0 °C was added
dropwise a solution of enyne alcohol 108a (100 mg, 6.25 mmol, 1.0 equiv) in THF(1 mL).
Stirring was continued for 40 min followed by addition of propargyl bromide (80% in toluene,
2.0 equiv) which was added dropwise, and the reaction was warmed to room temperature and
stirred for 4 h. The reaction was quenched with ice then water and extracted with ethyl acetate.
The combined extracts were dried over Na2SO4, filtered and the resulting crude product was
purified by flash column chromatography over silica gel using Et2O/pentane (1:9) to give the
enediyne product (96 mg, 79%) as a yellow oil; Rf (Et2O/pentane 1:9) = 0.76. 1H NMR (500
MHz, CDCl3) δ 7.44 (dd, J = 6.6, 3.0 Hz, 2H, 2CHAr), 7.32 (m, 3H, 3CHAr), 6.08 (dt, J = 10.9,
6.5 Hz, 1H, =CH), 5.88 (dt, J = 10.9, 1.5 Hz, 1H, =CH), 4.43 (dd, J = 6.5, 1.5 Hz, 2H, CH2),
4.19 (d, J = 2.4 Hz, 2H, CH2), 2.44 (t, J = 2.4 Hz, 1H, alkyneCH). 13C NMR (126 MHz, CDCl3)
δ 138.2, 131.5, 128.5, 128.4, 123.1, 112.42, 112.4, 95.5, 85.0, 79.7, 74.6, 67.5, 57.5. HRMS
(ESI-OTF) m/z calcd for C14H12ONa [M + Na]+ 219.0786, found 219.0793.

(Z)-(5-(Prop-2-yn-1-yloxy)hex-3-en-1-yn-1-yl)benzene 110b

The title compound was obtained as a colourless oil (134 mg, 68%) after flash column
chromatography (Et2O/pentane 1:9) following the general synthesis procedure of 110a using
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NaH (60%, 46 mg, 1.86 mmol), THF (3 mL), (Z)-6-phenylhex-3-en-5-yn-2-ol 110b (170 mg,
0.9 mmol) and propargyl bromide (80% in toluene, 0.18 mL, 1.97 mmol, 2 equiv). Rf
(Et2O/pentane 1:9) = 0.6. 1H NMR (500 MHz, CDCl3) 𝛿 7.45 – 7.44 (m, 2H, 2CHAr), 7.35 –
7.30 (m, 3H, 3CHAr), 5.91 – 5.80 (m, 2H, =CH), 4.76 (dq, J = 8.3, 6.4 Hz, 1H, CH(CH3)), 4.20
(dd, J = 15.6, 2.4 Hz, 1H, CHA(O)), 4.12 (dd, J = 15.6, 2.4 Hz, 1H, CHB(O)), 2.40 (t, J = 2.4
Hz, 1H, CH-alkyne), 1.34 (d, J = 6.4 Hz, 3H, CH3).

13C

NMR (126 MHz, CDCl3) 𝛿 43.3,

131.4, 128.4, 128.3, 123.0, 112.0, 94.9, 85.0, 80.3, 77.2, 77.0, 76.7, 73.8, 72.5, 55.7, 20.7. IR
(νmax/cm-1) 3294 (w), 2975 (m), 2199 (m), 1725 (s), 1612 (s), 1584 (s), 1442 (s), 1283 (s), 1370
(s), 1248 (s), 1072 (s), 915 (s), 742 (s), 689 (s), 533 (s). HRMS (ESI-OTF) m/z calcd for
C15H14ONa [M + Na]+ 233.0942, found 233.0945.

(E)-(5-(Prop-2-yn-1-yloxy)pent-3-en-1-yn-1-yl)benzene 110b′

CH3
O

The title compound was obtained as a colourless oil (35 mg, 57 %) after flash column
chromatography (Et2O/pentane 0.5:9.5) following the above general procedure of 110a using
NaH (14 mg, 0.3 mmol), THF (2 mL), (E)-6-phenylhex-3-en-5-yn-2-ol 108b′ (50 mg, 0.29
mmol), and propargyl bromide (80% in toluene, 0.05 mL). Rf (Et2O/pentane 2:8) = 0.6. 1H
NMR (500 MHz, CDCl3) δ 7.48 – 7.38 (m, 2H, 2CHAr), 7.33 – 7.27 (m, 3H, 3CHAr), 6.07 (dd,
J = 16.0, 7.7 Hz, 1H, =CH), 5.93 (dd, J = 16.0, 0.8 Hz, 1H, , =CH), 4.21 (dd, J = 15.7, 2.4 Hz,
1H, CHA(O)), 4.21– 4.19 (m, 1H, CH(CH3), 4.08 (dd, J = 15.7, 2.3 Hz, 1H, CHB(O)), 2.44 (t,
J = 2.4 Hz, 1H, CH-alkyne), 1.33 (d, J = 6.4 Hz, 3H, CH3(CH)). 13C NMR (126 MHz, CDCl3)
δ 143.6, 131.5, 128.3, 123.0, 112.1, 90.3, 87.0, 79.8, 74.7, 74.2, 55.47, 21.1. IR (νmax/cm-1)
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3058 (w), 2969 (m), 2853 (m), 1721 (s), 1600 (s), 1574 (s), 1442 (s), 1370 (s), 1128 (s), 1248
(s), 1070 (s), 881 (s), 760 (s), 697(s), 525 (s). HRMS (ESI-OTF) m/z calcd for C15H15O [M +
Na]+ 211.1123, found 211.1124.

(Z)-(5-(But-2-yn-1-yloxy)pent-3-en-1-yn-1-yl)benzene 110c

The title compound was obtained as a pale yellow liquid (89 mg, 67%) after flash column
chromatography (Et2O : penatane 0.5:9.5) following the above general synthesis procedure
using NaH (30 mg, 0.75 mmol, 1.2 equiv), THF (2 mL), (Z)-5-phenylpent-2-en-4-yn-1-ol 108a
(100 mg, 0.625 mmol, 1 equiv) and 1-bromo-2-butyne (0.10 mL, 1.25 mmol, 2 equiv), Rf
(Et2O/pentane 2:8) = 0.67. 1H NMR (500 MHz, CDCl3) δ 7.49 – 7.41 (m, 2H, 2ArCH), 7.34 –
7.27 (m, 3H, 2ArCH), 6.09 (dt, J = 10.8, 6.5 Hz, 1H, =CH), 5.87 (d, J = 10.8 Hz, 1H, =CH),
4.41 (dd, J = 6.5, 1.5 Hz, 2H, CH2(alkene)), 4.15 (d, J = 2.4 Hz, 2H, CH2(alkyne)), 1.84 (s, 3H,
CH3). 13C NMR (101 MHz, CDCl3) δ 138.9, 131.5, 128.3, 128.2, 123.2, 112.3, 90.1, 87.3, 82.9,
74.84, 69.2, 57.9, 3.6. IR (νmax/cm-1) 3412 (w), 2921 (s), 2853 (s), 2197 (m), 1714 (s), 1490
(m), 1259 (m), 1070 (s), 759 (s) 689 (s). HRMS (ESI-OTF) m/z calcd for C15H15O [M + H]+
211.1123 found 211.1083.

(E)-(5-(But-2-yn-1-yloxy)pent-3-en-1-yn-1-yl)benzene 110c′

142

The title compound was obtained as a pale-yellow liquid (61 mg, 48%) after flash column
chromatography (Et2O: penatane 0.5:9.5) following the general synthesis procedure using NaH
(30 mg, 0.75 mmol, 1.2 equiv), THF (2 mL), (E)-5-Phenylpent-2-en-4-yn-1-ol 108a′ (100 mg,
0.625 mmol, 1 equiv) and 1-bromo-2-butyne (0.10 mL, 1.25 mmol, 2 equiv), Rf (Et2O/pentane
2:8) = 0.67. 1H NMR (500 MHz, CDCl3) δ 7.46 – 7.41 (m, 2H, 2ArCH), 7.34 – 7.26 (m, 3H,
2ArCH), 6.28 – 6.17 (m, 1H, =CH), 5.97 (d, J = 16.0 Hz, 1H, =CH), 4.18 – 4.09 (m, 4H, 2CH2),
1.87 (d, J = 2.3 Hz, 3H, CH3).

13C

NMR (126 MHz, CDCl3) δ 138.8, 131.5, 128.3, 128.2,

112.3, 90.1, 87.3, 82.9, 74.8, 57.18, 3.6. IR (νmax/cm-1) 3412 (w), 2921 (s), 2853 (s), 2197 (m),
1618 (s), 1490 (m), 1377 (s), 1259 (m), 1070 (s), 759 (s) 689 (s), 529 (s). HRMS (ESI-OTF)
m/z calcd for C15H15O [M + H]+ 211.1123 found 211.1083.

(Z)-(5-(Prop-2-yn-1-yloxy)pent-3-en-1-yne-1,5-diyl)dibenzene 110d

O
Ph

The title compound was obtained as a pale-yellow liquid (32 mg, 58%) after flash column
chromatography (Et2O: pentane 0.5:9.5) following the above general synthesis procedure of
110a using NaH (10.2 mg, 0.2 mmol, 1.2 equiv), THF (2 mL), (Z)-1,5-diphenylpent-2-en-4yn-1-ol 108c (50 mg, 0.2 mmol, 1 equiv) and propargyl bromide (0.04 mL, 0.42 mmol, 2
equiv), Rf (Et2O/pentane 2:8) = 0.67. 1H NMR (500 MHz, CDCl3) δ 7.52 – 7.47 (m, 2H,
2ArCH), 7.49 – 7.43 (m, 2H, 2ArCH), 7.40 – 7.32 (m, 5H, 5ArCH), 7.34 – 7.26 (m, 1H, ArCH),
6.08 (dd, J = 10.6, 9.0 Hz, 1H, =CH), 5.92 (d, J = 10.6 Hz, 1H, =CH), 5.77 (d, J = 9.0 Hz, 1H,
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CH(Ph)), 4.29 – 4.13 (m, 2H, CHAHB(O)), 2.43 (t, J = 2.3 Hz, 1H, CH-alkyne). 13C NMR (126
MHz, CDCl3) δ 141.6, 139.9, 131.5, 128.6, 128.6, 128.5, 128.5, 128.4, 128.3, 127.9, 126.6,
123.0, 111.7, 95.2, 85.2, 79.8, 77.8, 74.4, 55.6. IR (νmax/cm-1) 3291 (w), 3060 (w), 2854 (w),
1596 (m), 1489 (m), 1442 (m), 1062 (s), 1026 (m), 914 (w), 753 (s), 690 (s), 525 (m). HRMS
(ESI-OTF) m/z calcd for C20H16ONa [M + Na]+ 295.1099 found 295.1087.

(Z)-5-Phenylpent-2-en-4-yn-1-yl propiolate 110e

In an oven dried Schlenk tube in propiolic acid (40.72 mg, 0.58 mmol, 2 equiv) was dissolved
in ether:THF (1:2) under a N2 atmosphere. DMAP (10 mg, 0.08 mmo, 2 mol%) was added then
immediately added and the yellow-coloured solution turned to colourless. The (Z)-5phenylpent-2-en-4-yn-1-ol 108a (50 mg, 0.29 mmol, 1 equiv) and DCC (0.08 mL, 0.058 mmol,
2 equiv) were added and the solution was stirred at room temperature for 18 h. The crude
reaction mixture was filtered through celite bed and the crude product was purified by flash
column chromatography using EtOAc:n-hexane (2:8) to give a colourless oil (56 mg, 86%
yield), Rf (Et2OAc/n-hexane 2:8) = 0.69. 1H NMR (500 MHz, CDCl3) δ 7.49 – 7.41 (m, 2H,
2ArCH), 7.37 – 7.24 (m, 3H, 3ArCH), 6.12 – 6.01 (m, 1H, =CH), 5.95 (dt, J = 10.8, 1.4 Hz,
1H, =CH), 5.03 (dd, J = 6.6, 1.4 Hz, 2H, CH2(O)), 2.91 (s, 1H, alkyne CH). 13C NMR (126
MHz, CDCl3) δ 152.5, 134.1, 131.6, 128.7, 128.4, 122.6, 114.1, 96.6, 84.2, 74.4, 63.8. IR
(νmax/cm-1) 3276 (w), 2201 (s), 1711 (s), 1489 (m), 1373 (m), 1207 (s), 948 (s), 751 (s), 667
(s).
HRMS (ESI-OTF) m/z calcd for C14H10O2Na [M + Na]+ 233.0578 found 233.0577.
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Au(I)-catalyzed Cycloaromatization of Enediyne (110a-e)

General Synthesis Procedure
To oven dried Schlenk flask at room temperature was added IPrAuCl (0.012 mmol) and
AgSbF6 (0.012 mmol). DCM (1.2 mL) was added under a N 2 atmosphere and stirring was for
continued for 1 min. (Z)-Enediyne 110 (0.25 mmol) was added and the mixture heated at reflux
for 12 h. The crude reaction mixture was filtered through a small bed of silica, concentrated
under reduced pressure and purified by flash column chromatography on silica gel.

(Z)-3-(4-Phenylbut-1-en-3-yn-1-yl)-2,5-dihydrofuran 158a

To oven dried Schlenk flask at room temperature was added IPrAuCl (6.6 mg, 0.012 mmol, 5
mol%) and AgSbF6 (4.3 mg, 0.012 mmol, 5 mol%). DCM (1.2 mL) was added under a N 2
atmosphere and stirring was for continued for 1 min. (Z)-(5-(Prop-2-yn-1-yloxy) pent-3-en-1yl)benzene 110a (50 mg, 0.25 mmol, 1.0 equiv) was added and allowed reaction for 5 min at
room temperature. The crude reaction mixture was filtered through a small bed of silica,
concentrated under reduced pressure and purified by flash column chromatography on silica
gel using ethyl acetate/n-hexane (0.5:9.5) resulting in product 158a as a colorless oil (30.5 mg,
61%), (Rf (ethyl acetate/n-hexane 1:9) 0.75. 1H NMR (500 MHz, CDCl3) δ 7.45 – 7.38 (m, 2H,

145

2ArCH), 7.35 – 7.22 (m, 3H, 3 ArCH), 6.47 (d, J = 11.4 Hz, 1H, =CH), 6.07 (s, 1H,
CH(CH2)O), 5.71 (d, J = 11.4 Hz, 1H, =CH), 5.20 (d, J = 2.3 Hz, 2H, OCH2), 4.72 (s, 2H,
OCH2). 13C NMR (125 MHz, CDCl3) δ 138.5, 131.6, 131.2, 129.2.128.5, 128.4, 123.1, 108.9,
96.1, 87.9, 75.0, 74.7. HRMS (ESI-OTF) m/z calcd for C14H13O [M + H]+ 197.0963 found
197.0966. IR (νmax/cm-1) 2959 (w), 2921 (w), 2194 (m), 1718 (m)1444 (w), 1259 (s), 1069 (w),
756 (s), 689 (s).

4-Phenyl-1,3-dihydroisobenzofuran 111a

To oven dried Schlenk flask at room temperature was added IPrAuCl (6.6 mg, 0.012 mmol, 5
mol%) and AgSbF6 (4.3 mg, 0.012 mmol, 5 mol%). DCM (1.2 mL) was added under a N 2
atmosphere and stirring was for continued for 1 min. (Z)-(5-(Prop-2-yn-1-yloxy) pent-3-en-1yl)benzene 110a (50 mg, 0.25 mmol, 1.0 equiv) was added and the mixture heated at reflux for
12 h. The crude reaction mixture was filtered through a small bed of silica, concentrated under
reduced pressure and purified by flash column chromatography on silica gel using ethyl
acetate/n-hexane (0.5:9.5) resulting in product 111a as a yellow oil (25.3 mg, 51%), (Rf
(ethylacetate/n-hexane 1:9) 0.75. 1H NMR (500 MHz, CDCl3) δ 7.48–7.31 (m, 8H), 5.22 (s,
2H), 5.19 (s, 1H). NMR data matches the literature values.104

(Z)-2-Phenyl-4-(4-phenylbut-1-en-3-yn-1-yl)-2,5-dihydrofuran 158b
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To oven dried Schlenk flask at room temperature was added IPrAuCl (6 mg, 0.009 mmol, 10
mol%) and AgSbF6 (3.20 mg, 0.009 mmol, 10 mol%). DCM (1.2 mL) was added under a N 2
atmosphere and stirring was for continued for 1 min. (Z)-(5-(Prop-2-yn-1-yloxy)hex-3-en-1yn-1-yl)benzene 110b (20 mg, 0.095 mmol, 1.0 equiv) was added and the mixture heated reflux
for 12 h. The crude reaction mixture was filtered through a small bed of silica, concentrated
under reduced pressure and purified by flash column chromatography on silica gel using ethyl
acetate: n-hexane (0.5:9.5) resulting in product 158b as yellow oil (17.2 mg, 87%), (Rf (ethyl
acetate/n-hexane 1:9) 0.63. 1H NMR (500 MHz, CDCl3) δ 7.47 – 7.34 (m, 2H, 2ArCH), 7.32
– 7.28 (m, 2H, 3ArCH), 6.29 (dd, J = 10.5, 2.0 Hz,1H, =CH), 5.86 (dd, J = 10.5, 2.0 Hz, 1H,
=CH), 5.51 (t, J = 1.5 Hz, 1H, =CH(CHCH3)), 4.93 (d, J = 14.5 Hz, 1H, 1CH2(O)), 4.45 (dd, J
= 14.5, 2.0 Hz, 1H, 1CH2(O)), 4.34-4.32 (m, 1H, CH(CH3)) 1.31 (d, J = 6.8 Hz, 3H, CH3). 13C
NMR (125 MHz, CDCl3) 𝛿 143.3 (CH (alkene), 134.9 (CH (alkene), 131.3(ArC), 128.3 (ArC),
128.2 (ArC), 125.9 (CH (alkene), 123.4 (ArC), 103.8 (CH(CH-CH3), 96.9 (C(alkyne), 86.2
(C(alkyne), 70.2 (CH(CH3), 65.5 (O-CH2), 20.6 (CH3). HRMS: was unstable to be obtained
due to product instability.

(Z)-6-Methyl-3-(3-phenylprop-2-yn-1-ylidene)-3,6-dihydro-2H-pyran 245b

This 245b was also isolated from the above reaction of 158b, by flash column chromatography
on silica gel using ethyl acetate/n-hexane (0.5:9.5) as colorless oil (2 mg, 10%), Rf (ethyl
acetate/n-hexane 1:9) 0.63. 1H NMR (500 MHz, CDCl3) δ 7.49 – 7.40 (m, 2H, 2ArCH), 7.38
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– 7.29 (m, 3H, 3ArCH), 6.46 (dt, J = 11.4, 0.8 Hz, 1H, =CH), 5.98 (q, J = 2.1 Hz, 1H, =CH),
5.73 – 5.70 (d, J = 11.5 Hz, 1H, =CH), 5.30 – 5.23 (m, 1H, CH(CH3)), 5.15 – 5.11 (m, 1H,
CH2(O)), 5.03 – 4.96 (m, 1H, CH(CH3)), 1.31 (d, J = 6.8 Hz, 3H, CH3(OCH). 13C NMR was
unable to be obtained due to product instability.

Synthesis of Substituted 1,3-enyne-ols (108d-k)

Methyl (Z)-5-(4-fluorophenyl)pent-2-en-4-ynoate (243b)

The title compound prepared using the general synthesis procedure for 243a, methyl (Z)-3iodoacrylate 242 (882 mg, 4.16 mmol), PdCl2(PPh3)2 (29 mg, 0.041 mmol, 1 mol%), CuI (7.9
mg, 0.041 mmol, 1 mol%), triethylamine (1.16 mL, 8.32 mmol 2 equiv) and 1-ethynyl-4fluorobenzene (0.47 mL, 4.16 mmol, 1 equiv). The crude product was purification by flash
column chromatography on silica gel using EtOAc/n-hexane (0.5:9.5) eluted as a pale-yellow
oil (600 mg, 71%). 1H NMR (400 MHz, CDCl3) δ 7.53 (dd, J = 8.9, 5.4 Hz, 2H), 7.04 (t, J =
8.8 Hz, 2H), 6.35 (d, J = 11.4 Hz, 1H), 6.16 (d, J = 11.4 Hz, 1H), 3.80 (s, 3H). 13C NMR (101
MHz, CDCl3) δ 165.23, 163.1 (d, JCF = 251.2 Hz), 134.2 (d, JCF = 8.7 Hz), 127.8, 123.1, 118.7
(d, JCF = 3.6 Hz), 115.8 (d, JCF = 22.3 Hz), 100.3, 86.1, 51.5. NMR data matches literature
values.153

(Z)-5-(4-Fluorophenyl)pent-2-en-4-yn-1-ol (108B)
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The title compound was obtained as a colorless liquid (242 mg, 94%) after flash column
chromatography (ethylacetate/hexane 1.5:8.5) using the synthesis procedure of 108a and
methyl (Z)-5-(4-fluorophenyl)pent-2-en-4-ynoate 243b (300 mg, 1.47 mmol, 1 equiv),
diisobutylaluminium hydride (1.0 M) in hexane (2.94 mL, 2 equiv). R f (EtOAc/n-hexane 2:8)
= 2.8. 1HNMR (400 MHz, CDCl3) δ 7.49 – 7.32 (m, 2H), 7.01 (t, J = 8.7 Hz, 2H), 6.14 (dt, J
= 10.9, 6.4 Hz, 1H), 5.78 (d, J = 10.9 Hz, 1H), 4.48 (dd, J = 6.4, 1.5 Hz, 2H), 2.00 (br s, 1H).
13C

NMR (101 MHz, CDCl3) δ 162.6 (d, JCF = 249.9 Hz), 141.4, 133.3 (d, JCF = 8.4 Hz), 119.1

(d, JCF = 3.6 Hz), 115.7 (d, JCF = 22.1 Hz), 110.4, 94.1, 84.7 (d, JCF = 1.5 Hz), 61.0. IR (νmax/cm1)

2967 (w), 2839 (w), 1067 (m), 1520 (s), 1373 (s), 1298 (s), 1114 (s), 1032 (s), 852 (s), 539

(s). HRMS (ESI-OTF) m/z calcd for C11H10OF [M + H] + 177.0710 found 177.0709.

(Z)-5-(4-Fluorophenyl)pent-2-en-4-ynal (244b)

The title compound was obtained as a Colorless liquid (260 mg, 99%) after flash column
chromatography (ether:pentane 1:9) using the synthesis procedure for 244a and (Z)-5-(4fluorophenyl)pent-2-en-4-yn-1-ol ( 265 mg, 1.5 mmol, 1 equiv), MnO2 (1.963 g, 22.58 mmol,
15 equiv) and dry CH2Cl2 (7.5 mL), Rf (EtOAc:n-hexane 1:9) = 0.78. 1H NMR (400 MHz,
CDCl3) δ 10.26 (d, J = 8.2 Hz, 1H, CHO), 7.63 – 7.38 (m, 2H, 2ArCH), 7.15 – 6.94 (m, 2H,
2ArCH), 6.85 (d, J = 10.8 Hz, 1H, =CH), 6.33 (dd, J = 10.8, 8.2 Hz, 1H, =CH). 13C NMR (101
MHz, CDCl3) δ 191.7, 163.3 (d, J = 252.4 Hz), 137.3, 134.0 (d, JCF = 8.7 Hz), 128.5, 117.8 (d,
JCF = 3.6 Hz), 116.0 (d, JCF = 22.3 Hz), 100.2, 83.8 (d, JCF = 1.7 Hz). IR (νmax/cm-1) 3358 (w),
2926 (w), 1893 (m), 1661 (s), 1598 (s), 1504 (s), 1295 (s), 1221 (s), 1122 (s), 834 (s), 733 (s),
598 (s). HRMS (ESI-OTF) m/z calcd for C11H8FO [M + H] + 175.0553 found 175.0553.
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(Z)-5-(4-Methoxyphenyl)pent-2-en-4-ynal (244c)

The title compound was prepared as a colorless liquid (211 mg, 71%), using the general
synthesis procedure for 244a using (Z)-5-(4-methoxyphenyl)pent-2-en-4-yn-1-ol (300 mg,
1.59 mmol), MnO2 (2.08 g, 23.9 mmol). 1H NMR (400 MHz, CDCl3) δ 10.26 (d, J = 8.3 Hz,
1H), 7.45 (d, J = 8.7 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 6.85 (d, J = 10.8 Hz, 1H), 6.28 (dd, J =
10.8, 2.0 Hz, 1H), 3.84 (s, 3H).

13C

NMR (101 MHz, CDCl3) δ 192.0, 160.8, 136.3, 133.7,

129.2, 114.3, 113.7, 102.1, 83.4, 55.4. NMR data matches the literature value.154

(Z)-5-(Trimethylsilyl)pent-2-en-4-ynal (244e)
TMS
O

This compound was prepared as a colourless liquid (207 mg, 60%), using the general synthesis
procedure for 244a using (Z)-5-(trimethylsilyl)pent-2-en-4-ynal (350 mg, 2.27 mmol), MnO2
(2.96 g, 34.09 mmol). 1H NMR (400 MHz, CDCl3) δ 10.16 (d, J = 8.3 Hz, 1H), 6.63 (d, J =
10.9 Hz, 1H), 6.29 (dd, J = 11.0, 8.2 Hz, 1H), 0.24 (s, 9H). NMR data matches literature
values.155

(Z)-6-(4-Fluorophenyl)hex-3-en-5-yn-2-ol (108d)

The title compound was obtained as colorless liquid (166 mg, 59%) after flash column
chromatography (EtOAc:n-hexane 2:8) following the synthesis procedure for 108a using 244b
(260 mg, 1.49 mmol, 1 equiv) dry THF (2.9 mL) and CH3MgCl (3.0 M) in THF (1.49 mL, 1.48
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mmol, 3 equiv), Rf (EtOAc:n-hexane 2:8) = 0.27. 1H NMR (500 MHz, CDCl3) δ 7.41 (dd, J =
8.8, 5.4 Hz, 1H, 2ArCH), 7.02 (t, J = 8.7 Hz, 2H, 2CHAr), 5.99 (dd, J = 10.9, 8.1 Hz, 1H, =CH
), 5.71 (dd, J = 10.9, 1.0 Hz, 1H, =CH ), 5.00 – 4.80 (m, 1H, CH(CH3)), 1.35 (d, J = 6.4 Hz,
3H, CH3(CH)). 13C NMR (126 MHz, CDCl3) δ162.5 (d, JCF = 249.9 Hz), 146.3, 133.3 (d, JCF
= 8.3 Hz), 119.1 (d, JCF = 3.6 Hz), 115.7 (d, JCF = 22.1 Hz), 109.0, 93.9, 84.7 (d, JCF = 1.6 Hz),
66.4, 22.6. IR (νmax/cm-1) 3349 (s), 2971 (m), 2885 (m), 1599 (s), 1506 (s), 1406 (s), 1368 (s),
1232 (s), 1157 (s), 1060 (s), 950 (s), 815 (s), 611 (s), 528 (s). HRMS (ESI-OTF) m/z calcd for
C12H11FONa [M + Na] + 213.0686 found 213.0688.

(Z)-6-(4-Methoxyphenyl)hex-3-en-5-yn-2-ol (108e)

The title compound was obtained as a colourless liquid (196 mg, 90%) after flash column
chromatography (EtOAc:n-hexane 1.5:8.5) following the synthesis procedure for 108a using
244c (200 mg, 1.07 mmol, 1 equiv) in dry THF (2.1 mL) and CH3MgCl (3.0 M) in THF (1.08
mL, 3 equiv), Rf (EtOAc:n-hexane 2:8) = 0.29. 1H NMR (500 MHz, CDCl3) δ 7.37 (d, J = 8.8
Hz, 2H, 2ArCH), 6.85 (d, J = 8.8 Hz, 2H, 2ArCH), 5.94 (dd, J = 10.8, 8.1 Hz, 1H, =CH), 5.71
(dd, J = 10.9, 1.0 Hz, 1H, =CH), 5.00 – 4.82 (m, 1H, CH(CH3)), 3.81 (s, 3H, OCH3), 1.35 (d,
J = 6.4 Hz, 3H, CH3(CH)), 1.85 (brs, 1H, OH). 13C NMR (101 MHz, CDCl3) δ 159.7, 145.4,
132.9, 115.1, 114.0, 109.4, 95.1, 83.8, 66.4, 55.3, 22.6. IR (νmax/cm-1) 3333 (w), 2943 (m),
2834 (m), 1603 (m), 1531 (s), 1509 (m), 1454 (m), 1350 (m), 1249 (m), 1171 (s), 1108 (m),
1025 (s). 832 (m), 606 (m). HRMS (ESI-OTF) m/z calcd for C13H15O2 [M + H]+ 203.1072,
found 203.1082.

(Z)-Undec-3-en-5-yn-2-ol (108f)
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HO

The title compound was obtained as pale-yellow liquid (193 mg, 87%) after flash column
chromatography using the general synthesis procedure for 108a using (Z)-dec-2-en-4-ynal
244d (200 mg, 1.21 mmol), CH3MgCl (3.0 M) in THF (1.21 mL, 3.65 mmol). 1H NMR (500
MHz, CDCl3) δ 5.84 (dd, J = 10.8, 7.9 Hz, 1H), 5.49 (dtd, J = 10.8, 2.2, 1.1 Hz, 1H), 4.81 (dtd,
J = 7.6, 6.4, 1.2 Hz, 1H), 2.33 (td, J = 7.2, 2.3 Hz, 2H), 1.79 (brs, 1H) 1.54 (q, J = 7.3 Hz, 2H),
1.35 (m, 4H), 1.30 (d, J = 6.4 Hz, 3H), 0.91 (t, J = 7.2 Hz, 3H). 13C NMR (126 MHz, CDCl3)
δ 144.9, 109.7, 96.6, 76.2, 66.3, 31.0, 28.3, 22.5, 22.1, 19.4, 13.9. NMR data matches literature
value.156

(Z)-6-(Trimethylsilyl)hex-3-en-5-yn-2-ol (108g)
TMS
HO
CH3

The title compound was obtained as a colourless liquid (325 mg, 59%) after flash column
chromatography (ether:pentane 1.5:8.5) following the synthesis procedure for 108a using 244e
(500 mg, 3.28 mmol, 1 equiv) in dry THF (6.5 mL) and CH3MgCl (3.0 M) in THF (3.28 mL,
9.8 mmol, 3 equiv). Rf (ether:pentane 2:8) = 0.32. 1H NMR (500 MHz, CDCl3) δ 5.96 (dd, J =
11.1, 7.9 Hz, 1H, =CH), 5.51 (dd, J = 11.1, 1.2 Hz, 1H, =CH), 4.83 (ddd, J = 7.9, 6.4, 1.2 Hz,
1H, (CH3)CH), 1.30 (d, J = 6.4 Hz, 3H, (CH)CH3), 0.19 (s, 9H, TMS). 13C NMR (126 MHz,
CDCl3) δ 147.8, 109.3, 100.9, 100.7, 66.5, 22.5, 0.0. IR (νmax/cm-1) 3326 (w), 2962 (m), 2150
(m), 1249 (s), 1059 (s), 956 (s), 836 (s), 758 (s), 697 (s), 632 (m). HRMS (ESI-OTF) m/z calcd
for C9H16OSiNa [M + Na] + 191.0863, found 191.0862.
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(Z)-8-Phenyloct-5-en-7-yn-4-ol (108h)

HO

The title compound was obtained as a pale yellow liquid (24 mg, 63%) after flash column
chromatography (EtOAc:n-hexane 2:8) following the synthesis procedure for 108a using 244a
(30 mg, 0.19 mmol, 1 equiv) and propylmagnesium bromide (2.0 M) in diethyl ether (0.28 mL,
3 equiv). Rf (EtOAc:n-hexane 2:8) = 0.31. 1H NMR (400 MHz, CDCl3) δ 7.46 – 7.40 (m, 2H,
2ArCH), 7.34 – 7.29 (m, 3H, 3ArCH), 5.95 (dd, J = 10.9, 8.3 Hz, 1H, =CH), 5.77 (dd, J = 10.9,
1.0 Hz, 1H, =CH), 4.79 (q, J = 6.5 Hz, 1H, CH(OH)), 1.83 (brs, 1H, OH), 1.74-1.52 (m, 2H,
CH2), 1.45 (m, 2H, CH2), 0.97 (t, J = 7.3 Hz, 3H, CH3). 13C NMR (101 MHz, CDCl3) δ 145.3,
131.4, 128.4, 128.3, 123.0, 109.8, 94.7, 85.3, 70.0, 38.8, 18.4, 14.0. IR (νmax/cm-1) 3339 (w),
2958 (m), 2930 (m), 2871 (m), 1724 (m), 1596 (m), 1489 (m), 1374 (m), 1243 (m), 1121 (m),
1006 (m), 913 (s), 753 (s), 689 (s). HRMS (ESI-OTF) m/z calcd for C14H17O [M + H] +
201.1279 found 201.1278.

(Z)-2-Methyl-7-phenylhept-4-en-6-yn-3-ol (108i)

HO

The title compound was obtained as pale-yellow liquid (250 mg, 77%) after flash column
chromatography (EtOAc:n-hexane 1.5:8.5) following the synthesis procedure for 108a using
244a (260 mg, 1.66 mmol, 1 equiv) and isopropylmagnesium chloride (2.0 M) in diethyl ether
(2.5 mL, 3 equiv). Rf (EtOAc:n-hexane 2:8) = 0.47. 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.39
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(m, 2H, 2ArCH), 7.34 – 7.29 (m, 3H, 3ArCH), 5.97 (dd, J = 11.0, 8.5 Hz, 1H, =CH(CH)OH),
5.82 (dd, J = 11.0, 0.9 Hz, 1H, =CH(alkyne)), 4.51 (ddd, J = 9.0, 6.1, 3.1 Hz, 1H, CH(OH)),
1.85 – 1.81 (m, 1H, CH(CH3)), 1.62 – 1.58 (m, 1H, OH), 1.02 (d, J = 6.8 Hz, 3H, CH3), 0.96
(d, J = 6.9 Hz, 3H, CH3). 13C NMR (101 MHz, CDCl3) δ 143.7, 131.4, 128.4, 128.3, 110.8,
94.6, 85.5, 75.1, 34.0, 18.1, 18.0. IR (νmax/cm-1) 3236 (w), 2969 (w) 1596 (m), 1488 (w), 1262
(m), 1021 (m), 752 (m), 686 (s), 524 (s). HRMS (ESI-OTF) m/z calcd for C14H16ONa [M +
Na] + 223.1099 found 223.1102.

(Z)-4-Methyl-6-phenylhex-3-en-5-yn-2-ol (108j)
CH3

HO

CH3

The title compound was obtained as a colorless liquid (386 mg, 93%) after flash column
chromatography using the general synthesis procedure for 108a using (Z)-3-methyl-5phenylpent-2-en-4-ynal (377 mg, 2.21 mmol), CH3MgCl (3.0 M) in THF (2.21 mL, 6.65
mmol). 1H NMR (400 MHz, CDCl3) δ 7.50 – 7.39 (m, 2H), 7.35 – 7.28 (m, 3H), 5.75 (dd, J =
8.3, 1.5 Hz, 1H), 4.86 (dq, J = 8.4, 6.3 Hz, 1H), 2.12 (s, 1H), 1.94 (d, J = 1.6 Hz, 3H), 1.31 (d,
J = 6.4 Hz, 3H, CH3CH). 13C NMR (101 MHz, CDCl3) δ 141.0, 131.5, 131.4, 128.3, 123.1,
119.0, 94.1, 87.4, 66.9, 23.0, 22.6. NMR data matches literature values.157
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General scheme for the synthesis of tethered-enediynes (160a-v).
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Method A: General Synthesis procedure of N-tethered enediynes (110f-l, and v)
The N-tethered enediynes (110f-l, and v) were prepared using the sulfonamide and alcohol
(108b, 108a, 108d-g and S5h) coupling procedure reported in the literature.158,159 In an oven
dried Schlenk flask, a solution of alcohols 108 (1 equiv.) in anhydrous THF (0.2 M) was added
Ph3P

(1.3

equiv)

and

sulfonamide

(1.15

equiv)

at

0

°C.

A

solution

of
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diisopropylazodicarboxylate (DIAD) (1.3 equiv) was added dropwise and allowed to warm to
room temperature and stirred for 3 h. The reaction mixture was quenched with aqueous
NaHCO3 (1 mL) and extracted with EtOAc. The combined extracts were washed with brine
and dried (Na2SO4). The crude product was purified by flash column chromatography on silica
gel (EtOAc:n-hexane) to obtain the pure enediynes (110f-l, and v).

(Z)-4-Methyl-N-(6-phenylhex-3-en-5-yn-2-yl)-N-(prop-2-yn-1-yl)benzenesulfonamide
(110f)

The title compound was obtained pale yellow oil (89.4 mg, 85%) after flash column
chromatography (EtOAc:n-hexane 1.5:8.5) following the general synthesis Method-A using
108b (50 mg, 0.29 mmol, 1 equiv), 4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide S10 (70
mg, 0.38 mmol, 1.15 equiv), PPh3 (102 mg, 0.38 mmol, 1.3 equiv) and DIAD (0.07 mL, 0.38
mmol, 1.3 equiv) in dry THF (3 mL). Rf (EtOAc:n-hexane 2:8) = 0.57. 1H NMR (500 MHz,
CDCl3) δ 7.81 (d, J = 8.3 Hz, 2H, 2ArCH), 7.49 – 7.46 (m, 1H, ArCH), 7.36 – 7.31 (m, 3H,
3ArCH), 7.19 (d, J = 7.8 Hz, 1H, ArCH), 6.09 (dd, J = 10.8, 9.0 Hz, 1H, =CH), 5.66 (dd, J =
10.8, 0.9 Hz, 1H, =CH ), 5.21 – 5.07 (m, 1H, CH(CH3)), 4.26 (dd, J = 18.5, 2.5 Hz, 1H,
CHA(N)), 4.11 (dd, J = 18.5, 2.5 Hz, 1H, CHB(N)), 2.36 (s, 3H, CH3(Ts)), 2.18 (t, J = 2.5 Hz,
1H, CH alkyne), 1.43 (d, J = 7.0 Hz, 3H, CH3(CH)). 13C NMR (126 MHz, CDCl3) δ 143.2,
140.7, 137.5, 131.6, 129.3, 128.5, 128.3, 127.6, 122.9, 110.6, 95.7, 84.8, 79.7, 72.9, 53.4, 33.4,
21.4, 19.5. IR (νmax/cm-1) 3287 (w), 2510 (m), 2160 (m), 1597 (s), 1434 (s), 1152 (s), 1078 (s),
901 (s), 746 (s), 662 (s), 573 (s). HRMS (ESI-OTF) m/z calcd for C22H21NO2SNa [M + Na] +
386.1191, found 386.1183.
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(Z)-4-Methyl-N-(5-phenylpent-2-en-4-yn-1-yl)-N-(prop-2-yn-1-yl)benzenesulfonamide
(110b)

The title compound was obtained as a colorless oil (185 mg, 84%) after flash column
chromatography (EtOAc/hexane 1.5:8.5) following the general procedure Method-A using 4methyl-N-(prop-2-yn-1-yl)benzenesulfonamide 109b (152 mg, 0.72 mmol), 108a (100 mg,
0.63 mmol), PPh3 (220 mg, 0.84 mmol) and DIAD(0.16 mL, 0.84 mmol) in dry THF (3.5 mL).
Rf (Et2O/pentane 1.5:8.5) = 0.45. 1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 8.3 Hz, 2H,
CHAr), 7.39-7.27 (m, 2H, CHAr), 7.34 – 7.24 (m, 5H, CHAr), 5.96 – 5.85 (m, 2H,
(alkyne)CH2), 4.19 (d, J = 5.8 Hz, 2H, =CH2), 4.13 (d, J = 2.5 Hz, 2H, (CH=CH)CH2NTs),
2.43 (s, 3H, TsCH3), 2.01 (t, J = 2.5 Hz, 1H, alkyneCH). 13C NMR (126 MHz, CDCl3) δ 143.6,
136.2, 135.7, 131.4, 129.5, 129.4, 128.5, 128.3, 127.8, 122.8, 113.9, 95.6, 84.6, 73.6, 45.8,
36.6, 21.5. IR (νmax/cm-1) 3287 (w), 2923 (m), 2160 (m), 1597 (m), 1490 (m), 1441 (m), 1345
(s), 1157 (s), 1094 (s), 1040 (s), 896 (m) 817 (m), 757 (m), 690 (m), 541 (s). HRMS (ESIOTF) m/z calcd for C21H19NO2SNa [M + Na] + 372.1034 found 372.1038.

(Z)-N-(6-(4-Fluorophenyl)hex-3-en-5-yn-2-yl)-4-methyl-N-(prop-2-yn-1yl)benzenesulfonamide (110h)

The title compound was obtained as a colorless oil (53 mg, 53%) after flash column
chromatography (EtOAc:n-hexane 1.2:8.8) following the general synthesis procedure
Method-A using 4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide 109b ( 63.3mg, 0.3 mmol),
(Z)-6-(4-fluorophenyl)hex-3-en-5-yn-2-ol 108d (50 mg, 0.26 mmol), PPh3 (70.7 mg, 0.3
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mmol) and DIAD (0.08 mL, 0.3 mmol) in dry THF (2 mL). Rf (EtOAc:n-hexane 2:8) = 0.79.
1H

NMR (500 MHz, CDCl3) δ 7.80 (d, J = 8.4 Hz, 2H, 2ArCH), 7.52 – 7.41 (m, 2H, 2ArCH),

7.23 – 7.17 (m, 2H, 2ArCH), 7.04 (t, J = 8.7 Hz, 1H, ArCH), 6.08 (dd, J = 10.8, 9.0 Hz, 1H,
=CH), 5.64 (dd, J = 10.8, 0.9 Hz, 1H, =CH), 5.17 (dtd, J = 8.9, 7.0, 6.1 Hz, 1H, CH(CH3)),
4.25 (dd, J = 18.6, 2.5 Hz, 1H, CHA(N) ), 4.10 (dd, J = 18.6, 2.5 Hz, 1H, CHB(N)), 2.37 (s, 3H,
CH3(Ts)), 2.19 (t, J = 2.5 Hz, 1H, CH-alkyne), 1.41 (d, J = 7.0 Hz, 3H, CH3(CH)). 13C NMR
(126 MHz, CDCl3) δ162.3 (d, JCF = 250.0 Hz), 143.2, 140.7, 137.4, 133.5 (d, JCF = 8.4 Hz),
129.3, 127.6, 119.0 (d, JCF = 3.5 Hz), 115.7 (d, JCF = 22.1 Hz), 110.6, 94.7, 84.5 (d, JCF = 1.5
Hz), 79.6, 72.9, 53.3, 33.2, 21.5, 19.5. IR (νmax/cm-1) 3293 (w), 2946 (w), 2834 (w), 1652 (m),
1531(s), 1506 (s), 1351 (s), 1231 (s), 1166 (s), 1095 (m), 838 (m), 582 (m). HRMS (ESI-OTF)
m/z calcd for C22H21NO2FS [M + H]+ 382.1277, found 382.1266.

(Z)-N-(6-(4-Methoxyphenyl)hex-3-en-5-yn-2-yl)-4-methyl-N-(prop-2-yn-1yl)benzenesulfonamide (110i) and (E)-N-(6-(4-Methoxyphenyl)hex-3-en-5-yn-2-yl)-4methyl-N-(prop-2-yn-1-yl)benzenesulfonamide (110i’).

The title compounds were obtained as a colorless oil (120 mg, 80%) after flash column
chromatography (EtOAc:n-hexane 1.5:8.5) (110i and 110i’= 1.2:1) following the general
procedure method-A using 4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide 109b (119 mg,
0.56 mmol), (Z)-6-(4-methoxyphenyl)hex-3-en-5-yn-2-ol 108e (100 mg, 0.49 mmol), PPh3
(172 mg, 0.65 mmol) and diisopropylazodicarboxylate (0.12 mL, 0.6 mmol) in dry THF (3.8
mL). Rf (EtOAc/hexane 2:8) = 0.71. 1H NMR (400 MHz, CDCl3) (110i:110i’= 1.2:1). δ 7.83
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(d, J = 8.3 Hz, 2H, 2ArCH, E-isomer), 7.80 (d, J = 8.4 Hz, 2H, 2ArCH, Z-isomer), 7.41 (d, J
= 8.8 Hz, 2H, 2ArCH, Z-isomer), 7.27 – 7.21 (m, 2H, 2ArCH, Z-isomer), 7.21 – 7.15 (m, 2H,
2ArCH, E-isomer), 7.10 (d, J = 8.8 Hz, 2H, 2ArCH, E-isomer), 6.86 (d, J = 8.8 Hz, 2H, 2ArCH,
E-isomer), 6.78 (d, J = 8.9 Hz, 2H, 2ArCH, Z-isomer), 6.13 – 6.06 (m, 1H, =CH, E-isomer),
6.02 (dd, J = 10.8, 8.9 Hz, 1H, =CH, Z-isomer), 5.64 (dd, J = 10.8, 0.9 Hz, 1H, =CH, Z-isomer),
5.56 (dd, J = 14.8, 1.6 Hz, 1H, =CH, E-isomer), 5.52 (dt, J = 4.8, 1.5 Hz, 1H, (CH3)CH, Zisomer), 5.20 – 5.10 (m, 1H, (CH3)CH, E-isomer ), 4.24 (dd, J = 18.6, 2.5 Hz, 1H, CHA(N) Zisomer), 4.10 (dd, J = 18.6, 2.5 Hz, 1H, CHB(NTs) Z-isomer), 4.05 (t, J = 2.3 Hz, 2H,
(CHACHB(N), E-isomer), 3.82 (s, 3H, OCH3, E-isomer), 3.79 (s, 3H, OCH3, Z-isomer), 2.36 (s,
3H, CH3(Ts) E-isomer), 2.36 (s, 3H, CH3(Ts) Z-isomer), 2.18 (t, J = 2.4 Hz, 1H, CH(alkyne)
Z-isomer), 2.12 (t, J = 2.5 Hz, 1H, CH(alkyne) E-isomer), 1.75 (dt, J = 6.4, 1.5 Hz, 3H,
(CH)CH3, E-isomer ), 1.42 (d, J = 7.0 Hz, 3H, (CH)CH3, Z-isomer).

13

C NMR (101 MHz,

CDCl3) δ 159.8, 159.7, 143.5, 143.1, 139.7, 137.6, 136.4, 133.1, 132.9, 130.9, 129.3, 129.3,
128.0, 126.7, 115.1, 114.3, 114.0, 114.0, 113.8, 111.0, 95.9, 87.7, 83.8, 81.9, 79.8, 79.5, 72.8,
72.2, 55.3, 55.3, 53.5, 52.28, 33.6, 33.4, 21.5, 19.6, 17.4. IR (νmax/cm-1) 3287 (w), 2935 (w),
2219 (w), 1601 (m), 1508 (s), 1443 (m), 1333 (m), 1290 (m), 1247 (m), 1158 (s), 1091 (m),
1029 (m), 865 (m), 747 (s), 573 (s), 543 (s). HRMS (ESI-OTF) m/z calcd for C23H24NO3S [M
+ H] + 394.1477, found 394.1471.

(Z)-4-Methyl-N-(prop-2-yn-1-yl)-N-(undec-3-en-5-yn-2-yl)benzenesulfonamide (110j)

The title compound was obtained as a pale yellow liquid (122 mg, 60%) after flash column
chromatography (EtOAc:n-hexane 1.5:8.5) following the general procedure Method-A using
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4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide 109b (133 mg, 0.63 mmol), (Z)-undec-3-en5-yn-2-ol 108f (100 mg, 0.5 mmol), PPh3 (194 mg, 0.73 mmol) and DIAD (0.14 mL, 0.7 mmol)
in dry THF (4.2 mL). Rf (EtOAc:n-hexane 1:9) = 0.51. 1H NMR 400 MHz, CDCl3) δ 7.82 –
7.75 (m, 2H, CHAr), 7.30 – 7.20 (m, 2H, CHAr), 5.99 – 5.82 (m, 1H, =CH), 5.41 (dtd, J =
10.8, 2.3, 1.0 Hz, 1H, =CH ), 5.12 – 4.95 (m, 1H, CHCH3), 4.21 (dd, J = 18.6, 2.5 Hz,
1H,CHA(N)), 4.05 (dd, J = 18.6, 2.5 Hz, 1H, CHB(N)), 2.41 (3H, CH3Ts), 2.38 – 2.28 (m, 2H,
CH2CH2), 2.16 (t, J = 2.5 Hz, 1H, CH2CH2), 1.62 – 1.52 (m, 2H, CH2CH2), 1.37 (d, J = 7.0
Hz, 3H, CH3CH), 0.91 (t, J = 7.1 Hz, 3H, CH3CH2). 13C NMR (101 MHz, CDCl3) δ 143.1,
139.3, 137.8, 129.2, 127.9, 127.6, 111.1, 97.3, 79.8, 72.6, 53.5, 33.4, 31.1, 28.3, 22.2, 21.5,
19.5, 19.57, 13.9. IR (νmax/cm-1) 3279 (w), 2956 (m), 2859 (m), 1598 (m), 1454(s), 1333(s),
1288 (m), 1154 (s), 1035 (s), 906 (s), 813 (s), 739 (m), 544 (s). HRMS (ESI-OTF) m/z calcd
for C21H27NO2SNa [M + Na] + 380.1160 found 380.1663.

(Z)-4-Methyl-N-(prop-2-yn-1-yl)-N-(6-(trimethylsilyl)hex-3-en-5-yn-2yl)benzenesulfonamide (110k) and (E)-4-Methyl-N-(prop-2-yn-1-yl)-N-(6(trimethylsilyl)hex-3-en-5-yn-2-yl)benzenesulfonamide (110k’).

TMS
TsN
CH3

The title product were obtained as a mixture of Z/E-isomers (1.6:1) as a colorless oil (133 mg,
62%) after flash column chromatography (ether/pentane 1.5:8.5) following the general
procedure Method-A using 4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide 109b ( 143 mg,
0.6 mmol), (Z)-6-(trimethylsilyl)hex-3-en-5-yn-2-ol 108g (100 mg, 0.59 mmol), PPh3 (176 mg,
0.6 mmol) and diisopropylazodicarboxylate (0.1 mL, 0.3 mmol) in dry THF (4 mL). Rf
(Et2O/pentane 1.5:8.5) = 0.8. 1H NMR (500 MHz, CDCl3) δ δ 7.79 (dd, J = 8.4, 4.9 Hz, 3H,
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ArCH, for each isomer), 7.31 – 7.20 (m, 4H for each isomer), 6.11 – 6.08 (m, 1H, =CH, Zisomer), 6.07 – 6.05 (m, 1H, =CH, E-isomer ). 5.59 (dd, J = 16.1, 1.9 Hz, 1H, =CH, E-isomer),
5.44 (dd, J = 10.9, 1.0 Hz, 1H, =CH, Z-isomer). 5.05 (ddd, J = 8.7, 7.0, 1.1 Hz, 1H, CH(CH3,
Z-isomer), ), 4.57 (ddd, J = 7.0, 5.3, 1.9 Hz, 1H, CH(CH3, E-isomer). 4.24 (dd, J = 18.6, 2.5
Hz, 1H, CHA(N), Z-isomer), 4.16 (dd, J = 18.5, 2.5 Hz, 1H, CHB(N), E-isomer), 4.06 (dd, J =
18.5, 2.5 Hz, 1H, CHA(N), Z-isomer)), 3.88 (dd, J = 18.5, 2.5 Hz, 1H, CHB(N)), E-isomer), δ
2.43 (s, 3H, CH3Ts, Z-isomer), 2.41 (s, 3H, E-isomer). δ 2.16 (t, J = 2.5 Hz, 1H, alkyne-CH,
Z-isomer), 1.61 (dd, J = 2.3, 1.0 Hz, alkyne-CH, 1H, E-isomer), 1.36 (d, J = 7.0 Hz, 3H,
CH3(CH), Z-isomer), 1.28 (d, J = 7.0 Hz, 3H, CH3(CH), E-isomer), 0.22 (s, 9H, TMS, Zisomer), 0.17 (s, 9H, TMS, E-isomer).

13C

NMR (126 MHz, CDCl3) δ 143.6, 143.3, 143.0,

142.5, 137.8, 137.7, 129.7, 129.7, 129.4, 127.7, 127.7, 112.5, 110.6, 102.5, 101.7, 100.5, 96.4,
79.9, 79.7, 73.0, 72.9, 54.6, 53.8, 33.8, 32.8, 21.7, 19.3, 17.5. IR (νmax/cm-1) 3344 (w), 2970
(s), 2932 (m), 1466 (m), 1379 (m), 1306 (s), 1159 (s), 1106 (s), 950 (s), 816 (s), 659 (m).
HRMS (ESI-OTF) m/z calcd for C19H25NO2SSiNa [M + Na] + 382.1268 found 382.1268.

(Z)-4-Nitro-N-(6-phenylhex-3-en-5-yn-2-yl)-N-(prop-2-yn-1-yl)benzenesulfonamide
(110l)

The title compound was obtained as a colorless oil (53 mg, 53%) after flash column
chromatography (EtOAc:n-hexane 2.:8) following the general procedure Method-A using 4nitro-N-(prop-2-yn-1-yl)benzenesulfonamide159 (106 mg, 0.3 mmol), (Z)-6-phenylhex-3-en-5yn-2-ol 108b (50 mg, 0.29 mmol), PPh3 (78.1 mg, 0.38 mmol) and DIAD (0.07mL, 0.38 mmol)
in dry THF (2.2 mL). Rf (EtOAc/hexane 3:7) = 0.69. 1H NMR (500 MHz, CDCl3) δ 8.21 (d,
J = 8.9 Hz, 2H, 2CHAr), 8.12 (d, J = 8.9 Hz, 2H, 2ArCH), 7.52 – 7.45 (m, 2H, 2ArCH), 7.40 –
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7.32 (m, 3H, 3ArCH), 6.04 (dd, J = 10.7, 9.3 Hz, 1H, =CH), 5.66 (dd, J = 10.7, 0.8 Hz, 1H,
=CH), 5.28 – 5.20 (m, 1H, CH(CH3)), 4.39 (dd, J = 18.7, 2.5 Hz, 1H, CHA(N)), 4.15 (dd, J =
18.7, 2.5 Hz, 1H, CHB(N)), 2.20 (t, J = 2.5 Hz, 1H, CH-alkyne), 1.45 (d, J = 7.0 Hz, 3H,
CH3(CH)).

13C

NMR (126 MHz, CDCl3) δ 146.2, 139.4, 131.5, 128.9, 128.8, 128.5, 123.8,

122.5, 111.5, 96.4, 84.5, 78.9, 53.7, 33.2, 19.7. IR (νmax/cm-1) 3351 (w), 3270 (w), 2971(s),
1646 (m), 1530 (s), 1404 (s), 1309 (s), 1161 (s), 1100 (s), 949 (s), 816 (s), 616 (s). HRMS
(ESI-OTF) m/z calcd for C21H18N2O4SNa [M + Na] + 417.0885, found 417.0887.

Method-B: N-tethered enediynes using the Mitsunobu coupling reaction (110m)

Tert-butyl (Z)-(6-phenylhex-3-en-5-yn-2-yl)(tosyl)carbamate (284)

To a stirred solution of tert-butyl tosylcarbamate 283 (157 mg, 0.58 mmol), (Z)-6-phenylhex3-en-5-yn-2-ol 108b (100 mg, 0.58 mmol) and PPh3 (205 mg, 0.784 mmol) in dry THF (3 mL)
at 0 °C was added diethyl azadicorboxylate (126 mg, 0.726 mmol). The mixture was stirred at
room temperature for 3 h. Water (1 mL) was added, and the mixture extracted with EtOAc (2
mL × 3). The combined extracts were washed with brine (3 mL) dried (Na 2SO4), filtered
through a pad of silica gel and washed with EtOAc. The crude product was purified by column
chromatography (EtOAc:n-hexane = 1:10 v/v) to provide as a White solid (151 mg, 62%), MP:
129 − 131°C, Rf (EtOAc:n-hexane 2:8) = 0.72. 1H NMR (500 MHz, CDCl3) δ 7.83 (d, J = 8.4
Hz, 2H, 2CHAr), 7.54 – 7.48 (m, 2H, 2CHAr), 7.32 – 7.27 (m, 2H, 2ArCH), 7.22 (d, J = 7.7 Hz,
2H, 2ArCH), 6.43 (dd, J = 10.6, 8.7 Hz, 1H, =CH), 5.88 – 5.79 (m, 2H, =CH and CH), 2.38 (s,
3H, TsCH3), 1.66 (d, J = 6.9 Hz, 3H, CH3), 1.33 (s, 9H, C(CH3)3). 13C NMR (126 MHz, CDCl3)
δ 150.6, 143.6, 141.9, 138.0, 131.7, 129.0, 128.4, 128.3, 127.7, 122.9, 111.4, 96.0, 85.1, 84.2,
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53.5, 27.9, 21.5, 20.5. IR (νmax/cm-1) 2982 (w), 2195 (m), 1719 (s), 1594 (s), 1491 (s), 1369
(s), 1249 (s), 1142 (s), 1087 (s), 994 (s), 760 (s), 693 (s), 579 (s). HRMS (ESI-OTF) m/z calcd
for C24H27NO4SNa [M + Na]+ 448.1559, found 448.1553

(Z)-4-Methyl-N-(6-phenylhex-3-en-5-yn-2-yl)benzenesulfonamide (285)

To a stirred solution of tert-butyl (Z)-(6-phenylhex-3-en-5-yn-2-yl) (tosyl)carbamate 284 (131
mg, 0.30 mmol) in dry DCM (3 mL) at 0 °C was added trifluoroacetic acid (0.1 mL 1.53 mmol)
dropwise and the reaction mixture was warm to room temperature and stirred for 3 h. The crude
reaction mixture was extracted with DCM (3 mL × 3) and combined extracts were washed with
aqueous NaHCO3 (3 mL), dried (Na2SO4), filtered through pad of silica gel and concentrated
under reduced pressure. The residue was purified by flash column chromatography (EtOAc:nhexane = 2:8) to afford S7. as a yellow oil (71 mg, 71%), Rf (EtOAc:n-hexane 2:8) = 0.35. 1H
NMR (500 MHz, CDCl3) δ 7.80 – 7.71 (m, 3H, 3CHAr), 7.40 – 7.36 (m, 2H, 2CHAr), 7.35 –
7.30 (m, 3H, ArCH), 7.24 – 7.13 (m, 2H, 2CHAr), 5.72 (dd, J = 10.7, 8.7 Hz, 1H, =CH), 5.58
(d, J = 10.8 Hz, 1H, =CH), 4.73 (br s, 1H, NH), 4.45 – 4.37 (m, 1H, CH(CH3)), 2.33 (s, 3H,
CH3(Ts)), 1.29 (d, J = 6.7 Hz, 3H, CH3(CH)). 13C NMR (101 MHz, CDCl3) δ 142.9, 137.2,
131.5, 129.7, 129.5, 128.5, 128.3, 127.4, 127.3, 109.9, 95.6, 84.7, 5.65, 21.8, 21.4. IR (νmax/cm1

) 3270 (s), 2975 (s), 2199 (m), 1748 (s), 1490 (s), 1425 (s), 1321(s), 1156 (s), 1091 (s), 841

(s), 690 (s), 548 (s). HRMS (ESI-OTF) m/z calcd for C19H19NO2SNa [M + Na] + 348.1034,
found 348.1037.

(Z)-4-Methyl-N-(pent-2-yn-1-yl)-N-(6-phenylhex-3-en-5-yn-2-yl)benzenesulfonamide
(110m)
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To a stirred solution of (Z)-4-methyl-N-(6-phenylhex-3-en-5-yn-2-yl)benzenesulfonamide 285
(80 mg, 0.25 mmol, 1 equiv) in dry acetonitrile (1.2 mL) was added anhydrous K 2CO3 (68 mg,
0.49 mmol, 2 equiv) and the resulting mixture stirred for 2 min, 1-bromopent-2-yne (0.03 mL,
0.31 mmol, 1.3 equiv) was added and the reaction stirred 80 °C for 5h. The mixture was cooled
to room temperature and the solvent was removed under reduced pressure. the crude residue
was purified by column chromatography (EtOAc:n-hexane = 1.5:8) to give pale yellow liquid
(58 mg, 56%). Rf (EtOAc:n-hexane 2:8) = 0.6. 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.4
Hz, 2H, 2CHAr), 7.50 – 7.45 (m, 2H, 2CHAr), 7.37 – 7.31 (m, 3H, 3CHAr), 7.18 (d, J = 7.6 Hz,
1H, 1CHAr), 6.13 (dd, J = 10.8, 9.0 Hz, 1H, =CH), 5.63 (dd, J = 10.9, 1.0 Hz, 1H, =CH), 5.16
(dtd, J = 8.9, 7.0, 6.0 Hz, 1H, CH(CH3)), 4.23 (dt, J = 18.4, 2.2 Hz, 1H, CHA(N)), 4.07 (dt, J =
18.4, 2.3 Hz, 1H, CHB(N)), 2.35 (s, 3H, CH3(Ts)), 2.04 (qt, J = 7.5, 2.3 Hz, 2H,
CH2(alkyne)and(CH3)), 1.41 (d, J = 7.0 Hz, 3H, CH3(CH)), 1.00 (t, J = 7.5 Hz, 3H, CH3(CH2)).
13C

NMR (126 MHz, CDCl3) δ 142.91, 141.4, 137.8, 131.5, 129.1, 128.4, 128.3, 127.7, 123.0,

110.1, 95.5, 86.4, 85.0, 75.1, 53.4, 33.9, 21.4, 19.6, 13.4, 12.2. IR (νmax/cm-1) 2976 (w), 2877
(w), 1597 (m), 1490 (s), 1332 (s), 1153 (s), 1030 (s), 904 (s), 814 (s), 754 (s), 691 (s), 544 (s).
HRMS (ESI-OTF) m/z calcd for C24H26NO2S [M + H] + 392.1684, found 392.1677.

Method-C: General procedure for the synthesis of O-tethered enediynes (110n-t):
Synthesis of O-tethered enediynes (110n-t) achieved via the reaction of the alcohol 108 with
propargyl bromide using procedure reported in the literature.158 To a stirriXg suspension of
NaH 60% in mineral oil (1.2 equiv) dissolved in anhydrous THF were added enyn-ols 108 at
0 °C, then the reaction stirred for 45 min at the same temperature. Finally, a dropwise solution
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of commercially available propargyl bromide (2 equiv) was added dropwise and stirring was
continued for another 3-4 h. Water was added, and the mixture was extracted with diethyl ether.
The combined organic extracts were washed with brine and dried (Na2SO4). The pure products
(1k-s and 1v) were obtained after flash column chromatography using silica gel (ether:pentane
0.5:9.5).

(Z)-1-Fluoro-4-(5-(prop-2-yn-1-yloxy)hex-3-en-1-yn-1-yl)benzene (110n)

The tittle compound was obtained as a colorless oil (58 mg, 81%) after flash column
chromatography (Et2O:penatane 0.5:9.5) following the general procedure Method-C using
NaH (15 mg, 0.37 mmol) THF (2 mL), (Z)-6-(4-fluorophenyl)hex-3-en-5-yn-2-ol 108d (60
mg, 0.31 mmol) and propargyl bromide (80% in toluene, 0.058 mL, 0.63 mmol, 2 equiv), R f
(Et2O/pentane 1:9) = 0.77. 1H NMR (500 MHz, CDCl3) δ 7.44 (dd, J = 8.9, 5.3 Hz, 1H, 2CHAr),
7.03 (t, J = 8.7 Hz, 2H, 2CHAr), 5.93 – 5.68 (m, 2H, 2=CH), 4.73 (dd, J = 7.1, 5.7 Hz, 1H,
CH(CH3)), 4.20 (dd, J = 15.6, 2.4 Hz, 1H, CHA(O)), 4.11 (dd, J = 15.6, 2.4 Hz, 1H, CHB(O)),
2.41 (t, J = 2.4 Hz, 1H, CH-alkyne), 1.34 (d, J = 6.4 Hz, 3H, CH3(CH)). 13C NMR (126 MHz,
CDCl3) δ 162.5 (d, JCF = 250.0 Hz), 143.3, 133.3 (d, JCF = 8.4 Hz), 119.1 (d, JCF= 3.4 Hz),
115.7 (d, JCF = 22.1 Hz), 111.9, 93.8, 84.7 (d, JCF = 1.5 Hz), 80.3, 73.8, 72.3, 55.7, 20.7. IR
(νmax/cm-1) 3291 (w), 2977 (w), 2202 (w), 1724 (m), 1664 (m), 1599 (w), 1505 (s), 1443 (m),
1227 (s), 1156 (m), 1073 (s), 835 (s), 632 (m), 527 (s). HRMS (ESI-OTF) m/z calcd for
C15H13OFNa [M + Na] + 251.0848, found 251.0846.

(Z)-1-Methoxy-4-(5-(prop-2-yn-1-yloxy)hex-3-en-1-yn-1-yl)benzene (110o)
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The tittle compound was obtained as a colourless oil (38 mg, 51%) after flash column
chromatography (Et2O/pentane 0.7:9.3) following the general procedure Method-C using NaH
(11.8 mg, 0.29 mmol) THF (2 mL), (Z)-6-(4-methoxyphenyl)hex-3-en-5-yn-2-ol 108e (50 mg,
0.2 mmol), and propargyl bromide (80% in toluene, 0.046 mL, 0.49 mmol, 2 equiv). Rf
(Et2O/pentane 1:9) = 0.5. 1H NMR (400 MHz, CDCl3) δ 7.39 (d, J = 8.8 Hz, 2H, 2CHAr), 6.85
(d, J = 8.8 Hz, 2H, 2CHAr), 5.86 (d, J = 10.9 Hz, 1H, =CH), 5.79 (dd, J = 10.8, 8.7 Hz, 1H,
=CH), 4.82 – 4.68 (m, 1H, CH(CH3)), 4.20 (dd, J = 15.6, 2.4 Hz, 1H, CHA(O)), 4.11 (dd, J =
15.6, 2.4 Hz, 1H, CHB(O)), 3.82 (s, 3H, OCH3), 2.39 (t, J = 2.4 Hz, 1H, CH alkyne), 1.34 (d,
J = 6.4 Hz, 3H, CH3(CH)). 13C NMR (101 MHz, CDCl3) δ 159.7, 142.5, 132.9, 115.2, 114.0,
112.2, 94.9, 83.8, 80.4, 73.7, 72.5, 55.7, 55.3, 20.7. IR (νmax/cm-1) 3343 (w), 2970 (s), 2933
(m), 1648 (m), 1468 (m), 1408 (m), 1379 (s), 1305 (m), 1128 (s), 816 (m), 633 (m). HRMS
(ESI-OTF) m/z calcd for C16H16O2Na [M + Na] + 263.1043 found 263.1042.

(Z)-2-(Prop-2-yn-1-yloxy)undec-3-en-5-yne (110p)

O

The title compound was obtained as a pale yellow liquid (28 mg, 46%) after flash column
chromatography on silica gel (Et2O:penatane 0.3:9.7) following the general procedure
Method-C using NaH (13.2 mg, 0.33 mmol) THF (2 mL), (Z)-undec-3-en-5-yn-2-ol 108f (50
mg, 0.27 mmol) and propargyl bromide (80% in toluene, 0.058 mL, 0.5 mmol, 2 equiv); R f
(Et2O/pentane 1:9) = 0.78. 1H NMR (500 MHz, CDCl3) δ 5.69 (dd, J = 10.8, 8.6 Hz, 1H, =CH),
5.63 (dt, J = 11.0, 2.1 Hz, 1H, =CH), 4.62 (dq, J = 8.6, 6.4 Hz, 1H, CHCH3), 4.16 (dd, J = 15.5,
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2.4 Hz, 1H, CHA(O)), 4.06 (dd, J = 15.6, 2.4 Hz, 1H, CHB(O)), 2.39 (t, J = 2.4 Hz, 1H, CHalkyne), 2.33 (td, J = 7.1, 2.1 Hz, 2H, CH2CH2), 1.59 – 1.51 (m, 2H, CH2CH2), 1.44 – 1.31 (m,
4H, CH2CH2), 1.29 (d, J = 6.3 Hz, 3H, CH3(CH)), 0.91 (t, J = 7.2 Hz, 3H, CH3(CH2)). 13C
NMR (126 MHz, CDCl3) δ 142.0, 112.5, 96.4, 80.4, 76.2, 73.5, 72.5, 55.6, 31.1, 28.3, 22.2,
20.7, 19.4, 14.0. IR (νmax/cm-1) 3313 (w), 2957 (s), 2871 (s), 1645 (m), 1460 (m), 1378 (m),
1080 (m), 1014 (s), 624 (m). HRMS (ESI-OTF) m/z calcd for C14H20OSNa [M + Na]

+

227.1406 found 227.1407.

(Z)-(5-(Prop-2-yn-1-yloxy)oct-3-en-1-yn-1-yl)benzene (110q)

O

The compound was obtained as a pale-yellow liquid (36 mg, 61%) after flash column
chromatography on silica gel (ether:penatane 0.5:9.5) following general procedure Method-C
using NaH (12 mg, 0.3 mmol) THF (2 mL), (Z)-8-phenyloct-5-en-7-yn-4-ol 108h (50 mg, 0.25
mmol) and propargyl bromide (80% in toluene, 0.047 mL, 0.5 mmol, 2 equiv), R f
(Et2O/pentane 2:8) = 0.8. 1H NMR (400 MHz, CDCl3) δ 7.49 – 7.41 (m, 2H, 2ArCH), 7.38 –
7.29 (m, 3H, 3ArCH), 5.92 (dd, J = 10.8, 0.7 Hz, 1H, =CH), 5.81 (dd, J = 10.9, 9.1 Hz, 1H,
=CH), 4.70 – 4.54 (m, 1H, CHCH3), 4.21 (dd, J = 15.6, 2.4 Hz, 1H, CHA(O)), 4.11 (dd, J =
15.6, 2.4 Hz, 1H, CHB(O)), 2.38 (t, J = 2.4 Hz, 1H, CH-alkyne), 1.74 – 1.63 (m, 1H, CHCH2),
1.57 – 1.37 (m, 3H, 3CHCH2), 0.96 (t, J = 7.2 Hz, 3H, (CH2CH2)CH3). 13C NMR (101 MHz,
CDCl3) δ 142.7, 131.4, 128.4, 128.3, 128.3, 128.3, 123.1, 112.7, 94.6, 85.3, 80.4, 76.1, 73.6,
55.8, 36.9, 18.4. IR (νmax/cm-1) 1326 (w), 3061 (m), 2959 (m), 2932 (m), 2872 (m), 1597 (m),
1490 (m), 1360 (m), 1269 (m), 1072 (s), 756 (s), 690 (s), 524 (m). HRMS (ESI-OTF) m/z calcd
for C17H18ONa [M + Na]+ 261.1255 found 261.1265.
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(Z)-(6-Methyl-5-(prop-2-yn-1-yloxy)hept-3-en-1-yn-1-yl)benzene (110r)

O

The title compound was obtained as a pale yellow liquid (18 mg, 25%) after flash column
chromatography on silica gel (Et2O:pentane 0.4:9.6) following the general procedure MethodC using NaH (14.4 mg, 0.36 mmol) THF (2.5 mL), (Z)-2-methyl-7-phenylhept-4-en-6-yn-3-ol
108i (60 mg, 0.3 mmol, 1 equiv) and propargyl bromide (0.56 mL, 0.6 mmol, 2 equiv), Rf
(Et2O/pentane 2:8) = 0.71. 1H NMR (400 MHz, CDCl3) δ 7.49 – 7.41 (m, 2H, 2ArCH), 7.33 –
7.28 (m, 3H, 2ArCH), 5.98 (dd, J = 10.9, 0.7 Hz, 1H, =CH(CH)OH ), 5.82 (dd, J = 11.0, 9.4
Hz, 1H, =CH(alkyne)), 4.34 (ddd, J = 9.4, 6.7, 0.7 Hz, 1H, CH(isopropyl)), 4.22 (dd, J = 15.7,
2.4 Hz, 1H, CH(O)propargyl), 4.10 (dd, J = 15.7, 2.4 Hz, 1H, CH(O)propargyl), 2.37 (t, J =
2.4 Hz, 1H, CH(propargyl alkyne), 1.93 – 1.80 (m, 1H, CH(CH3, CH3), 1.03 (d, J = 6.7 Hz,
3H, CH3), 0.94 (d, J = 6.9 Hz, 3H, CH3). 13C NMR (101 MHz, CDCl3) δ 141.1, 131.4, 128.4,
128.3, 123.2, 113.7, 94.4, 85.6, 81.3, 80.6, 73.5, 55.98, 32.7, 18.6, 18.0. IR (νmax/cm-1) 2961
(w), 2921 (w), 2852 (w), 1258 (s), 1078 (s) 1011 (s), 865 (m), 791 (s), 691 (w). HRMS (ESIOTF) m/z calcd for C17H18ONa [M + Na] + 261.1255 found 261.1263.

(Z)-(3-Methyl-5-(prop-2-yn-1-yloxy)hex-3-en-1-yn-1-yl)benzene (110s)

The title compound obtained as pale yellow liquid (89 mg, 74%) after flash column
chromatography (Et2O:pentane 0.8:9.2) following general synthesis procedure Method-C
using NaH (25.7 mg, 0.64 mmol) THF (2.5 mL), (Z)-4-methyl-6-phenylhex-3-en-5-yn-2-ol
108k (100 mg, 0.53 mmol) and propargyl bromide (80% in toluene, 0.1 mL, 1.07 mmol, 2

168

equiv), Rf (Et2O/pentane 2:8) = 0.8. 1H NMR (400 MHz, CDCl3) δ 7.50 – 7.41 (m, 2H,
2ArCH), 7.35 – 7.28 (m, 3H, 3ArCH), 5.59 (dd, J = 9.1, 1.5 Hz, 1H, =CH), 4.67 (dq, J = 9.1,
6.3 Hz, 1H, CHCH3), 4.19 (dd, J = 15.5, 2.4 Hz, 1H, CHA(O)), 4.10 (dd, J = 15.6, 2.4 Hz, 1H,
CHB(O)), 2.37 (t, J = 2.4 Hz, 1H, CH-alkyne), 1.98 (d, J = 1.5 Hz, 3H, CH3(alkene)), 1.31 (d,
J = 6.4 Hz, 3H, CH3(CH)). 13C NMR (101 MHz, CDCl3) δ 138.0, 131.5, 128.3, 128.3, 123.1,
121.8, 94.0, 87.5, 80.6, 73.5, 73.3, 55.5, 23.2, 20.9. IR (νmax/cm-1) 3296 (w), 3081 (m), 2923
(m), 1629 (m), 1597 (m), 1490 (m), 1267 (m), 1141 (s), 1093 (s), 1046 (s), 926 (s), 756 (s),
835 (s), 758 (s), 668 (s), 527 (m). HRMS (ESI-OTF) m/z calcd for C16H17O [M + H] + 225.1274
found 225.1275.

(Z)-(3-((5-Phenylpent-2-en-4-yn-1-yl)oxy)prop-1-yn-1-yl)benzene (110t)

This title compound was prepared according to a literature synthesis procedure.160 A stirred
suspension of NaH (48 mg, 1.25 mmol, 2 equiv) in dry THF (3 mL) cooled to 0 °C and (Z)-5phenylpent-2-en-4-yn-1-ol 108a (100 mg, 0.625 mmol, 1 equiv) THF (1 mL) and the mixture
stirred for the 45 min. To this slurry was added a dropwise a solution of (3-chloroprop-1-yn-1yl)benzene (0.1 mL, 0.75 mmol, 1.2 equiv), the reaction mixture warm to room temperature
and stirred for 6 h. Ice water was added and the mixture was extracted with diethyl ether (3x2
mL). The combined extracts were dried (Na2SO4) and evaporated under reduced pressure. The
crude product was purified by flash column chromatography on silica gel using Et2O/pentane
(1.5:8.5) to give the tittle compound as a yellow oil (80 mg, 47%), Rf (EtOAc:n-hexane 2:8) =
0.75. 1H NMR (500 MHz, CDCl3) δ 7.41 (m, 2H, 2ArCH), 7.33 – 7.19 (m, 3H, 3ArCH), 6.13
(dt, J = 10.8, 6.6 Hz, 1H, =CH), 5.91 (d, J = 10.9 Hz, 1H, =CH), 4.51 (dd, J = 6.6, 1.5 Hz, 2H,
CH2-alkene), 4.43 (s, 2H, CH2-propagyl). 13C NMR (126 MHz, CDCl3) δ 138.3, 131.8, 131.5,
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128.4, 128.3, 128.3, 128.3, 128.2, 123.0, 122.6, 112.4, 95.4, 86.4, 85.0, 85.0, 67.4, 58.2. IR
(νmax/cm-1) 3293 (w), 3033 (w), 2851 (w), 2117 (w), 1614 (m), 1441 (m), 1335 (m), 1092 (s),
940 (m), 754 (s), 689 (s), 633 (s), 527 (s). HRMS (ESI-OTF) m/z calcd for C20H17O [M + H]+
273.1279 found 273.1269.

General procedure for the rhodium(I)-catalyzed cycloaromatization of enediynes (110a,
b, d and f-u)

In an oven-dried Schlenk flask, [Rh(COD)Cl]2 (5 mol%), (rac)-BINAP (12 mol%) was
dissolved in dry DCE (0.5 mL) then immediately AgSbF6 (20 mol%) was added under a N2
atmosphere. The resulting mixture was stirred for 2 min to dissolve the catalyst to form the
active cationic Rh(I)-catalyst, the enediyne 110a, b, d and f-u (20 mg, 1.0 equiv) in DCE (0.5),
was added and the solution was then degassed and stirred at room temperature for 1-12 h. The
crude reaction mixture was filtered through by small silica bed then concentrated under reduced
pressure. The crude product was purified by silica gel flash column chromatography to provide
the corresponding pure products 160a, b, d and f-u.
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1-Methyl-5-phenyl-2-tosylisoindoline (160f)

The product was obtained as a white Solid (15.7 mg, 79%) after flash column chromatography
(Et2O/pentane 2:8) following the general procedure using Z)-4-methyl-N-(6-phenylhex-3-en5-yn-2-yl)-N-(prop-2-yn-1-yl)benzenesulfonamide 110f (20 mg, 0.055 mmol) in DCE (0.5
mL), [Rh(COD)Cl]2 (1.3 mg, 0.002mmol) , (±)-BINAP (4.1 mg, 0.006 mmol) and AgSbF6 (3.7
mg, 0.011 mmol) in DCE (0.5 mL), the solution was stirred at room temperature for 12 h. Mp:
131−136 °C, Rf (EtOAc/hexane 1:9) = 0.39. 1H NMR (500 MHz, CDCl3) δ 7.78 – 7.76 (d, J
= 8.3 Hz, 2H, 2CHAr), 7.51 – 7.49 (d, J = 7.5 Hz, 2H, 2CHAr), 7.46 (d, J = 9.5 Hz, 1H, 1CHAr),
7.42 (t, J = 7.6 Hz, 2H, , 2CHAr ), 7.34 (m, 2H, , 2CHAr), 7.30 – 7.28 (d, J = 8 Hz, 2H, 2CHAr),
7.16 (d, J = 8.0 Hz, 1H, ArCH). 4.94 (dt, J = 8.7, 4.3 Hz, 1H, CH(CH3)), 4.79 (dd, J = 13.9,
2.6 Hz, 1H, CHA(N)), 4.60 (d, J = 13.5 Hz, 1H, CHB(N)), 2.38 (s, 3H, CH3(Ts)), 1.72 (d, J = 6
Hz, 3H, CH3(CH)). 13C NMR (126 MHz, CDCl3) δ 143.6, 141.2, 140.6, 140.4, 135.5, 134.2,
129.8, 128.8, 127.5, 127.5, 127.0, 126.9, 122.6, 121.1, 61.7, 53.7, 23.8, 21.5. IR (νmax/cm-1)
2973 (w), 1597 (w), 1486 (w) 1344 (s), 1160 (s), 1090 (s), 758 (s), 661 (s), 553 (s). HRMS
(ESI-OTF) m/z calcd for C22H21NO2NaS [M + H] + 364.1371, found 364.1365.

5-Phenyl-2-tosylisoindoline (160g)
NTs
Ph

The product was obtained as a white solid (14.2 mg, 71%) after flash column chromatography
(Et2O/pentane 1.5:8.5) following the general synthesis procedure using (Z)-4-methyl-N-(5-
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phenylpent-2-en-4-yn-1-yl)-N-(prop-2-yn-1-yl)benzenesulfonamide 110g (20 mg, 0.05 mmol)
in DCE (0.5 mL), [Rh(COD)Cl2 (1.41 mg, 0.002mmol), (±)-BINAP (4.27 mg, 0.006 mmol)
and AgSbF6 (3.9 mg, 0.01 mmol) in DCE (0.5 mL), the solution was stirred at room
temperature for 12 h. Rf (EtOAc/hexane 2:8) = 0.65. 1H NMR (500 MHz, CDCl3) δ 7.79 (d, J
= 8.3 Hz, 2H), 7.52 – 7.49 (m, 2H,), 7.45 – 7.40 (m, 2H), 7.38 – 7.34 (m, 2H), 7.34 – 7.31 (m,
2H), 7.24 (d, J = 7.6 Hz, 1H), 4.67 (s, 2H), 4.66 (s, 2H), 2.41 (s, 3H). 13C NMR (126 MHz,
CDCl3) δ 143.7, 141.2, 140.4, 136.7, 135.0, 129.8, 128.8, 127.6, 127.5, 127.0, 126.8, 122.9,
121.3, 53.7, 53.5, 21.5. NMR data matches literature values.161

5-(4-Fluorophenyl)-1-methyl-2-tosylisoindoline (160h)

The product was obtained as a pale-yellow solid (24.1 mg, 80%) after flash column
chromatography (Et2O/pentane 2:8) following the general procedure using 5-(4-fluorophenyl)1-methyl-2-tosylisoindoline 110h (30 mg, 0.078 mmol) in DCE (0.5 mL), [Rh(COD)Cl2 (1.94
mg, 0.003 mmol), (±)-BINAP (5.87 mg, 0.009 mmol) and AgSbF6 (5.4 mg, 0.15 mmol) in
DCE (0.5 mL), the solution was stirred at room temperature for 12 h. Mp: 58−65 °C, Rf
(EtOAc/hexane 2:8) = 0.66. 1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 8.3 Hz, 2H, 2CHAr),
7.49 – 7.42 (m, 2H, 2CHAr), 7.42 – 7.36 (m, 1H, 1CHAr), 7.32 – 7.27 (m, 3H, 3CHAr), 7.16 (d,
J = 7.9 Hz, 1H, 1CHAr), 7.12 – 7.06 (m, 2H, 2CHAr), 5.00 – 4.89 (m, 1H, CH(CH3)), 4.77 (dd,
J = 13.8, 2.6 Hz, 1H, CHA(N)), 4.61 (dd, J = 13.9, 1.1 Hz, 1H, CHB(N)), 2.38 (s, 3H, CH3(Ts)),
1.70 (d, J = 6.4 Hz, 3H, CH3(CH)). 13C NMR (101 MHz, CDCl3) δ 162.5 (d, JCF = 246.9 Hz),
143.6, 140.7, 140.3, 136.7 (d, JCF = 3.3 Hz), 135.7, 134.6, 129.8, 128.6 (d, JCF = 8.1 Hz), 127.5,
126.8, 122.7, 121.0, 115.7 (d, JCF = 21.6 Hz), 61.7, 53.7, 23.8, 21.4. IR (νmax/cm-1) 2966 (w),
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2925 (w), 1598 (m), 1518 (m), 1490 (m), 1340 (s), 1222 (s), 1158 (s), 1092 (m), 1035 (m), 888
(m), 813 (m), 761 (m), 707 (m), 663 (m), 626 (s), 597 (s), 577 (s). HRMS (ESI-OTF) m/z calcd
for C22H21NO2FSNa [M + Na]+ 404.1096, found 404.1080.

5-(4-Methoxyphenyl)-1-methyl-2-tosylisoindoline (160i)

The product was obtained as a white crystalline powder (15.6 mg, 78%), after flash column
chromatography (Et2O/pentane 2:8) following the general procedure using (E/Z)-N-(6-(4methoxyphenyl)hex-3-en-5-yn-2-yl)-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide

110i

and 110i’ (20 mg, 0.050 mmol) in DCE (0.5 mL), [Rh(COD)Cl]2 (1.25 mg, 0.002mmol) , (±)BINAP (3.8 mg, 0.006 mmol) and AgSbF6 (3.49 mg, 0.01 mmol), in DCE (0.5 mL), the
solution was stirred at room temperature for 12 h. Mp: 135−138 °C, Rf (EtOAc/hexane 2:8) =
0.30. 1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 8.3 Hz, 2H, 2ArCH), 7.46 – 7.38 (m, 3H,
3ArCH), 7.30 – 7.26 (m, 2H, 2ArCH), 7.13 (d, J = 7.9 Hz, 1H, ArCH), 6.95 (d, J = 8.8 Hz, 2H,
2ArCH), 4.94 (qd, J = 6.4, 2.4 Hz, 1H, CH(CH3)), 4.77 (dd, J = 13.8, 2.6 Hz, 1H, CHA(N)),
4.60 (dd, J = 13.8, 1.0 Hz, 1H, CHB(N)), 3.84 (s, 3H, OCH3), 2.38 (s, 3H, CH3(Ts)), 1.70 (d, J
= 6.4 Hz, 3H, CH3(CH)). 13C NMR (101 MHz, CDCl3) δ 159.3, 143.5, 140.8, 140.1, 135.6,
134.6, 133.0, 129.7, 128.1, 127.5, 126.5, 122.6, 120.6, 114.3, 61.7, 55.3, 53.7, 23.8, 21.4. IR
(νmax/cm-1) 3345 (w), 2985 (w), 1065 (m), 1520 (m), 1491 (m), 1437 (m), 1251 (m), 1185 (m),
1161 (m), 1088 (m), 881 (w), 763 (s), 662 (m), 600 (m), 544 (s), 525 (s), 492 (s). HRMS (ESIOTF) m/z calcd for C23H24NO3S [M + H] + 394.1477, found 394.1491.
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1-Methyl-5-pentyl-2-tosylisoindoline (160j)

The product was obtained as a colourless liquid (16.5 mg, 83%) after flash column
chromatography (Et2O/pentane 1.5:8.5) following the general procedure using (Z)-4-methylN-(prop-2-yn-1-yl)-N-(undec-3-en-5-yn-2-yl)benzenesulfonamide 110j (20 mg, 0.05 mmol) in
DCE (0.5 mL), [Rh(COD)Cl2 (3.06 mg, 0.002 mmol), (±)-BINAP (3.9 mg, 0.006 mmol) and
AgSbF6 (3.63 mg, 0.01 mmol) in DCE (0.5 mL), the solution was stirred at room temperature
for 12 h. Rf (EtOAc/hexane 2:8) = 0.45. 1H NMR (500 MHz, CDCl3) δ 7.75 (d, J = 8.3 Hz,
2H, 2ArCH), 7.29 – 7.23 (d, J = 8.3 Hz, 2H, 2ArCH ), 7.04 (dd, J = 7.8, 1.5 Hz, 1H, ArCH),
6.99 (d, J = 7.9 Hz, 1H, ArCH), 6.94 (s, 1H, ArCH), 4.87 (qd, J = 6.3, 2.3 Hz, 1H, CHCH3),
4.69 (dd, J = 13.7, 2.6 Hz, 1H, CHA(N)), 4.52 (dd, J = 13.6, 1.0 Hz, 1H, CHB(N)), 2.57 – 2.51
(m, 2H, CH2CH2), 2.38 (s, 3H, CH3Ts), 1.65 (d, J = 6.3 Hz, 3H, CH3CH), 1.60 – 1.49 (m, 2H,
CH2CH2), 1.34 – 1.24 (m, 4H), 0.87 (t, J = 7.0 Hz, 3H, CH3CH2). 13C NMR (126 MHz, CDCl3)
δ 143.4, 142.8, 138.9, 134.9, 134.6, 129.7, 128.0, 127.5, 122.2, 122.0, 61.7, 53.7, 35.7, 31.4,
31.2, 23.8, 22.4, 21.48, 13.9. IR (νmax/cm-1) 3301 (w), 2929 (m), 2836 (m), 1599 (m), 1451
(m), 1347 (m), 1164 (s), 1097 (m), 1019 (s), 665 (m). HRMS (ESI-OTF) m/z calcd for
C21H27NO2SNa [M + Na] + 380.1160 found 380.1671.

1-Methyl-2-tosyl-5-(trimethylsilyl)isoindoline (160k)
CH3
NTs
TMS

The product was obtained as a yellow solid (11 mg, 55%), after flash column chromatography
(Et2O/pentane 2:8) following the general procedure using (Z)-4-methyl-N-(prop-2-yn-1-yl)-N(6-(trimethylsilyl)hex-3-en-5-yn-2-yl)benzenesulfonamide 110k (20 mg, 0.055 mmol) in DCE
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(0.5 mL), [Rh(COD)Cl2 (1.37 mg, 0.002mmol), (±)-BINAP (4.1 mg, 0.006 mmol) and AgSbF6
(3.7 mg, 0.01 mmol) in DCE (0.5 mL), the solution was stirred at room temperature for 12 h.
Mp: 251−255 °C, Rf (EtOAc/hexane 1:9) = 0.7. 1H NMR (400 MHz, CDCl3) δ 7.79 – 7.69
(m, 2H, 2ArCH), 7.39 (dd, J = 7.6, 1.0 Hz, 1H, ArCH), 7.26 – 7.24 (m, 2H, 2ArCH), 7.11 –
7.07 (m, 1H, ArCH), 4.90 (dt, J = 6.5, 3.3 Hz, 1H, CH-CH3(NTs)), 4.73 (dd, J = 13.7, 2.7 Hz,
1H, CHA(N)), 4.55 (dd, J = 13.7, 1.0 Hz, 1H, CHB(N)), 2.38 (s, 3H, CH3(Ts)), 1.68 (d, J = 6.4
Hz, 3H, CH3(CH)), 0.23 (s, 9H,CH3-TMS).

13C

NMR (101 MHz, CDCl3) δ 144.6, 143.4,

141.4, 135.7, 135.5, 133.8, 130.8, 128.7, 128.3, 122.8, 63.0, 54.9, 24.8, 22.6, 1.1. IR (νmax/cm1)

3339 (w), 2970 (s), 2932 (m), 2883 (m), 1466 (m), 1408 (s), 1379 (s), 1306 (s), 1160 (s),

1107 (s), 950 (s), 816 (s). HRMS (ESI-OTF) m/z calcd for C19H25NO2SSiNa [M + Na] +
382.1268 found 382.1268.

1-Methyl-2-((4-nitrophenyl)sulfonyl)-5-phenylisoindoline (160l)

The product was obtained as a white solid (26 mg, 81%) after flash column chromatography
(Et2O/pentane 2:8) following the general procedure using (Z)-4-methyl-N-(6-phenylhex-3-en5-yn-2-yl-3-d)-N-(prop-2-yn-1-yl)benzenesulfonamide 110l (33 mg, 0.090 mmol) in DCE (1.0
mL), [Rh(COD)Cl]2 (2.2 mg, 0.004mmol) , (±)-BINAP (6.76 mg, 0.010 mmol) and AgSbF6
(6.21 mg, 0.018 mmol) in DCE (0.5 mL), the solution was stirred at room temperature for 12
h. Mp: 71−73 °C, Rf (EtOAc/hexane 1:9) = 0.39. 1H NMR (400 MHz, CDCl3) δ 8.35 (d, J =
8.9 Hz, 2H, 2ArCH), 8.07 (d, J = 8.9 Hz, 2H, 2ArCH), 7.53 – 7.46 (m, 3H, 3ArCH), 7.45 –
7.39 (m, 2H, 2ArCH), 7.38 – 7.31 (m, 2H, 2ArCH), 7.18 (d, J = 8.0 Hz, 1H, 2ArCH), 5.03 (qd,
J = 6.4, 2.4 Hz, 1H, CH(CH3)), 4.83 (dd, J = 13.9, 2.6 Hz, 1H, CHA(N)), 4.66 (dd, J = 13.8,
1.0 Hz, 1H, CHB(N)), 1.70 (d, J = 6.4 Hz, 3H, CH3(CH)).13C NMR (101 MHz, CDCl3) δ 150.1,
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143.7, 141.7, 140.3, 140.0, 134.9, 128.8, 128.5, 127.6, 127.3, 127.1, 124.4, 122.7, 121.2, 62.2,
53.7, 23.8. IR (νmax/cm-1) 3102 (w), 2867 (w), 1607 (s), 1527 (s), 1483 (s), 1400 (m), 1347 (s),
1312 (m), 1163 (s), 1092 (m), 1101 (m), 855 (m), 760 (s), 745 (m), 733 (m), 686 (m), 638 (m),
619 (s). HRMS (ESI-OTF) m/z calcd for C21H19N2O4S [M + H]+ 395.1070, found 395.1081.

4-Ethyl-1-methyl-5-phenyl-2-tosylisoindoline (160m)

The product was obtained as a white solid (16.1mg, 81%) after flash column chromatography
(Et2O/pentane 2:8) following the general procedure using Z)-4-methyl-N-(pent-2-yn-1-yl)-N(6-phenylhex-3-en-5-yn-2-yl)benzenesulfonamide 110m (20 mg, 0.051 mmol) in DCE (0.5
mL), [Rh(COD)Cl]2 (1.26 mg, 0.002mmol) , (±)-BINAP (3.81 mg, 0.006 mmol) and AgSbF6
(3.49 mg, 0.010 mmol) in DCE (0.5 mL), the solution was stirred at room temperature for 12
h. Mp: 125−127 °C, Rf (EtOAc/hexane 1.5:8.5) = 0.43. 1H NMR (500 MHz, CDCl3) δ 7.79
(d, J = 8.3 Hz, 2H, 2CHAr), 7.41 – 7.32 (m, 3H, 3CHAr), 7.30 (d, J = 7.8 Hz, 1H, 1CHAr), 7.24
– 7.20 (m, 2H, 2CHAr), 7.10 (d, J = 7.8 Hz, 1H, 1CHAr), 6.96 (dd, J = 7.8, 0.9 Hz, 1H, 1CHAr),
4.94 (qd, J = 6.3, 2.5 Hz, 1H, CH(CH3)), 4.79 (dd, J = 13.7, 2.7 Hz, 1H, CHA(N)), 4.59 (d, J =
13.7 Hz, 1H, CHB(N)), 2.44 (dd, J = 7.6, 4.1 Hz, 2H, CH2(Ar) and (CH3)), 2.40 (s, 3H,
CH3(Ts)), 1.71 (d, J = 6.4 Hz, 3H, CH3(CH)), 0.94 (t, J = 7.6 Hz, 3H, CH3(CH2)). 13C NMR
(126 MHz, CDCl3) δ 143.5, 141.4, 141.0, 140.9, 136.3, 134.5, 133.9, 130.2, 129.8, 129.1,
128.0, 127.5, 127.0, 119.4, 62.0, 53.1, 23.8, 23.6, 21.5, 14.3. IR (νmax/cm-1) 2963 (w), 2866
(w), 1596 (s), 1444 (s), 1375 (s), 1340 (s), 1159 (s), 1092 (s), 834 (s), 766 (s), 656 (s), 547 (s).
HRMS (ESI-OTF) m/z calcd for C24H26NO2S [M + H] + 392.1684, found 392.1694.
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Synthesis of 5-phenyl-1,3-dihydroisobenzofuran from (Z)-(5-(prop-2-yn-1-yloxy)pent-3en-1-yn-1-yl)benzene (160a)

The product was obtained as a colourless liquid (13 mg, 65%) after flash column
chromatography (Et2O/pentane 1:9) following the general procedure using (Z)-(5-(prop-2-yn1-yloxy)hex-3-en-1-yn-1-yl)benzene 110a (20 mg, 0.051 mmol) in DCE (0.5 mL),
[Rh(COD)Cl]2 (2.34 mg, 0.004 mmol) , (±)-BINAP (7.1 mg, 011.42 mmol) and AgSbF6 (6.5
mg, 0.019 mmol) in DCE (0.5 mL), the solution was stirred at room temperature for 1 h. Rf (
EtOAc/hexane 8:2) = 0.76. 1H NMR (500 MHz, CDCl3) δ 7.58 – 7.56 (m, 2H, ), 7.50 – 7.48
(d, J = 10, 1H), 7.45 – 7.42 (m, 3H), 7.37 – 7.31 (m, 1H), 7.30 (d, J = 8.5, 1H), 5.17 – 5.16 (m,
4H).13C NMR (126 MHz, CDCl3) δ 141.0, 140.8, 139.9, 138.2, 128.8, 127.3, 127.2, 126.5,
121.2, 119.7, 73.5, 73.4. NMR data matches literature values.161

1-Methyl-5-phenyl-1,3-dihydroisobenzofuran from(Z)-(5-(prop-2-yn-1-yloxy)hex-3-en1-yn-1-yl)benzene (160b)

The product was obtained as a colourless liquid (13.1 mg, 66%) after flash column
chromatography (Et2O/pentane 1:9) following the general procedure using (Z)-(5-(prop-2-yn1-yloxy)hex-3-en-1-yn-1-yl)benzene 110b (20 mg, 0.051 mmol) in DCE (0.5 mL),
[Rh(COD)Cl]2 (2.34 mg, 0.004 mmol) , (±)-BINAP (7.1 mg, 011.42 mmol) and AgSbF6 (6.5
mg, 0.019 mmol) in DCE (1.0 mL), the solution was stirred at room temperature for 12 h. Rf (
EtOAc/hexane 8:2) = 0.76. 1H NMR (500 MHz, CDCl3) δ 7.60 – 7.55 (m, 2H, 2ArCH), 7.50
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(d, J = 7.8 Hz, 1H, ArCH), 7.47 – 7.40 (m, 3H, 3ArCH), 7.39 – 7.32 (m, 1H, ArCH), 7.23 (d,
J = 7.8 Hz, 1H, ArCH), 5.41 – 5.26 (m, 1H, CHA(O)), 5.19 (dd, J = 12.1, 2.4 Hz, 1H, CHB(O)),
5.10 (ddt, J = 12.0, 1.8, 0.9 Hz, 1H, (CH3)CH), 1.55 (d, J = 0.8 Hz, 3H, CH3). 13C NMR (126
MHz, CDCl3) δ 142.6, 141.0, 140.9, 140.0, 128.7, 127.3, 127.2, 126.6, 121.2, 119.7, 79.8, 72.2,
21.7. IR (νmax/cm-1) 3058 (w), 2969 (w), 2853 (w), 1762 (m), 1574 (s), 1481 (s), 1370 (s), 1128
(s), 1070 (s), 760 (s), 697 (s), 525 (s). HRMS (ESI-OTF) m/z calcd for C15H15O [M + H]+
211.1123, found 211.1119

5-(4-Fluorophenyl)-1-methyl-1,3-dihydroisobenzofuran (160n)

The product was obtained as a yellow liquid (13.2 mg, 66%) after flash column
chromatography (Et2O/pentane 1:9) following the general procedure using (Z)-1-fluoro-4-(5(prop-2-yn-1-yloxy)hex-3-en-1-yn-1-yl)benzene 110n (20 mg, 0.087 mmol) in DCE (0.5 mL),
[Rh(COD)Cl]2 (2.16 mg, 0.004 mmol), (±)-BINAP (6.5 mg, 0.01 mmol) and AgSbF6 (6.01
mg, 0.017 mmol), the solution was stirred at room temperature for 12 h. Rf (EtOAc/hexane
0.5:9.5) = 0.31. 1H NMR (500 MHz, CDCl3) δ 7.53 (dd, J = 8.8, 5.3 Hz, 2H, 2CHAr), 7.46 –
7.44 (m, 1H, 1CHAr), 7.38 (s, 1H, 1CHAr), 7.23 (d, J = 7.9 Hz, 1H, 1CHAr), 7.17 – 7.09 (m, 2H,
2CHAr), 5.41 – 5.31 (m, 1H, CH(CH3)), 5.18 (d, J = 2.4 Hz, 1H, CH(O)), 5.10 (d, J = 12.2 Hz,
1H, CH(O)), 1.54 (d, J = 6.3 Hz, 3H, CH3(CH)). 13C NMR (126 MHz, CDCl3) δ 162.5 (d, JCF
= 246.4 Hz), 142.6, 140.2, 139.9, 137.2, 128.7 (d, JCF = 8.0 Hz), 126.5, 121.3, 119.6, 115.6 (d,
JCF = 21.4 Hz), 79.8, 72.2, 21.7. IR (νmax/cm-1) 3361 (w), 2936 (m), 1760 (m), 1601 (m), 1516
(m), 1488 (s), 1346 (m), 1022 (s), 824 (s), 529 (m). HRMS (ESI-OTF) m/z calcd for
C15H13OFNa [M + Na] + 229.1029, found 229.1036.
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5-(4-Methoxyphenyl)-1-methyl-1,3-dihydroisobenzofuran (160o)

The product was obtained as a white solid (14 mg, 70%) after flash column chromatography
(EtOAc/hexane 1:9) following the general procedure using (Z)-1-methoxy-4-(5-(prop-2-yn-1yloxy)hex-3-en-1-yn-1-yl)benzene 110o (20 mg, 0.08mmol) in DCE (0.5 mL), [Rh(COD)Cl]2
(2.05 mg, 0.004mmol) , (±)-BINAP (6.21 mg, 0.009 mmol) and AgSbF6 (5.71 mg, 0.016 mmol)
in DCE (1.0 mL), the solution was stirred at room temperature for 12 h. Mp: 94−96 °C, Rf
(EtOAc/hexane 0.5:9.5) = 0.58. 1H NMR (400 MHz, CDCl3) δ 7.50 (d, J = 8.8 Hz, 2H,
2ArCH), 7.45 (d, J = 7.8 Hz, 1H ArCH), 7.38 (s, 1H, ArCH), 7.20 (d, J = 7.8 Hz, 1H ArCH),
6.97 (d, J = 8.8 Hz, 2H, 2ArCH), 5.35 (qd, J = 6.3, 3.1 Hz, 1H, CH(CH3)), 5.18 (dd, J = 12.2,
2.4 Hz, 1H, CHA(O) ), 5.08 (dd, J = 12.3, 2.0 Hz, 1H, CHB(O)), 3.85 (s, 3H, OCH3), 1.53 (d, J
= 6.4 Hz, 3H, CH3(CH)). 13C NMR (101 MHz, CDCl3) δ 159.2, 142.0, 140.5, 140.0, 133.6,
128.2, 126.1, 121.1, 119.2, 114.2, 79.8, 72.2, 55.3, 21.7. IR (νmax/cm-1) 3476 (w), 2967 (m),
2921 (m), 2839 (m), 1067 (m), 1520 (m), 1489 (m), 1373 (s), 1298 (m), 1184 (m), 1070 (s),
852 (s). HRMS (ESI-OTF) m/z calcd for C16H17O2 [M + H] + 241.1223 found 241.1222.

1-Methyl-5-pentyl-1,3-dihydroisobenzofuran (160p)

The product was obtained as a yellow liquid (15 mg, 75%) after flash column chromatography
(Et2O/pentane 1:9) following the general procedure using (Z)-2-(prop-2-yn-1-yloxy)undec-3en-5-yne 110p (20 mg, 0.091 mmol) in DCE (0.5 mL), [Rh(COD)Cl]2 (2.21 mg, 0.004 mmol),
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(±)-BINAP (6.8 mg, 0.011 mmol) and AgSbF6 (6.2 mg, 0.018 mmol) in DCE (0.5 mL), the
solution was stirred at room temperature for 12 h. Rf (EtOAc/hexane 1:9) = 0.89. 1H NMR
(500 MHz, CDCl3) δ 7.94 (d, J = 7 1H, CHAr), 7.05 (d, J = 7.5 Hz, 1H, CHAr), 7.03 (s, 1H,
CHAr), 5.33 – 5.25 (m, 1H, CHCH3), 5.10 (dd, J = 12.1, 2.5 Hz, 1H, CHA(O)), 5.05 – 4.98 (dt,
J = 12, 1 Hz, 1H, CHB(O)), 2.64 – 2.58 (m, 2H, CH2), 1.60 (s, 4H, 2CH2), 1.48 (d, J = 6.3 Hz,
2H, , CH3CH), 1.37 – 1.21 (m, 2H), 0.92 – 0.87 (m, 4H, , 2CH2), .13C NMR (125 MHz, CDCl3)
δ 142.3, 140.8, 139.4, 127.5, 120.7, 120.6, 79.8, 72.1, 35.8, 31.5, 31.4, 22.5, 21.8, 14.0, 14.0.
IR (νmax/cm-1) 3340 (w), 2970 (s), 2883 (m), 1466 (m) 1408 (s), 1341 (s), 1305 (s), 1160 (s),
1107 (s), 950 (s), 816 (s), 637 (w), 487 (s). HRMS (ESI-OTF) m/z calcd for C14H20ONa [M +
Na]+ 227.1412 found 227.1420.

5-Phenyl-1-propyl-1,3-dihydroisobenzofuran (160q)

O
Ph

The product was obtained as a colourless liquid (13.9 mg, 70%) after flash column
chromatography (Et2O/pentane 0.6:9.4) following the general procedure using (Z)-(5-(prop-2yn-1-yloxy)oct-3-en-1-yn-1-yl)benzene 110qp (20 mg, 0.08 mmol) in DCE (0.5 mL),
[Rh(COD)Cl]2 (2.07 mg, 0.004 mmol), (±)-BINAP (6.27 mg, 0.01 mmol) and AgSbF6 (5.7
mg, 0.016 mmol) in DCE (0.5 mL), the solution was stirred at room temperature for 9 h. Rf (
EtOAc/hexane 0.5:9.5) = 0.44. 1H NMR (500 MHz, CDCl3) δ 7.60 – 7.54 (m, 2H, 2ArCH),
7.49 (ddd, J = 7.9, 1.7, 0.9 Hz, 1H, ArCH), 7.47 – 7.40 (m, 3H, 3ArCH), 7.38 – 7.29 (m, 1H,
ArCH), 7.23 (d, J = 7.8 Hz, 1H, Ar), 5.30 – 5.26 (m, 1H, CH(propyl)), 5.17 (dd, J = 12.1, 2.4
Hz, 1H, CHA(O)), 5.11 (d, J = 12.1 Hz, 1H, CHB(O)), 1.92 – 1.77 ( (m, 1H, CH2), 1.77 – 1.66
(m, 1H, CH2), 1.55 – 1.45 (m, 3H, CH2), 0.99 (t, J = 7.4 Hz, 3H, CH3). 13C NMR (126 MHz,
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CDCl3) δ 141.4, 141.0, 140.7, 140.2, 128.7, 127.2, 127.1, 126.4, 121.3, 119.6, 83.6, 72.4, 38.4,
18.4, 14.1. IR (νmax/cm-1) 3058 (m), 3031 (m), 2956 (m), 2869 (m), 1733 (m), 1600 (m), 1481
(m), 1349 (m), 1250 (m), 1064 (s), 830 (m), 759 (s), 696 (s), 521 (m). HRMS (ESI-OTF) m/z
calcd for C17H18ONa [M + Na]+ 261.1255 found 261.1260.

1,7-Dimethyl-5-phenyl-1,3-dihydroisobenzofuran (160s)
CH3

CH3
O

Ph

The product was obtained as a yellow liquid (13.9 mg, 70%) after flash column
chromatography (Et2O/pentane 0.5:9.5) following the general procedure using (Z)-(3-methyl5-(prop-2-yn-1-yloxy)hex-3-en-1-yn-1-yl)benzene 110s (20 mg, 0.08 mmol) in DCE (0.5 mL),
[Rh(COD)Cl]2 (2.2 mg, 0.004 mmol), (±)-BINAP (6.6 mg, 0.01 mmol) and AgSbF6 (6.1 mg,
0.01 mmol) in DCE (0.5 mL), the solution was stirred at room temperature for 1.3 h. Rf
(EtOAc/hexane 1.5:85) = 0.66. 1H NMR (400 MHz, CDCl3) δ 7.60 – 7.52 (m, 2H, 2ArCH),
7.52 – 7.38 (m, 2H, 2ArCH), 7.38 – 7.29 (m, 1H, ArCH), 7.29 – 7.22 (m, 2H, 2ArCH), 5.49 –
5.37 (qd, J = 9.2, 4 HZ, 1H, CHCH3 ), 5.22 (dd, J = 12.4, 2 Hz, 1H, CHA(O)), 5.07 (dd, J =
12.3, 1.0 Hz, 1H, CHB(O)), 2.36 (s, 3H, CH3Ar), 1.52 (d, J = 6.3 Hz, 3H, CH3CH). 13C NMR
(101 MHz, CDCl3) δ 141.2, 141.1, 141.0, 139.8, 131.6, 128.7, 128.1, 127.2, 127.2, 117.2, 79.9,
72.1, 21.0, 18.86. IR (νmax/cm-1) 3060 (w), 3030 (w), 2864 (w), 1734 1663 (m), 1598 (m), 1490
(m), 1378 (m), 1068 (s), 1014 (m), 871 (s), 763 (s), 698 (s). HRMS (ESI-OTF) m/z calcd for
C16H17O [M + H] + 225.1274 found 225.1274.

4,5-Diphenyl-1,3-dihydroisobenzofuran (160t)
O
Ph
Ph
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The product was obtained as a yellow solid (16.2 mg, 81%),

after flash column

chromatography (Et2O/pentane 0.6:9.4) following the general procedure using (Z)-(3-((5phenylpent-2-en-4-yn-1-yl)oxy)prop-1-yn-1-yl)benzene 110t (20 mg, 0.07 mmol) in DCE
(0.5), [Rh(COD)Cl]2 (1.81 mg, 0.003 mmol), (±)-BINAP (5.4 mg, 0.008 mmol) and AgSbF6
(5.04 mg, 0.014 mmol) in DCE (0.5 mL), the solution was stirred at room temperature for 4.5
h. Rf ( EtOAc/hexane 1.5:85) = 0.63. 1H NMR (500 MHz, CDCl3) δ 7.41 – 7.36 (m, 1H,
ArCH), 7.28 (dt, J = 7.8, 0.9 Hz, 1H, ArCH ), 7.25 – 7.14 (m, 6H, 6ArCH), 7.12 – 7.08 (m,
2H, 2ArCH), 7.07 – 7.03 (m, 2H, 2ArCH), 5.23 (s,1H, OCH2), 5.00 (s, 1H, OCH2). 13C NMR
(126 MHz, CDCl3) δ 141.0, 140.3, 139.2, 138.7, 134.7, 130.2, 130.1, 129.6, 128.2, 127.9,
127.0, 126.6, 120.1, 74.2, 73.9. NMR data matches literature values.162

Method-D: Synthesis of C-tethered enediyne (1u):
This C-tethered Enediyne (1u) was prepare according to a literature procedure.163
Br

CO2Me
MeO2C

+

MeO2C
Cl

109a

MeO2C

NaH

MeO2C

THF, 0 °C−rt
4h

THF, 0 °C−rt
overnight
Ph
287

286

CO2Me

NaH, TBAI

Ph
288, 82%

Ph
110u, 72%

(Z)-(5-Chloropent-3-en-1-yn-1-yl)benzene (287)

Cl

In an oven dried Schlenk flask, (Z)-5-phenylpent-2-en-4-yn-1-ol 108a and MsCl (0.21 mL, 2.8
mmol, 1.15 equiv) were dissolved in dry DCM (3.1 mL) then the resulting solution was cooled
to 0 °C, Et3N (0.35 mL, 2.56 mmol, 1.6 equiv) was added dropwise and the reaction mixture
was warmed to room temperature and stirred overnight. The ice water was added, and the
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mixture was extracted with DCM (3×2 mL). The combined extracts were washed with 1M
HCl, saturated NaHCO3 and brine, dried (Na2SO4). The crude product was purified by flash
column chromatography (ether:pentane 0.5:8.5) to give 287 as a colorless oil (240 mg, 87%);
Rf (ether:pentane 1:9) = 0.67. 1H NMR (500 MHz, CDCl3) δ 7.48 – 7.43 (m, 2H, 2ArCH),
7.35 – 7.32 (m, 3H, 3ArCH), 6.09 (dt, J = 10.5, 7.5 Hz, 1H, =CH), 5.88 (d, J = 10.5 Hz, 1H,
=CH), 4.38 (dd, J = 7.6, 1.0 Hz, 2H, CH2(Cl)). 13C NMR (126 MHz, CDCl3) δ 136.9, 131.5,
128.7, 128.4, 122.7, 113.1, 96.6, 84.0, 41.1. IR (νmax/cm-1) 3033 (w), 2862 (w), 2195 (w), 1727
(m), 1489 (m), 1254 (m), 753 (s), 687 (s). HRMS (ESI-OTF) m/z calcd for C9H7ClNa [M +
Na] + 173.0129 found 173.0121.

Synthesis of dimethyl (Z)-2-(5-phenylpent-2-en-4-yn-1-yl)malonate (288)

MeO2C

CO2Me

Ph

This compound was prepared according to a literature procedure to afford the title compound
as a colourless oil (169 mg, 82%). 1H NMR (500 MHz, CDCl3) δ 7.48 – 7.42 (m, 2H), 7.32
(dd, J = 5.0, 2.0 Hz, 3H), 5.99 – 5.92 (m, 1H), 5.82 – 5.72 (m, 1H), 3.75 (s, 8H), 3.57 (t, J =
7.5 Hz, 1H), 2.99 (td, J = 7.5, 1.3 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 169.39, 138.30,
131.71, 128.53, 128.51, 123.44, 95.16, 85.50, 52.84, 51.22, 29.60. NMR data matches
literature values.164
Synthesis of dimethyl (Z)-2-(5-phenylpent-2-en-4-yn-1-yl)-2-(prop-2-yn-1-yl)malonate
(110u)
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MeO2C
MeO2C

Ph

A solution of 288 (50 mg, 0.18 mmol, 1.0 equiv) in THF (2.5 mL) was added dropwise to a
slurry solution of NaH (14 mg, 0.36 mmol, 2 equiv, 60% wt) in dry THF (1.8 mL) at 0 °C.
After 40 min a homogeneous suspension was formed and propargyl bromide (0.02 mL, 0.22
mmol, 1.2 equiv) was added, the resulting suspension was stirred for 4 h at 25 °C and water
was added to the mixture extracted with diethyl ether (3×2 mL). The extracts were washed with
brine and dried (Na2SO4). The crude product was purified by flash column chromatography on
silica gel (0.5:9.5 Et2O/pentane) to give as a pale-yellow oil (41 mg, 72%), Rf (Et2O/pentane
0.5:9.5) = 0.48. 1H NMR (400 MHz, CDCl3) δ 7.48 – 7.42 (m, 2H, 2ArCH), 7.34 – 7.28 (m,
3H, 3ArCH), 5.89 – 5.81 (m, 2H, 2=CH), 3.75 (s, 6H, 2OCH3), 3.19 (dd, J = 4.9, 1.6 Hz, 2H,
CH2-alkene), 2.86 (d, J = 2.7 Hz, 2H, CH2-propargyl), 2.01 (t, J = 2.7 Hz, 1H, propargyl-CH).
13C

NMR (101 MHz, CDCl3) δ 170.1, 136.0, 131.5, 128.3, 128.3, 128.2, 123.3, 113.5, 94.5,

85.4, 78.7, 71.6, 56.9, 52.9, 33.1, 23.2. IR (νmax/cm-1) 3292(w), 2923 (w), 1732 (s), 1595 (m),
1436 (m), 1288 (m), 1199 (s), 1029 (m), 755 (s), 690 (s), 526 (w). HRMS (ESI-OTF) m/z calcd
for C19H18O4Na [M + Na] + 333.1103 found 333.1116.

Dimethyl 5-phenyl-1,3-dihydro-2H-indene-2,2-dicarboxylate (160u)
CO2Me
Ph

CO2Me

The product was obtained as a pale-yellow oil (15.4 mg, 77%) after flash column
chromatography (Et2O/pentane 0.4:9.6) following the general procedure using dimethyl (Z)-2(5-phenylpent-2-en-4-yn-1-yl)-2-(prop-2-yn-1-yl)malonate 110u (20 mg, 0.06 mmol) in DCE
(0.5 mL), [Rh(COD)Cl]2 (1.5 mg, 0.003 mmol), (±)-BINAP (4.8 mg, 0.007 mmol) and AgSbF6
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(4.4 mg, 0.012mmol) in DCE (0.5 mL), the solution was stirred at room temperature for 1.3 h.
Rf (EtOAc/hexane 1.5:8.5) = 0.5. 1H NMR (400 MHz,CDCl3) δ 7.57 – 7.52 (m, 2H, ArCH),
7.45 – 7.38 (m, 4H, 4ArCH), 7.35 – 7.27 (m, 1H, 1ArCH), 7.28 – 7.24 (m, 1H, 1ArCH), 3.76
(s, 6H, OCH3), 3.66 (s, 2H, CH2), 3.64 (s, 2H, CH2). 13C NMR (101 MHz, CDCl3) δ 172.0,
141.2, 140.5, 140.4, 139.0, 128.7, 127.1, 127.1, 126.2, 124.4, 123.0, 60.4, 53.0, 40.6, 40.3.
NMR data matches literature values.161

5. Deuterium isotope labelling Study:
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Synthesis of methyl (Z)-3-iodoacrylate-2-d (242-D)

To a solution of sodium iodide (1.33 g, 8.91 mmol, 1.5 equiv) in acetic acid-d (99%, 3.49 mL,
1.7 M) at room temperature was added methyl propiolate 240 (0.50 g, 5.94 mmol, 1 equiv) and
the solution was then heated at reflux for 16 h. The reaction was cooled to room temperature
and diluted with water and ethyl acetate. The organic layer was separated, and the aqueous
layer extracted with EtOAc (3×10 mL). The combined extracts were washed with 3 M aqueous
potassium hydroxide solution, brine, dried (Na2SO4) and concentrated in vacuo to yield the S1
as a pale-yellow oil (1.16 g, 91%). 1H NMR (500 MHz, CDCl3) δ 7.48 (d, J = 9.0 Hz, 0.09H)
7.48 (brs, 0.91H, =CH), 6.92 (d, J = 9.0 Hz, 0.09 H, =CH(D)), 3.79 (s, 3H, OCH3). 13C NMR
(126 MHz, CDCl3) δ 165.0, 129.2 (t, JCD = 25.3), 95.1, 51.6. IR (νmax/cm-1) 1729 (w) 1597 (w),
1346 (m), 1205 (w), 1163 (s), 761 (m), 665 (s). HRMS (ESI-OTF) m/z calcd for C4H5DO2I [M
+ H] + 213.9491, found 213.9490.
Methyl (Z)-5-phenylpent-2-en-4-ynoate-2-d (243-D)

A solution of methyl (Z)-3-iodoacrylate-2-d 242-D (996 mg, 4.67 mmol, 1 equiv) in THF (9.3
mL) was sparged over 30 min with nitrogen then cooled to 0 °C, PdCl2(PPh3)2 (32 mg, 0.046
mmol, 1 mol%), CuI (8.9 mg, 0.046 mmol, 1 mol%), triethylamine (1.3 mL, 9.35 mmol 2
equiv) and phenylacetylene (0.51 mL, 4.67 mmol, 1 equiv) were added the mixture was
warmed to room temperature and stirred for 16 h. The reaction mixture was filter of through a
pad of silica gel and washed with EtOAc. The crude product was purified by flash column
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chromatography on silica gel using EtOAc/n-hexane (0.5:9.5) to give 243-D (862 mg, 96%) as
a colorless oil; Rf (EtOAc/n-hexane 1:9) = 0.78. 1H NMR (500 MHz, CDCl3) δ 7.55 – 7.52 (m,
1H, ArCH), 7.43-7.40 (m, 2H, 2ArCH) 7.37 – 7.33 (m, 2H, 2ArCH), 6.37 (d, J = 11.4 Hz, 0.09
H, =CH), 6.37 (brs, 0.94H, =CH), 6.15 (d, J = 11.4 Hz, 0.09H, =CH(D)), 3.80 (s, 3H, OCH3).
13C

NMR (126 MHz, CDCl3) δ 165.2, 132.1, 129.2, 128.4, 127. 4 (t, JCD = 25.7 Hz), 123.1,

122.6, 101.4, 86.9, 51.5. IR (νmax/cm-1) 3021(w), 2949 (w), 2199 (m), 1708 (s), 1602 (s), 1489
(s), 1434 (s), 1353 (s), 1241 (s), 1203 (s), 1061 (s), 987 (s), 789 (s), 690 (s), 528 (s). HRMS
(ESI-OTF) m/z calcd for C12H9DO2Na [M + Na]+ 210.0657, found 210.0656.

(Z)-5-Phenylpent-2-en-4-yn-2-d-1-ol (108a-D)

To a solution of 243-D (600 mg, 3.20 mmol, 1 equiv) in dry CH2Cl2 (16 mL, 0.2 M) at −78 °C
was added dropwise diisobutylaluminium hydride (1.0 M) in hexane (6.41 mL, 6.41 mmol, 2
equiv). The mixture was stirred at the same temperature for 4 h. 1 M aqueous HCl (3 mL) was
added and the mixture was warm to room temperature. The reaction mixture was extracted into
CH2Cl2 (3 × 4 mL) the combined extracts were dried (Na2SO4) and concentrated under vacuo.
The crude product was purified by flash column chromatography on silica gel using EtOAc/nhexane (2:8) to give 108a-D (493 mg, 97%) as a colorless liquid; Rf (EtOAc/n-hexane 2:8) =
0.38. 1H NMR (500 MHz, CDCl3) δ 7.46 – 7.40 (m, 2H, 2CHAr), 7.34 – 7.30 (m, 3H, 3CHAr),
5.81 (brs, 1H, =CH), 4.49 (d, J = 1.6 Hz, 2H, CH2(OH)), 1.67 (brs, 1H, OH). 13C NMR (126
MHz, CDCl3) δ 141.8 (t, JCD = 24.4 Hz),131.4, 128.5, 128.3, 122.9, 110.6, 95.2, 84.9, 61,0. IR
(νmax/cm-1) 3308 (w), 2924 (m), 2205 (m), 1951 (m), 1601 (s), 1488 (s), 1069 (s) 753 (s), 688
(s), 526 (s). HRMS (ESI-OTF) m/z calcd for C11H10DO [M + H]+ 160.0873, found 160.0878.
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(Z)-5-Phenylpent-2-en-4-ynal-2-d (244a-D)

To a stirred solution of 108a-D (300 mg, 1.88 mmol, 1 equiv) in dry DCM (9 mL) was added
MnO2 (2.45 g, 28.2 mmol, 15 equiv). After 4.5 h the mixture was filtered through a pad of
silica gel and crude product was purified by flash column chromatography (ether:pentane 1:9)
to give the title product as colorless oil (201 mg, 68%), Rf (EtOAc:n-hexane 1:9) = 0.76. 1H
NMR (500 MHz, CDCl3) δ 10.28 (s, 1H, CHO), 7.51 – 7.49 (m, 2H, 2ArCH), 7.41 – 7.35 (m,
3H, 3ArCH), 6.87 – 6.85 (m, 1H, =CH). 13C NMR (126 MHz, CDCl3) δ 191.9, 136.9 (t, JCD =
25.4 Hz) 131.9, 129.8, 128.6, 128.6, 121.7, 101.4, 84.0. IR (νmax/cm-1) 3058 (w), 2917 (w),
2192 (w), 1670 (s), 1489 (m), 1078 (m), 916 (m), 754 (s), 687 (s). HRMS (ESI-OTF) m/z calcd
for C11H8DO [M +H]+ 158.0716 found 158.0722.

(Z)-6-Phenylhex-3-en-5-yn-3-d-2-ol (108b-D)

In an oven dried Schlenk flask 244a-D (180 mg, 1.14 mmol, 1 equiv) was dissolved in dry
THF (2.3 mL) and the solution was cooled to −5 °C. A solution of CH3MgCl (3.0 M) in THF
(1.14 mL, 3.43 mmol, 3 equiv) was added dropwise over 2 min. After 5 min, the mixture was
warmed to room temperature and quenched with 1 M aqueous HCl (1 mL). The reaction
mixture was extracted with EtOAc (3 × 1.5 mL) and the combined extracts dried (Na2SO4) and
concentrated under vacuo the resulting oil was purified by flash column chromatography
(EtOAc:n-hexane 2:8) to give 108a-D as colorless oil (186 mg, 93%), Rf (EtOAc/n-hexane 2:8)
= 0.25. 1H NMR (500 MHz, CDCl3) δ 7.46 – 7.40 (m, 2H, 2ArCH), 7.35 – 7.28 (m, 3H,
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3ArCH), 5.99 (dd, J = 10.9, 8.1 Hz, 0.08H, =CH), 5.53 (dd, J = 10.9, 8.1 Hz, 0.08H, =CH)
5.73 (brs, 1H, =CH), 4.95 – 4.91 (q, J = 6.8 Hz, 1H, CH(CH3) ), 2.01 (brs, 1H, OH), 1.35 (d, J
= 6.4 Hz, 3H, CH3(CH)). 13C NMR (126 MHz, CDCl3) δ 145.9 (t, JCD = 24.3 Hz), 131.4, 128.4,
128.3, 123.0, 109.0, 94.9, 85.0, 66.3, 22.5. IR (νmax/cm-1) 3324 (w), 2970 (m), 1603 (s), 1571
(s), 1488 (s), 1367 (s), 1115 (s), 1057 (s), 916 (s), 886 (s), 686 (s), 524 (s). HRMS (ESI-OTF)
m/z calcd for C12H12DO [M + H] + 174.1029, found 174.1034.

(Z)-4-Methyl-N-(6-phenylhex-3-en-5-yn-2-yl-3-d)-N-(prop-2-yn-1yl)benzenesulfonamide (110f-D)

The title compound was obtained as colourless liquid (40 mg, 47%) after flash column
chromatography (EtOAc:n-hexane 2:8) following the general procedure Method-A using 4methyl-N-(prop-2-yn-1-yl)benzenesulfonamide (69.5 mg, 0.33 mmol, 1.1 equiv), (Z)-6phenylhex-3-en-5-yn-3-d-2-ol 108b-D (50 mg, 0.28 mmol, 1.0 equv), PPh3 (100.8 mg, 0.38
mmol, 1.3 equiv) and DIAD (0.07 mL, 0.38 mmol, 1.3 equiv). Rf (EtOAc/hexane 2:8) = 0.56.
1H

NMR (400 MHz, CDCl3) δ 7.80 (d, J = 8.4 Hz, 2H, 2CHAr), 7.50 – 7.45 (m, 2H, 2CHAr),

7.35 – 7.32 (m, 3H, 3ArCH), 7.19 (d, J = 8.0 Hz, 2H, 2ArCH), 5.65 (s, 1H, =CH), 5.15 (q, J =
7.0 Hz, 1H, CH(CH3)), 4.26 (dd, J = 18.6, 2.5 Hz, 1H, CHA(N)), 4.10 (dd, J = 18.6, 2.5 Hz,
1H, CHB(N)), 2.36 (s, 3H, CH3(Ts)), 2.18 (t, J = 2.5 Hz, 1H, CH alkyne), 1.43 (d, J = 7.0 Hz,
3H, CH3(CH) ). 13C NMR (101 MHz, CDCl3) δ 143.2, 140.5 (d, JCD = 24.5), 137.6, 131.6,
129.3, 128.5, 128.4, 127.6, 123.0, 110.6, 95.8, 84.9, 79.7, 72.8, 53.4, 33.4, 21.5, 19.5. IR
(νmax/cm-1) 2924 (w), 2863 (w), 1597(w), 1476 (w), 1402 (s), 1160 (s), 1091 (s), 1011 (s), 910
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(m), 761 (m), 662 (s), 565 (s). HRMS (ESI-OTF) m/z calcd for C22H21DNO2S [M + H] +
365.1434, found 365.1423.

1-Methyl-5-phenyl-2-tosylisoindoline-6-d (160f-D)

The product was obtained as a white Solid (26 mg, 81%) after flash column chromatography
(Et2O/pentane 2:8) following the general procedure using (Z)-4-methyl-N-(6-phenylhex-3-en5-yn-2-yl-3-d)-N-(prop-2-yn-1-yl)benzenesulfonamide 110f-D (33 mg, 0.090 mmol) in DCE
(0.5 mL), [Rh(COD)Cl]2 (2.2 mg, 0.004mmol) , (±)-BINAP (6.76 mg, 0.010 mmol) and AgSbF6
(6.21 mg, 0.018 mmol) in DCE (1.0 mL), the solution was stirred at room temperature for 12
h. Mp: 126−128 °C, Rf (EtOAc/hexane 1:9) = 0.39. 1H NMR (400 MHz, CDCl3) δ 7.77 (d, J
= 8.3 Hz, 2H, 2CHAr), 7.54 – 7.46 (m, 2H, 2CHAr), 7.41 (t, J = 7.5 Hz, 2H, 2CHAr), 7.36 – 7.31
(m, 2H, 2CHAr), 7.29 (d, J = 8.0 Hz, 2H, 2CHAr), 7.16 (s, 1H, 1CHAr), 4.96 (qd, J = 6.4, 2.3
Hz, 1H, CH(CH3)), 4.78 (dd, J = 14.2, 2.7 Hz, 1H, CHA(N)), 4.61 (d, J = 13.8 Hz, 1H, CHB(N)),
2.38 (s, 3H, CH3(Ts)), 1.71 (d, J = 6.4 Hz, 3H, CH3(CH)).

13C

NMR (126 MHz, CDCl3) δ

143.5, 141.1, 140.7, 140.5, 135.6, 134.5, 129.8, 128.8, 127.5, 127.5, 127.1, 122.5, 121.1, 61.7,
53.7, 23.8, 21.4. IR (νmax/cm-1) 2926 (s), 2865 (w), 1597 (m), 1344 (s), 1160 (s), 1305 (m),
1091 (s), 910 (w), 814 (m), 662 (m). HRMS (ESI-OTF) m/z calcd for C22H21DNO2S [M + H]
+

365.1434, found 365.1446.

Stacked proton NMR spectra of non-deuterated and deuterated isondoline.
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Controlled mechanistic study:
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We have conducted further investigation on the mechanism, where we have prepared
substituted 110v and treated this compound under Rh(I)-cycloaromatization conditions,
however this reaction did not proceed, upon heating the starting material had decomposed.

(Z)-2-Methyl-5-phenylpent-2-en-4-yn-1-ol (108k)
CH3
HO

The title compound was obtained as a colourless liquid (211 mg, 87%) after flash column
chromatography (EtOAc/n-hexane 1.5:8.5) using synthesis procedure for 243a using (Z)-3iodo-2-methylprop-2-en-1-ol 289 (280 mg, 1.41 mmol, 1 equiv), dry THF (2.82 mL),
PdCl2(PPh3)2 (10 mg, 0.014 mmol, 1 mol%), CuI (2.7 mg, 0.014 mmol, 1 mol%),
trimethylamine (0.39 mL, 2.28 mmol 2 equiv) and phenylacetylene (0.15 mL, 1.41 mmol, 1
equiv). Rf (EtOAc/n-hexane 2:8) = 0.41. 1H NMR (400 MHz, CDCl3) δ 7.46 – 7.37 (m, 2H,
2ArCH), 7.33–7.29 (m, 3H, 3ArCH), 5.61 (s, 1H, =CH), 4.44 (s, 2H, CH2(OH)), 1.94 (d, J =
1.6 Hz, 3H, CH3), 1.81 (bs, 1H, OH).

13C

NMR (101 MHz, CDCl3) δ 150.2, 131.3, 128.3,

128.1, 126.6, 123.4, 93.1, 80.8, 64.1, 20.3. IR (νmax/cm-1) 3340 (w), 2970 (m), 1466 (m), 1048
(m), 1160 (m), 1128 (s), 950 (s), 816 (m). HRMS (ESI-OTF) m/z calcd for C12H13O [M + H]+
173.0961 found 173.0960.

(Z)-4-Methyl-N-(2-methyl-5-phenylpent-2-en-4-yn-1-yl)-N-(prop-2-yn-1yl)benzenesulfonamide (110v)

The title compound was obtained as colourless liquid (65 mg, 64%); after flash column
chromatography (EtOAc:n-hexane 1.7:8.3) following the general procedure Method-A using
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4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide 109b (69.9 mg, 0.3 mmol, 1.15 equiv), (Z)2-methyl-5-phenylpent-2-en-4-yn-1-ol 108k (50 mg, 0.29 mmol, 1equiv), PPh3 (101 mg, 0.38
mmol, 1.3 equiv) and DIAD (0.07 mL, 0.3 mmol, 1.3 equiv), Rf (EtOAc:n-hexane 2:8) = 0.7.
1H

NMR (500 MHz, CDCl3) δ 7.79 (d, J = 8.3 Hz, 2H, 2ArCH), 7.35 – 7.29 (m, 4H, 4ArCH),

77.29 – 7.24 (m, 3H, 3ArCH), 5.75 (d, J = 1.3 Hz, 1H, =CH), 4.15 (s, 2H, CH2(CHCH3), 4.06
(d, J = 2.5 Hz, 2H, CHACHB(N)), 2.43 (s, 3H, Ts-CH3), 1.93 (d, J = 1.5 Hz, 3H, CH3(CH)),
1.89 (t, J = 2.4 Hz, 1H, alkyne-CH). 13C NMR (126 MHz, CDCl3) δ 144.9, 143.6, 135.7, 131.2,
129.4, 128.2, 128.1, 127.9, 123.32, 110.6, 93.20, 85.7, 73.6, 49.1, 36.2, 21.6, 20.6. IR (νmax/cm1)

3288 (w), 2977 (s), 2122 (s), 1597 (m), 1490 (m), 1402 (s), 1306 (m), 1152 (s), 1090 (s), 901

(m), 813 (m), 754 (s), 690 (s), 577 (s), 544 (s). HRMS (ESI-OTF) m/z calcd for C22H22NO2S
[M + H] + 364.1371, found 364.1381.

7. Stereocontrolled experiment:

1-Methyl-5-phenyl-1,3-dihydroisobenzofuran (160b).

193

The product was obtained as a colourless liquid (13.5 mg, 68%) after flash column
chromatography (Et2O/pentane 1:9) following the synthesis procedure 160f using (E)-(5-(prop2-yn-1-yloxy)hex-3-en-1-yn-1-yl)benzene (110b’) (20 mg, 0.0951 mmol) in DCE (0.5 mL),
[Rh(COD)Cl]2 (2.34 mg, 0.004 mmol) , (±)-BINAP (7.1 mg, 011.42 mmol) and AgSbF6 (6.5
mg, 0.019 mmol) in DCE (O.5 mL). Rf (EtOAc/hexane 8:2) = 0.76. 1H NMR (500 MHz,
CDCl3) δ 7.60 – 7.55 (m, 2H, 2ArCH), 7.50 d, J = 7.8 Hz, 1H, ArCH), 7.47 – 7.40 (m, 3H,
3ArCH), 7.39 – 7.32 (m, 1H, ArCH), 7.23 (d, J = 7.8 Hz, 1H, ArCH), 5.41 – 5.26 (m, 1H,
CH(CH3)), 5.19 (dd, J = 12.1, 2.4 Hz, 1H, CHA(O)), 5.10 (ddt, J = 12.0, 1.8, 0.9 Hz, 1H,
CHB(O)), 1.55 (d, J = 0.8 Hz, 3H, CH3). 13C NMR (126 MHz, CDCl3) δ 142.6, 141.0, 140.8,
140.0, 128.7, 127.3, 127.2, 126.6, 121.2, 119.7, 79.8, 72.2, 21.7. IR (νmax/cm-1) 3058 (w), 2969
(w), 2853 (w), 1762 (m), 1574 (s), 1481 (s), 1370 (s), 1128 (s), 1070 (s), 760 (s), 697 (s), 525
(s). HRMS (ESI-OTF) m/z calcd for C15H15O [M + H]+ 211.1123, found 211.1119.

Product modification reactions:
Oxidation of isoindoline to isoindolinone.

3-Methyl-6-phenyl-2-tosylisoindolin-1-one (310)
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To a stirred solution of 1-methyl-5-phenyl-2-tosylisoindoline 160f (1 mL) in DCE:H2O 4:1 v/v
at r.t was added NaClO2 (14.9 mg, 0.16 mmol, 3 equiv), the reaction was mixture heated at 65
°C for 24 h. The crude reaction mixture was cooled to rt and quenched with sat. Na2S2O3 (2
mL). The aqueous phase was extracted into DCM (2 × 2mL) and the combined extracts were
washed with brine and dried (Na2SO4). as white solid (12.5 mg, 60%), Mp: 183-186 °C. 1H
NMR (400 MHz, DCl3) δ 8.05 (d, J = 8.3 Hz, 2H, 2ArCH), 7.97 (d, J = 1.8 Hz, 1H, ArCH),
7.86 (dd, J = 8.0, 1.8 Hz, 1H, ArCH), 7.58 – 7.52 (m, 2H, 2ArCH), 7.52 – 7.42 (m, 3H, 3ArCH),
7.38 – 7.36(m, 3ArCH), 5.34 (q, J = 6.5 Hz, 1H, CHCH3), 2.42 (s, 3H, CH3Ts), 1.82 (d, J =
6.5 Hz, 3H, CH3CH). 13C NMR (101 MHz, CDCl3) δ 166.3, 146.1, 145.0, 142.4, 139.4, 136.2,
133.1, 129.6, 129.6, 129.0, 128.2, 128.1, 127.1, 123.1, 122.8, 58.6, 21.6, 21.5. IR (νmax/cm-1).
2951 (w), 2867 (w), 1596 (w), 1453 (w), 1377 (m), 1344 (s), 1160 (s), 1089 (s), 887 (s), 814
(s), 692 (s), 615 (s). HRMS (ESI-OTF) m/z calcd for C22H20O3NS [M + H] + 378.1158 found
378.1158.

Oxidation of isobenzofuran 160a to isobenzofuranone 311

Isobenzofuranones (311 and 311’) were synthesized form isobenzofuran 160a by following
procedure for 310, isolated white solid (23.1 mg, 87%). 1H NMR (400 MHz, CDCl3) (311’)
7.98 (d, J = 8.0 Hz, 1H), 7.78 – 7.71 (m, 1H), 7.67 (s, 1H), 7.60 – 7.53 (m, 2H), 7.54 – 7.39
(m, 3H), 5.37 (s, 2H). δ 8.13 (d, J = 1.7 Hz, 1H), 7.92 (dd, J = 8.0, 1.7 Hz, 1H), 7.65 – 7.58
(m, 2H), 7.57 (dd, J = 8.0, 0.8 Hz 1H), 7.54 – 7.39 (m, 3H), 5.37 (s, 2H). 13C NMR (101 MHz,
CDCl3) (311 & 311’) δ 171.0, 170.9, 147.5, 147.4, 145.2, 142.7, 139.7, 139.4, 133.2, 129.1,
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129.1, 128.6, 128.5, 128.2, 127.5, 127.2, 126.5, 126.1, 124.5, 124.0, 122.4, 120.6, 69.6. proton
NMR data matches the literature..135

Deprotection of the N-Ts group:

1-Methyl-5-phenylisoindoline (312)
CH3
NH
Ph

To an oven dried Schlenk flask was added 1-methyl-5-phenyl-2-tosylisoindoline 160f (20 mg,
0.05 mmol) and powdered Mg (66.6 mg, 2.75 mmol) then the reaction flask was sealed with a
rubber septum. The flask was filled with argon after evacuating under vacuum, then dry THF
(0.36 mL) was added and the reaction mixture was swirled until the starting material appeared
to be dissolved. Followed by addition of dry MeOH (1.1 mL) and resulting reaction mixture
was shaken vigorously before been sonicated for 45 min (sonication was paused roughly every
2 mins for the first 10 mins to shake the reaction flask). The reaction mixture was diluted with
EtOAc and filtered through a pad of celite and the crude residue was concentrated under
reduced pressure. The pale pink coloured liquid obtained was judged requisings to further pure
purification (10.5 mg, 91.2%). (The product decomposed upon purification by column
chromatography). 1H NMR (500 MHz, CDCl3) δ 7.60 – 7.54 (m, 2H, 2ArCH), 7.47 – 7.40 (m,
4H, 4ArCH), 7.36 – 7.30 (m, 1H, ArCH), 7.24 (d, J = 1.1 Hz, 1H, ArCH), 4.48 (d, J = 6.7 Hz,
1H, CHCH3), 4.30 (d, J = 14.2 Hz, 1H, CHA(N)), 4.22 (d, J = 14.2 Hz, 1H, CHB(N)), 1.47 (d,
J = 6.5 Hz, 3H, CH3CH). 13C NMR (126 MHz, CDCl3) δ 145.4, 142.6, 141.3, 140.2, 128.7,
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127.2, 127.1, 126.0, 122.0, 121.1, 58.8, 51.7, 21.5. (HRMS & IR data were not recorded due
to decomposition of isoindoline product 312).

Synthesis of (Z)-N-(but-3-yn-1-yl)-4-methyl-N-(5-phenylpent-2-en-4-yn-1yl)benzenesulfonamide

N-(but-3-yn-1-yl)-4-methylbenzenesulfonamide (315)
The title compound was prepared according to previously reported method.165

NHTs
1H

NMR (500 MHz, CDCl3) δ 7.76 (d, J = 8.4 Hz, 2H), 7.33 (dd, J = 8.6, 0.7 Hz, 2H), 4.81

(t, J = 6.5 Hz, 1H), 3.11 (q, J = 6.5 Hz, 2H), 2.44 (s, 3H), 2.35 (td, J = 6.5, 2.6 Hz, 2H), 2.01
(t, J = 2.6 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 144.1, 137.2, 130.2, 127.5, 80.7, 71.4,
42.0, 22.0, 20.2. NMR data matches literature values.165

(Z)-N-(but-3-yn-1-yl)-4-methyl-N-(5-phenylpent-2-en-4-yn-1-yl)benzenesulfonamide
(316)
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Ph
TsN

A solution of PPh3 (182.6 mg, 0.69mmol, 1.1 equiv), (Z)-5-phenylpent-2-en-4-yn-1-ol 108a
(100 mg, 0.63 mmol, 1 equiv) and N-(but-3-yn-1-yl)-4-methylbenzenesulfonamide 315 (155
mg, 0.69 mmol, 1.1 equiv) in dry THF (3 mL) was allowed to stir for 10 min. The reaction
mixture was cooled to 0 °C then a solution of DIAD (140.8 mg, 0.69 mmol, 1.1 equiv) in THF
(1 mL) was added dropwise. After being stirred for 12 hours at room temperature, water was
added, and the crude residue was extracted in to EtOAc (3x2 mL) and dried Na2SO4. The pure
product was obtained as a colourless oil (160 mg, 70%) after flash column chromatography
using EtOAc:hexane (1.5:8.5); Rf = 0.63 (EtOAc 2:8). 1H NMR (400 MHz, CDCl3) 𝛿 7.74 (d,
J = 8.4 Hz, 2H, 2ArCH), 7.41 – 7.38 (m, 2H, 2ArCH), 7.32 – 7.29 (m, 5H, 5ArCH), 5.85 –
5.83 (m, 2H, =CH), 4.18 (d, J = 5.6, 2H, 2CH(alkene)), 3.37 – 3.33 (m, 2H, CH2(NTs)), 2.55
– 2.50 (m, 2H, CH2(Alkyne)), 2.43 (s, 3H, CH3(Ts)), 1.95 (t, J = 2.8, 1H, alkyne-CH).

13C

NMR (101 MHz, CDCl3) 143.5, 137.0, 136.7, 131.5, 129.8, 128.6, 128.3, 127.2, 122.7, 113.4,
84.5, 80.9, 70.2, 47.3, 46.5, 21.5, 19.2. HRMS (ESI-OTF) m/z calcd for C22H21NO2S [M + Na]
+

386.1191, found 386.1181.

Synthesis of (Z)-2-((5-phenylpent-2-en-4-yn-1-yl)oxy)acetonitrile (320)

To a suspension of NaH (30.3 mg, 0.75 mmol) in THF (1 mL) was added the alcohol 108a in
(100 mg, 0.63 mmol) in (THF 0.5 mL) at 0 °C. After being stirring for 45 min,
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bromoacetonitrile (0.09 mL, 1.26 mmol) was added slowly over 30 min, the reaction was
stirred for 48 h at room temperature. Saturated NH4Cl solution (1 mL) was added to the reaction
mixture, which was stirred for another 20 min, diluted with EtOAc, and washed with water and
brine solution, dried over NaSO4, filtered, and the solvent was evaporated. The resulting oil
was purified by flash column chromatography and was obtained as a pale-yellow liquid (32
mg, 26%). Rf = 0.72 (EtOAc/hexane 2:8); 1H NMR (400 MHz, CDCl3) δ 7.55 – 7.44 (m, 2H,
2ArCH), 7.39 – 7.26 (m, 3H, 3ArCH), 6.08 – 5.94 (m, 2H, 2=CH), 4.48 (d, J = 5.6 Hz, 2H,
CH2(alkene)), 4.28 (s, 2H, CH2(nitrile). 13C NMR (101 MHz, CDCl3) δ 135.6, 131.6, 128.7,
128.4, 122.6, 116.0 (nitrile), 114.6, 96.3, 84.3, 68.6, 55.1. HRMS is not recorded due to Covid19 restrictions, IR. 3034 (m), 2860 (m), 2195 (m), 1614 (m), 1489 (s), 1441(s), 1268 (m), 1097
(s), 885 (s), 755 (s), 690 (s), 527 (s).
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